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1
1. Pain
Classically, pain has been understood from the narrow viewpoint of nociceptive processing. 
However, the feeling of pain is not only a physiological process, but also depends on many 
psychological factors and environmental issues, which will be discussed later in the present 
thesis. Pain has a protective function and activates automatic responses that let us avoid or 
remove damaging stimuli.
1.1. Pain definition
According to the International Association for the Study of Pain (IAPS), pain is defined as 
“an unpleasant sensory and emotional experience, associated with actual or potential 
tissue-damage or described in terms of such damage” [1]. This definition fits into the 
current biopsychosocial approach to health and diseases, assuming that not only biological 
factors, such as genetics and pathophysiology, but also psychological and social factors may 
influence the development, course of disease, and effectiveness of pain treatment. IAPS 
further stated that “pain is always subjective. Each individual learns the application of the 
word through experiences related to injury in early life”.
 Despite the fact that the IAPS definition is generally accepted and seems to be 
satisfactory, paradoxically it does not take into account the behaviour of people suffering 
from it. Moreover, the IAPS definition of pain does not seem to apply to individuals that 
are incapable of self-report (e.g. infants, small children, comatose, demented, mentally 
retarded, or verbally handicapped individuals) [2]. Accordingly, IAPS added a sentence 
to the definition that reads “The inability to communicate verbally does not negate the 
possibility that an individual is experiencing pain and is in need of appropriate pain-relieving 
treatment” (http://www.iasp-pain.org./terms-p.html). Finally, difficulties arise from the fact 
that the IAPS pain definition omits the role of cognition in pain experience.
 The most recent definition of pain was proposed by de Williams and Craig [3]: pain 
is “a distressing experience associated with actual or potential tissue damage with sensory, 
emotional, cognitive, and social components”.
1.2. Types of pain
Two types of pain, acute and chronic, are commonly recognized. Acute pain is a sensation 
that is sudden, short, intense and with predictable time limits. It is a warning signal and has 
a protective function; regardless of the will, it limits the behavioural activity of the subject 
and forces the body to escape from the harmful stimulus. Therefore, the aetiology of acute 
pain is clarified (usually it has one-cause: recent tissue injuries such as a cut, burn or other 
physical injury or disease) and its location is specific. Acute pain may evolve into chronic 
pain [4,5]. In the absence of treatment or ineffective analgesic therapy, persistent acute pain 
might induce pathological changes in individual cells of the nervous system. These changes 
are physio-chemical and transform acute pain into a disruptive and more intense chronic 
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pain. Chronic pain is cyclical and extends beyond the normal recovery time or lasts longer 
than six months. There are numerous types and characteristics of chronic pain but this is not 
a key topic of the present work.
 In the framework of the present thesis, it is important to describe one type of acute 
pain, which is elicited in laboratory conditions by the use of specific devices: experimental 
pain. Experimental pain elicitation allows us to study the psychological aspects of pain (pain 
threshold and tolerance can be carefully measured), which in a clinical setting are more 
difficult to establish. Experimental pain can be induced by various experimental techniques 
that selectively stimulate nociceptive A-delta and C fibres. Examples are intracutaneous 
low current intensity electrical stimulation [6], intraepidermal electrical stimulation [7], 
contact heat stimulation [8], and pulsed IR laser thermal stimulation [9]. However, all these 
techniques are either invasive or expensive. In the present thesis, electric stimulation was 
used. This technique is not selective since non-nociceptive A-β fibres are also co-stimulated; 
however, it is widely used in experimental studies of pain perception [10–12] due to the 
reliability of the method and affordable price of the electric stimulator devices. 
 The physiological nature of experimental pain is akin to acute pain [13]. 
Experimental pain is caused by stimulation with known characteristics and the response 
to their action is the focus of research. In experimental pain, the subject is aware of its 
duration (the subject is acquainted with the test procedure) and most often people under 
experimental conditions are placed in an unnatural environment [13].
1.3. Pain in neurobiological context
Nociception is defined as “the afferent neural activity transmitting sensory information 
about noxious stimuli” [14] and is generally recognised as a cause of pain. However, 
nociception is not synonymous with pain. Nociception may trigger brain response without 
causing a pain sensation [15,16], and non-nociceptive activation may cause the feeling of 
pain. Therefore, pain is a conscious, subjective experience that is most commonly driven by 
nociceptive activity.
 The nociception of pain originates largely from the free nerve ending through 
myelinated A-delta and unmyelinated C-fibres named nociceptors (early pain processing). The 
central integration of the signal comprises spatial summation and temporal transformation 
at the spinal levels, and sensory gating at the thalamic level. Finally, the expression of pain 
perception take places at the cortical level [14,17,18] (see Figure 1).
 Nociceptive stimuli is processed in numerous cortical and subcortical brain 
structures that are designated as the so-called pain matrix [18–24]. In the last decades, 
the pain matrix was reduced to a mere representation of cortical pain [25]. The core of the 
pain matrix constitutes the primary (SI) and secondary (SII) somatosensory cortices, the 
insula (INS), and the anterior cingulate cortex (ACC) [20–24]. Other brain structures also 
have been shown to respond to nociceptive stimuli, e.g. the amygdala, the prefrontal and 
parietal cortices, various parts of the brainstem, and the cerebellum [20,21,25]. However, 
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these structures were often excluded from the pain matrix because in different studies they 
have not been consistently identified as nociceptive specific [20,26].
 The pain matrix is now described as a part of central pain processing that consists 
of the sensory discriminative, affective-motivational network, and cognitive evaluative 
networks [26–28]. In brief, the pain matrix recognises two parallel pathways: the lateral and 
the medial. The lateral (sensory discriminative) pathway includes the ventral posterolateral 
(VPL) thalamic nucleus, SI and SII [29]. The medial (affective-motivational) pathway includes 
the dorsomedial (DM) thalamic nucleus, the INS, the ACC [29], and the dorsolateral prefrontal 
cortex (dlPFC). The latter is known as a component of the cognitive evaluative pain system 
(see Figure 1) [27]. These pathways are associated with top-down (cognitive, motivational 
and affective pain aspects) and bottom up (sensory and discriminatory aspects of stimuli) 
processes [21,30,31]. Information from those subsystems is integrated in the insula [32]. 
There are also afferents from the spinal cord to the pain-mediating areas of the brain stem, 
spinal cord, and descending pain pathways from the cortex, hypothalamus, and brain stem 
to the spinal cord (the descending facilitation and descending inhibition of pain) [33].
 There are studies that support the idea that the pain matrix network is specifically 
involved in the perception of pain. For instance, it has been shown that the neural response 
in the pain matrix highly and positively correlates with perceived intensity of pain stimuli 
[34–37] and is modulated by factors that modulate pain [38,39]. However, recent studies 
have indicated that the cortical activity involved in the generation of pain is not necessarily 
and specifically reflected in the pain matrix [40–43]. A broader array of brain regions are 
more important to the pain experience than those classically included in the pain matrix 
[21,44,45].
Figure 1. Major constituents of the nociceptive system. Note: the arrows represent multiple cortical connections 
between regions and systems; the green rectangle represents one component of the cognitive-evaluative pain 
system (dlPFC); SI - primary somatosensory cortex; SII -secondary somatosensory cortex; ACC - anterior cingulate 
cortex; dlPFC -dorsolateral prefrontal cortex. Modified from Treede [14] and Xie et al. [29]. 
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1.4. Pain in psychological context
Only a few pain theories were developed in the last century and some of them draw attention 
to the importance of psychological and contextual factors in pain experience [46]. In the 
context of the present dissertation, in which the influence of the aforementioned factors 
on pain perception are our main interest, there are four pain theories/models that should 
be discussed: the biopsychosocial model, the gate-control theory, the specificity theory, and 
the three dimensions theory.
 The theory of pain that is gaining increasing acceptance is the biopsychosocial 
model of pain; it is considered to be the most comprehensive theoretical perspective of pain 
[47–50]. The biopsychosocial model of pain, as well as biological factors, takes into account 
the contribution of psychological, social, behavioural, cognitive, and affective factors that 
influence pain perception. According to the biopsychosocial model, pain perceived by an 
individual is not only based on sensory phenomena, but also on the interaction of beliefs 
and appraisals with factors such as emotions, social influences, environmental conditions 
and behavioural responses [51]. Moreover, the biopsychosocial model explains why some 
people may perceive pain without a specific aetiology and others may perceive different 
levels of pain in the same context (e.g. injury and disease). All this makes this model relevant 
for the present dissertation, in which factors that modify pain perception are investigated.
 Another important theory that was built upon the biopsychosocial model and 
that led to extensive recognition of the necessity of the investigation of psychological 
factors in the understanding of pain, is the gate-control theory of pain [46, 52]. This theory 
assumes that there are a mechanisms in the central nervous system that are responsible for 
selection, transformation or suppression of the information flowing from the pain receptors 
(nociceptors) to the cortical areas that are responsible for the conscious reception of pain 
stimuli. In the cells of the spinal cord and in the entire spinal-thalamic system, facilitation or 
inhibition of pain conduction takes place. 
 A “gate” is a certain place in the spinal cord through which each pain pulse can 
be inhibited. Specifically, Melzack and Wall [52] proposed that a gate is localized in the 
substantia gelatinosa (lamina II of dorsal horn of the spinal cord - SG). The gate control 
theory states that an input from non-painful stimuli to the SG closes the gates to painful 
input, which prevents pain sensations from traveling to the brain. Therefore, stimulation by 
non-noxious input, often a cortical descending input, is able to suppress pain. Furthermore, 
inputs from Aβ and Aα fibres, which conduct impulses from mechanoreceptors and 
proprioceptors, will inhibit the processing of inputs from Aδ and C fibres to higher nerve 
centres and hence suppress pain. Therefore, the activation of the gate mechanism consists 
in “closing the exit” of pain impulses from the spinal cord through the activity of other 
neurons. Moreover, Melzack and Wall [52] described the mechanism of central inhibition 
of pain through psychological factors. Fear or anxiety can “open” the gate and contribute to 
the pain response and its development. Distracting attention from the source of pain may 
result in closing the gate, making it impossible or less likely to perceive painful stimuli.
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 The theories presented above are in sharp contrast to the biomedical specificity 
theory that had vast influence through the first half of the 20th century. According to this 
theory, pain is the result of the activation of a specific sensory system and it proposes that 
a specific pain system transmits information from receptors to the brain. In this theory, 
activation of the receptors led invariably to the feeling of pain [14]. 
 This theory does not leave space for the important role of psychological processes 
(emotion, attention, past experience) and cognitive processes in the (study of) perception 
of pain. The main characteristics of this theory were criticised because the relation between 
perception of pain and nociception is variable, for example, sometimes nociceptive stimuli 
do not elicit pain.
 The cortical representation of pain makes it necessary to take into account pain’s 
multiple dimensions. According to Melzack and Casey [53], pain has three dimensions: 
sensory–discriminative (pain intensity), affective–motivational (unpleasantness of pain), 
and cognitive–evaluative. Generally speaking, the sensory–discriminative dimension is 
characterized by the ability to analyse its intensity, location, quality (type and variability) and 
duration, i.e. it quantifies the pain sensation. In turn, the affective–motivational dimension 
determines the unpleasantness of pain and the tendency of the individual to escape from 
the unpleasant experience. This dimension helps to control pain and includes automatic 
emotional and motor reactions. Finally, the cognitive–evaluative dimension concerns 
cognitive processes such as attention and distraction, suggestibility, prior experiences, 
knowledge and cultural values [53]. The cognitive activity, intrapersonal and interpersonal 
factors and social context may influence both the sensory–discriminative and the affective–
motivational dimensions of pain. The sensory–discriminative component of pain has been 
described as the lateral nociceptive system, due to the projection through the lateral 
thalamic nuclei to the SI and SII (see Figure 1). The affective–motivational component of 
pain has been described as the medial nociceptive system due to the projection through the 
medial and intralaminar thalamic nuclei [14].
 Summing up, pain has a multidimensional character whose experience is shaped 
by not only biomedical variables, but also psychological and social ones and responses of 
individuals. This multidimensionality allows us to understand the diverse pain responses of 
individuals to similar conditions. Psychological factors may also have a direct influence on the 
physiological parameters associated with nociception. When investigating pain, researchers 
have to take into account the relationship between all aspects of pain experience (biological, 
psychological, and social) and the way each of these aspects may modulate pain experience 
via descending pathways in the central nervous system.
1.5. Factors influencing pain perception
A wide range of psychological and socio-cultural factors have a modulatory influence on 
pain perception. The most frequently mentioned psychological factors are: personality 
traits, emotional states and traits, cognitive processes (such as attention, anticipation, 
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expectations, catastrophizing, appraisal, reappraisal and perceived control over pain), 
previous and learned pain experiences, the sex of the individual, the sex of the experimenter, 
coping skills, tendency to catastrophize, locus of control, predictability of pain and duration of 
pain [46,47,54,55]. The socio-cultural factors that were shown to influence pain perception 
include gender roles, gender stereotypes, lifestyle, different types of changes over lifetime 
of the individual, and, in the case of clinical pain, and factors related to the disease [56–58]. 
Taking into account the subject of the focus of the present thesis, the most crucial factors 
that were shown to influence pain perception will be discussed. 
1.5.1. Gender of the participants and experimenter
The relation between pain and gender1 is complicated; however, there seems to be 
no debate with regard to whether differences exist [55,59]. The results of laboratory 
studies in which healthy individuals were examined using experimental pain indicate 
unambiguously that some methods are associated with stronger sex effects, and 
electrical stimulation especially produces show the strongest effects [60,61]. Most 
laboratory studies showed that females have a lower pain threshold and a lower 
tolerance to pain compared to males [27,55,59,61]. Under laboratory settings, females 
assess pain as more intense and show more neurophysiological activity compared to 
males [26,62]. Intriguingly, sex differences in the circuitry of different brain structures 
associated with experiencing pain have also been established in fMRI studies [26,63–66].
 The sex of the experimenter is a second factor that may influence the pain threshold 
and pain tolerance. There is some evidence that the way in which subjects perceived pain 
intensity depends on the gender of the person performing the study. However, the results of 
different studies are contradictory. For instance, in the study of Kállai et al. [67], males and 
females experience more pain when the experimenter applying painful stimuli is a female. 
In another study, only males experienced stronger pain when a female experimenter 
examined them. In another study, only males experienced stronger pain when they were 
examined by a female experimenter [68]. In contrast, lower intensity of pain was observed 
in males when the experimenter was a woman while the perception of pain in women was 
not affected by the sex of the experimenter [69]. 
1.5.2. Social context
The example of the social influence on pain originates from studies that investigated how pain 
behaviour of the other person influenced the pain ratings of the observer. It has been shown 
that children who observed their mother indicating a low pain threshold and exaggerating
1   In many research articles, the terms sex and gender are used interchangeably. However, the term sex refers to the biological, hormonal, anatomic 
and physiological differences between women and men, which affect the body’s metabolism and biochemical changes in the brain of each of them 
[255]. The term gender is related with psychological, social, cultural dimensions attributed to a specific anatomical sex. These dimensions affect 
the attitudes, beliefs and perceptions of a person, which determines the way of thinking, behavior and feeling of a woman or man respectively in 
a given environment [256]. The above-mentioned definitions illustrate the complexity of the term “gender” and the variety of consequences that 
may be associated with identifying one of them. In the present thesis we will use both gender and sex interchangeably.
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her display of pain behaviour reported a lower pain threshold than children observing a 
normal pain threshold and non-exaggerating pain behaviour. The composition of the social 
context in terms of gender and the number of people present during the study has also been 
shown to influence pain perception. A decrease in pain ratings was observed only in males 
with an increase in the number of female observers [70]. A recent study indicated that the 
gender of the observers (the sex and the nature of the participant-observer relationship) 
influenced pain as well [71].
 Moreover, the context can influence pain perception via a placebo manipulation; 
this will be discussed in some detail in the following subsection (see Subsection 2.1).
1.5.3. Fear and anxiety and pain perception – definition, influence on pain
The role of negative emotional states such as fear and anxiety on pain perception have 
received considerable attention over the past decade [21,72,73]. However, the proper 
definitional distinction between fear and anxiety requires clarification before taking into 
consideration their influence on pain.
Definition of anxiety and fear
The definitional boundaries between fear and anxiety remain controversial due to the 
conflicting positions that can be found in the literature. Some authors emphasize the 
differences between fear and anxiety [74–79], while others posited that both concepts are 
interchangeable [80,81]. A standard distinction between both emotional states is that fear 
occurs in response to a specific object and anxiety is a trait and does not require a specific 
eliciting stimulus or situation. Fear is an immediate alarming reaction to the presence of 
threat, whereas anxiety is future-oriented and characterized by apprehensive anticipation of 
threat (see below). Despite this, the distinction between fear and anxiety is not historically 
clear [82]; however, a growing body of research across multiple domains has presented 
evidence that fear and anxiety are different emotions [74,76,77,83]. The preponderance 
of evidence suggests that avoidance behaviours (e.g. fight, flight, or freeze responses) are 
specific to fear, not anxiety [83–85]. Fear results from the activation of a motivational system 
responsible for defensive behaviour [78,86,87]. Anxiety motivates hypervigilance (wherein 
the organism exhibits enhanced sensitivity to external stimuli during approach) that is 
elicited when coping attempts fail [83]. Moreover, others posited that anxiety is caused by 
overestimation of threat in ambiguous situations [74,83] and/or inability to avoid fearful 
stimuli [75,83].
 In order to properly interpret the results of our studies that investigated the 
influence of fear and anxiety on pain perception, it is important to differentiate between 
measurements of the trait and state of both emotions. Cattell and Scheier [88] distinguish 
between two types of anxiety: anxiety in the light of the psychology of individual differences, 
a generalized, constant feature of an individual; and anxiety which is a transient state, 
induced situationally. State fear and anxiety are usually induced in experimental conditions 
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and measured by self-reports, whereas trait fear and anxiety are more stable tendencies 
that may be measured by specific questionnaires.
 In the present dissertation, the influence of the trait fear (as measured by the 
Fear of Pain Questionnaire – FPQ-III), trait anxiety (as measured by Pain Anxiety Symptoms 
Scale – PASS) the state fear (measured by self-reported ratings) and experimentally induced 
state fear (fear of movement related pain - FMRP) and state anxiety (contextual pain related 
anxiety - CPRA) on pain perception was investigated.
Influence
Previous studies reported that high levels of fear of pain (trait) increase [89,90] or decrease 
pain [91]. Fear induced by exposure to an electric shock (state) increased the pain threshold 
(resulting in hypoalgesia - decreased pain) [91–94]. In those studies, conditioned fear 
procedures were used where a light was paired with a highly arousing painful electrical shock.
 There are also studies that have examined the effect of experimentally induced 
anxiety (state) on pain perception, and the majority of participants reported enhanced pain 
[95,96]. These results are in accordance with the outcomes of studies in which verbal threat 
of painful stimuli elicited anxiety and resulted in hyperalgesia (pain intensity increase [91]) 
or hypoalgesia [93,96]. Moreover, when pain stimuli application is unpredictable, it elicits 
state anxiety and has been associated with increased pain ratings compared to the condition 
when the pain stimuli application is predictable (this condition elicit state fear) [97].
1.5.4. Attention
The sensory and affective aspects of pain experience are profoundly shaped by attention 
[73,98]. Attention allocates processing resources to relevant external and internal events, 
attenuates physiological and behavioural responses to irrelevant events, and amplifies 
responses to relevant events [54,99].
 Focussed attention [92–94] and distraction [95–100] are two types of down-
regulation strategies (top-down processes) that influence pain perception. Focused 
attention motivates people to directly address the sensory component of pain (e.g. intensity 
or location of the sensation) [100,101], whereas distraction is associated with reorienting 
attention from pain to anther sensation (visual, auditory, or somatosensory), leading to 
cross-modality sensory inhibition [102–107].
 Focussing attention on a nociceptive stimulus may exaggerate pain sensation 
[98,108,109]. These findings are in line with a correlation study in which chronic pain 
patients, who reported greater attention to pain, also exhibited greater pain reports [110]. 
Focussing attention away from nociceptive stimuli locations (either on another task or on 
another perceptual object) reduced pain [98,111–114]. Reduced pain ratings were also 
observed in studies where subjects’ attention was distracted from pain stimuli by cueing 
stimuli [107], visual stimuli [105] and heterotopic cold painful stimuli [104]. Moreover, the 
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direction of spatial attention was shown to modulate event-related potentials produced by 
painful stimuli [104,107,115,116].
 It can be concluded that the effect of focused attention and/or distraction on 
pain is not always straightforward. In general, pain is attention-demanding [98]. The fact 
that attention manipulation modulates pain perception (specifically focussing attention 
exaggerates pain) is crucial to understanding the results obtained in the study presented in 
Chapter 6.
1.6. Pain assessment – behavioural and ERPs measurements
Pain measurements that are usually used in experimental and clinical research may be 
classified as either behavioural (pain scales), psychophysical (e.g. pain threshold and pain 
tolerance) or psychophysiological (e.g. heart rate, respiration rate, ERPs) measurements.
1.6.1. Behavioural measurements
Self-reports require self-awareness and attention; they rely on verbal (Verbal ratings scale 
– VAS) or written reports (Numerical ratings scale – NRS) and capture subjective experience 
of pain. Mostly, the NRS and VAS scales used numbers to represent pain intensity levels 
with anchors from 0 to 10 or from 0 to 100. Usually, a value of 0 is described as ‘no pain 
sensation’ and a value of 10 (or 100) is described as the ‘strongest pain sensation imaginable’. 
However, the description of the highest value differs across studies, for instance: 100 = 
‘worst imaginable pain’ [117,118]; 10 = ‘unbearable pain’ [119]; 10 = ‘maximum imaginable 
pain’ [120]; 10 = ‘worst possible pain’ [121]. There are also scales that allow both painful 
and non-painful stimuli to be investigated at the same time. Such rating scales range from 0 
= ‘no pain, no sensation at all’ to 10 = ‘worst imaginable pain’, with additional anchors at 1 = 
‘just perceived, but not painful’, 2 = ‘clearly perceived, but not painful, warm sensation’, 3 = 
‘slightly painful’, 4 = ‘perceived painful sensation’, 5 = ‘moderately clearly painful’, 6 = ‘highly 
painful, but tolerable’ [117]. It is important to note that pain scores from different scales are 
not necessarily equivalent.
1.6.2. Psychophysical variables
Pain threshold (t) and pain tolerance (T) are classically used as objective variables. Pain 
threshold is a measure of the discriminative aspect of the pain experience, while tolerance 
is a measure more reflective of the affective and motivational aspects of pain [122, p.1695]. 
Pain threshold is a psychophysical measurement that is defined as the first sensation of 
pain that occurs as a result of increasing stimulation intensities. Put into other words, it 
is a particular sensory experience in which the subject distinguishes between stimuli that 
he/she considers non-painful or painful. Pain tolerance is the maximum intensity of pain 
stimuli that a person can withstand. Pain threshold and tolerance are reported in terms of 
a stimulus value (in C, µV, or kg), or the time that a person tolerates a constant, sustained 
stimulus (in s) [122, p.1695]. The pain threshold is more frequently used than pain tolerance 
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because measurement of pain tolerance is associated with significant disadvantages (higher 
variability within and across subjects; highly influenced by past experiences; cannot be 
reached without tissue injury; more stressful for the subjects; welfare and ethical issues) 
[122, p.1695]. The lower the pain threshold and the lower the pain tolerance, the more 
sensitive the person is to painful stimuli.
1.6.3. Psychophysiological variables 
ERPs are commonly used as a direct measure of the response of the brain towards painful 
stimuli [118]. They are frequently used as an objective measurement of pain compared to 
subjective pain ratings [123,124].
 Different techniques have been used to evoke pain-evoked potentials (PREPs): 
somatosensory evoked cortical potentials (SEPs) that follow galvanic painful stimulations, 
electrical or mechanical stimulation; laser evoked potentials (LEPs), and contact heat pain 
evoked potentials (CHEPs). PREPs are characterised by a negative peak around 130–240 
ms poststimulus and a positive peak around 230–390 ms poststimulus [125]. In one of 
our studies presented in this dissertation (Chapter 6), a positive late component of SEPs 
that followed electric painful stimulations (after 250–400 ms – P3 component [126]) was 
investigated. The late somatosensory-evoked brain potentials are not pain specific as they 
vary with demands and task relevance or the saliency of the stimulus and depend on the 
psychological meaning of the stimulus [127,128]. This is why the P3 was investigated in 
our studies when attention was manipulated [126]. The P3 may have two subcomponents: 
P3a and P3b. In contrast  to the P3b, the P3a has a more frontal topography (larger in Cz 
than Pz) and is thought to be an index of involuntary attention allocation to novel, salient, 
and threatening stimuli that appear outside of the attention focus [129–133]. Therefore, 
only the P3a will be investigated in Chapter 6. Other psychophysiological variables, such as 
heart rate and electrodermal activity, which measure reactions to painful stimuli, will not be 
introduced here because they have not been used in the present thesis.
2. Methods of analgesia 
Since ancient times many methods have been proposed to relieve pain, such as invasive 
therapies (surgical operation), drug therapies (anaesthetics), non-invasive strategies (prayer, 
religious meditation, exercise), and palliative care. After surgery, the most important therapy 
against pain was the development of anaesthesia and analgesia. 
 Sometimes drug therapies are not sufficient and other options need to be explored, 
among them psychologically based treatment approaches [134]. Three psychosocial 
interventions are frequently used: cognitive-behavioural therapy, operant behavioural 
therapy, and self-hypnosis training [46].
 The placebo effect is the most known and studied proof of the psychological 
influence on pain perception. While placebo prescription in clinical conditions is highly 
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controversial due to obvious ethical reasons, recent evidence suggests that medical 
providers frequently apply placebo treatments. The topic of placebo analgesia has been 
widely investigated in experimental studies [135–137], but there are still ambiguities and 
unexplored fields. 
 Next to the placebo effect, recent studies have pointed to a new experimental 
method that was strong enough to elicit analgesia: crossing hands over the body midline 
[138,139]. Results of this study demonstrated that the perceived intensity of painful stimuli 
is shaped by how an individual represents her body and space surrounding it. This opens a 
new field of research.
 In summary, the influence of placebo and hand position on pain perception will be 
investigated in the context of experimental pain. In the following subsection, the terms and 
methods that will be used to elicit both placebo analgesia and crossed-hands analgesia will 
be briefly described.
2.1. Analgesia induced by placebo
Considering that placebo is a complicated phenomenon that is difficult to catch in one simple 
definition, in the next paragraph it will be described but not defined. Next, other terms that 
are associated with placebo will be introduced such as the placebo effect, types of placebo 
effect, placebo response, and placebo-related effect. Next, the factors that influence the 
magnitude of placebo analgesia will be introduced.
2.1.1. Definitions
Placebo definition
The term placebo is derived from the stem placebit (lat. it will please) [140] and was used 
for the first time in a medical context in the late 18th century. In this medical context the 
term placebo was used to describe a commonplace method or medicine prescribed for “the 
satisfaction of the patient’s mind” [140,141].
 The conceptualization of the placebo term has been taken up by numerous authors 
since the second half of the 20th century; it has resulted in more than one definition [142]. 
Among the many definitions proposed by placebo researchers, the definition presented 
by Shapiro seems the most adequate: “placebo is any treatment (e.g. drugs, surgery, 
psychotherapy, and fake therapy) that is used for its ameliorative effect on a symptom 
or disease, but that actually is ineffective or is not specifically effective for the condition 
being treated” [142]. However, this definition is criticised as the terms “unspecific” or 
“non-specific” are vague and not helpful in defining the concept of placebo because the 
anaesthesia caused by a placebo exerts a comparable effect on pain as painkillers do [143].
 The term placebo, as used in experimental and clinical studies, may stand for 
specific devices, procedures and treatments, including chirurgical operations [144], or 
psychotherapeutic procedures to induce placebo effects [145]. The treatment effects are 
based on the use of non-specific factors [146], although the inclusion of psychotherapeutic 
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methods [142] in the scope of the placebo concept is not universally accepted [147]. 
Interestingly, a placebo could be a substance that is pharmacologically active (e.g. antibiotics 
used during bacterial inflammation). It is relevant that all the mentioned placebos serve 
in a specific context that seems to be the core of the concept of each particular placebo. 
Therefore, the effectiveness of an intervention, treatment, device, or procedure is affected 
by the context in which it is used (e.g. features of the therapeutic method, characteristics of 
the environment in which the treatment is carried out, patient/participants and physician 
characteristics and characteristics of their relationship) [148]. Benedetti determined the 
influence of context on the effect of treatment when no placebo is administered as a 
placebo-related effect (described later) [149]. Miller and Kaptchuk [150] proposed that the 
placebo effect is actually contextual healing. 
 Summing up, the reasons for difficulties in formulating a uniform definition of 
placebo can be seen in its interdisciplinary character, in the wide range of issues that are 
addressed by the placebo term and in the diversity of forms and procedures of its use. In 
order to be more precise, the context of placebo should be included in the definition of 
placebo.
Placebo effect definition and types of placebo effects 
The word placebo effect was first used in the 1950s [151]. In the publication titled “The 
powerful placebo” Beecher [152] reviewed 1.802 patients’ responses to placebo medications 
across 15 clinical trials. The author reported that the placebo response occurred in 26% to 
58% of participants (with an average of 35%). Despite the fact that Beecher’s work has been 
criticized on methodological grounds [153], the notion that roughly one third of patients 
responds to placebo has since been persistently repeated in medical texts. 
 Most often, the placebo effect is associated with reduction/exaggeration of the 
symptoms or improvement/deterioration of the individual functioning under the influence 
of a placebo. Shapiro and Shapiro [142] defined the placebo effect as “the non-specific 
psychological or psychophysiological therapeutic effect produced by a placebo, but may be 
the effect of a spontaneous improvement attributed to the placebo”. In a clinical context, the 
placebo effect is defined as a “psychological or psychophysiological improvement attributed 
to therapy with an inert substance or a simulated (sham) procedure” [154]. Hróbjartsson [155] 
described three main meanings of the placebo effect: change after a placebo medication, 
the effect of a placebo intervention, and the effect of the patient-provider interaction.
 The definitions of the placebo effect presented above have not explained how 
the placebo effect was estimated. The effect of any precisely defined intervention should 
be evaluated in a specific manner [155]. Accordingly, the most precise definition states 
that the placebo effect is the “difference in outcome between a placebo-treated group 
and an untreated group in an unbiased experiment” [122, p.1836]. Specifically, it can only 
be considered that there was a placebo effect if the group of people receiving a placebo 
treatment experiences a significantly greater therapeutic effect than the group of subjects 
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who have not undergone any treatment procedure. Such a procedure makes it possible 
to show that the therapeutic effect is not the result of factors other than the placebo 
effect, which may include the Hawthorne effect, regression to the average, natural course 
of the disease and spontaneous remission, bias of investigator and subject, low reactivity, 
placebo active ingredients, additional measures taken outside placebo, changes between 
measurements, or low reliability of measurements [156,157].
 Some authors distinguished more different types of placebo effect [158,159]. Hahn 
[158] presents criteria for classifying placebo effects based on expectations (positive or 
negative) and the result obtained (positive or negative). The placebo effect is the result of 
positive expectations and is associated with beneficial (positive) effects of placebo, while 
the nocebo effect is different from the expectations and is negative. The nocebo effect (a 
phenomenon opposite to the placebo effect) is sometimes defined as the negative effects 
of placebo.
 The terms placebo effect and placebo response are sometime used interchangeably, 
but they are different phenomena. The term placebo response (or perceived placebo effect) 
refers to the “change in an individual caused by a placebo manipulation” [122, p.1834]. 
The placebo response refers to “the difference resulting from subtracting the pain ratings 
without placebo/nocebo induction from the pain ratings with placebo/nocebo induction 
at an individual level” [160]. In contrast to a placebo response, the placebo effect is 
determined by the comparison of the effect between a treatment and a non-treatment 
group (statistically ascertained differences at the group level) [160].
 Another term that can be found in the placebo literature is placebo-related effects. 
Placebo-related effects are defined as the effect elicited when no placebo is given. The 
effects are usually attributed to the context of the treatment [149].
Definition of placebo vs nocebo hyperalgesia
Placebo has been found to influence clinical and experimental pain [137,161–164]. Placebo 
analgesia is defined as: “pain reduction that results from a subject’s perception of a 
therapeutic intervention, regardless of whether the intervention is an active or inert agent” 
[122, p. 1833] or as “the reduction or the disappearance of pain, when an inert treatment 
(the placebo) is administered to a subject who is told that it is a painkiller” [122, p.1834]. 
Interestingly, there are also data confirming that placebo may increase the magnitude of 
pain [165]. The nocebo effect for pain is called nocebo hyperalgesia and is defined as an 
increase of pain after administration of placebo (inert treatment) [166,167]. 
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2.1.2. Methods of induction of the placebo effect (procedures used in experimental 
studies)
Three procedures are commonly used in both experimental and clinical studies to elicit 
placebo effects: classical conditioning, verbal suggestions, and social learning. In some 
studies a combination of classical conditioning and verbal suggestion has been used. 
Classical conditioning 
Classical conditioning (associative learning) is a learning procedure first demonstrated 
by Pavlov [168], and fully developed by Wickramasekera [169]. In this context, placebo 
and nocebo effects are a conditioned reaction (CR) resulting from the combination 
of a conditional stimulus (CS, placebo; e.g. colour or shape of the tablet or pill) and an 
unconditional stimulus (UCS, active ingredient in the tablet, electric stimuli) [149,170,171]. 
 More precisely, during the conditioning procedure the placebo stimulus, which is 
initially a neutral stimulus, becomes a CS due to the repetitive association with surreptitiously 
decreased (or increased) intensity of painful stimuli. Painful stimuli are presented as UCS. 
Next, a placebo stimulus (neutral stimulus) is paired with a reduced intensity of the UCS. 
 Classical conditioning, as a method for placebo induction, consists of two phases: 
the conditioning phase described above and the testing phase. In the testing phase, 
participants have to evaluate painful stimulation after the presentation of the placebo 
stimulus, while its intensity is no longer reduced. The conditioning is successful if the subjects 
evaluate the intensity of the UCS in the test phase as weaker than before conditioning took 
place. In turn, nocebo hyperalgesia occurs when placebo (neutral stimulus) is associated 
with stronger pain, and the participants in the testing phase of the experiment assess pain 
after placebo stimuli as stronger. In experimental studies in which conditioning procedures 
have been used, placebo (neutral stimuli) can take various forms, e.g. an inert cream used 
as a painkiller [172–178], saline injections [179–181], an inert capsule, a pill used as a real 
medicine [182–184] or a shame electrode with colour stimuli that are paired with reduction 
or absence of pain [120,185–187].
 There are two ways to conduct a conditioning procedure: hidden and open. In a 
hidden conditioning procedure, the participants are not aware of the relation of CS and UCS 
as they are not informed about their relation, i.e. participants are not provided with any 
expectations of benefit or harm or any information related to the meaning of the cue. In 
an open conditioning procedure, the participants are informed about the relation between 
placebo (CS) and the active substance or procedure (UCS). There are studies in which both 
hidden and open conditioning procedures were used to induce placebo or nocebo effects 
[178,188–190]. Those studies showed that hidden conditioning produced a significant 
placebo effect [178,189,190], whereas open conditioning elicited a smaller or no effect 
[178,188–190]. In one of the cited studies, the expectancy was shown to predict placebo 
analgesia [190]. However, this finding was based on the results across all participants, 
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without distinguishing between the hidden and open conditioning groups. In accordance to 
this fact, the role of expectancy in elicitation of placebo effect should be further investigated.
 Recently, the number of studies investigating nocebo hyperalgesia has increased. 
There is evidence that placebo mechanisms can also amplify pain [166,186,191–194] 
suggesting that both placebo analgesia and nocebo hyperalgesia result from the same 
general learning mechanisms. Nocebo hyperalgesia was shown to be more readily induced 
by verbal instruction than placebo analgesia [186]. However, to date, no study has induced 
nocebo hyperalgesia via conditioning without verbal suggestion. Therefore, it remains 
unclear whether conditioning alone, next to verbal suggestion alone and conditioning 
combined with verbal suggestion, can induce the formation of nocebo hyperalgesia. 
 In contrast to other methods of placebo induction (e.g. verbal suggestion [195–
197], discussed in next paragraph), the impact of fear (trait) of pain in the formation of 
both types of placebo effect via hidden conditioning is unknown and should be explored in 
order to interpret and understand the large variability in placebo effect and hence estimate 
it better in laboratory conditions. Moreover, collecting of fear self-reports (state) during 
experimental trials is not a common procedure in placebo studies. In one such study, the 
placebo analgesia elicited by conditioning was shown to be related to reduction of fear of 
pain (state) [190]. The role of self-reported fear on formation of nocebo hyperalgesia is still 
unknown.
 To conclude, based on these previous results it is hypothesized that hidden 
conditioning compared to open conditioning will be more effective in inducing a placebo 
effect. 
Verbal suggestions
Placebo effects can also be obtained by the use of verbal suggestion about the effect of the 
treatment. In order to elicit placebo analgesia, a placebo (inert treatment such as cream, 
capsules, saline injection, or shame electrode) is given along with verbal suggestions of 
improvement, decrease, and/or reduction of pain [120,149,191,198]. Likewise, to obtain 
nocebo hyperalgesia, a placebo is given along with verbal suggestions of worsening and/or 
increasing of pain sensations [149,191]. In both cases, the participants are not aware that 
the placebo used is inert, and in the case of experimental studies, they are not aware that 
the pain stimuli they receive have the same intensity. 
 Placebo analgesia induced by verbal suggestion was broadly investigated 
[120,173,199–201,178,181,184,190,195–198]. However, only some of the cited studies 
investigated the emotional factors that have an influence on the magnitude of the placebo 
effect [195–197,200,201]. Research of the influence of state fear and state anxiety (self-
reports) in the case of placebo effect induced by verbal suggestion is rare and the obtained 
results offer unclear conclusions. For instance, there is a study [197] in which experimentally 
induced fear understood as a state was shown to eliminate placebo effects induced by verbal 
suggestions. However, it is unclear whether the authors were measuring self-reported fear 
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or anxiety. A common method to induce fear involves a fear-conditioning procedure [84] 
and an experimental procedure that uses the threat of shock (as in study [197]) is usually 
used to elicit anxiety [91]. In other placebo studies [202–204] self-reported anxiety (state) 
was collected after analgesic suggestion about the use of a potentiate painkiller. The authors 
indicated that participants who showed decreased state anxiety during the placebo session 
had better pain tolerance than those who experienced increased anxiety [202,203]. Also, 
in more recent studies [204,205] decreased level of anxiety (state) was shown to be central 
for the placebo effect to occur. Although the above-mentioned authors usually use either 
the term ‘fear’ or ‘anxiety’ [190,197], it seems that anxiety is treated as a synonym of 
fear rather than a different psychological phenomenon. Consequently, it is not clear what 
actually influences placebo effects: fear, anxiety, or both. In general, according to the results 
of previous studies, it is accepted that the analgesic placebo effect is associated with a 
reduction in the state anxiety level [202–205].
 Concluding, verbal suggestion is a less complicated method of eliciting the placebo 
effect. In Chapter 5, in the context of a new paradigm that is used to explore placebo 
phenomenon (see paragraph 4.2; investigating influence of experimentally induced state 
fear and state anxiety), the effect of verbal suggestion will be investigated.
Conditioning with verbal suggestion
Crucially, some authors used procedures in which conditioning was combined with verbal 
suggestion in order to elicit placebo or nocebo effects [172–174,178,187]. It is the most 
effective method to elicit a placebo effect compared to either conditioning or verbal 
suggestions alone [187,198,206]. A verbal suggestion that conflicts with the information 
about the effect of UCS is shown to reduce the size of the placebo response [183,206]. 
Moreover, verbal suggestions can completely abolish the effect of conditioning [206]. 
Clinical trials have shown that different analgesic effects were obtained when using different 
verbal instructions about certain and uncertain expectations of analgesia. As a result of such 
suggestions, a dramatic change of behaviour has been observed (reduction of opiate intake) 
[207–209].
Social learning
Learning can take place by observing a behaviour and the consequences of this behaviour 
of others; this phenomenon is called social learning, observational learning or modelling 
[210]. In the context studies of placebo effects, social learning was introduced for the first 
time by Colloca and Benedetti [120]. The core of modelling in experimental studies is the 
process of learning through the observation of the pain behaviour of another person (the 
model) and association of a placebo with less intense pain stimuli. The model that presents 
pain behaviour is an experimenter helper who can be observed in reality [120,211,212] or in 
a video presented on a TV screen [213,214]. The model always rated stimuli that are paired 
with placebo stimuli as non-painful. After the modelling phase, the participant undergoes 
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the same procedure as was presented to the model, but he/she is not aware of receiving 
the same intensity of painful stimuli after all the placebo and no-placebo stimuli. A placebo 
effect would be elicited if the participant gave lower pain ratings to the stimuli preceded by 
placebo stimuli (cues). The nocebo effect would be elicited if the participant gave higher 
pain ratings to the stimuli preceded by placebo stimuli.
 At the time of writing of this dissertation, the only investigated factor that has 
been shown to have an effect on placebo analgesia induced by social learning was empathy 
[120]. Personality traits, such as pain anxiety and fear of pain, are shown to influence an 
individual’s response to pain [89–91,215] and their response to placebo analgesic treatment 
[195,197,215–217]. Precisely, the results of the study by Staats et al. [215] indicated that 
participants that scored high in pain-anxiety questionnaires (trait anxiety) demonstrated 
the highest response to placebo and nocebo intervention. Moreover, high levels of fear 
of pain (trait) are shown to decrease placebo analgesia induced by verbal suggestion 
[195,197,216,217]. It is still unknown whether both trait anxiety and trait fear have an 
analogous influence on placebo effect induced by observational learning.
It is concluded that social learning can be effective in inducing a placebo effect and that 
future studies should investigate factors such as anxiety and fear (both understood as traits) 
that might have an influence on the magnitude of the placebo effect. The effects of these two 
emotions on the placebo effect induced by social learning will be investigated in Chapter 3.
2.2. Analgesia induced by changing body position
A new method of inducing analgesia – crossed-hands analgesia (crossing hands over the 
body midline) – has been shown to decrease pain sensations elicited by tactile electric 
[138], painful laser [138] and mechanical painful stimuli [139]. Clinical studies also indicate 
that spontaneous pain in complex regional pain syndrome (CRPS) patients can be reduced 
when patents keep their hands crossed [218].
2.2.1. Definition of crossed-hands analgesia
Crossed-hands analgesia, a term that was firstly used by Gallace et al. [138], implies  that 
non-nociceptive and nociceptive stimuli, when applied to the crossed hands, are perceived 
as less intense and elicit smaller event-related potentials (ERPs).
2.2.2. Methods of induction of crossed-hands analgesia
Painful and non-painful stimuli to the right and left hand kept in either an uncrossed or 
crossed position are differently perceived, as found by pain ratings and by ERPs [138]. In 
another study in which hand position was manipulated, the authors contradicted the original 
findings of Gallace et al. [138], and concluded that vision is critical in eliciting crossed-hands 
analgesia [219]. It is also unknown if placebo analgesia will be elicited in a procedure in 
which the spatial side to which pain is delivered is known to the participant (manipulation of 
the attention focus). A design in which participants’ attentional focus is manipulated seems 
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to be closer to real medical treatment conditions in which, for instance, an injection or other 
painful procedure will be applied.
3. Mechanisms of analgesia
After the description of the methods of analgesia induction, the mechanisms that underlay 
both placebo and crossed-hands analgesia will be discussed. The mechanisms underlying 
the placebo effect can be discussed from either psychological or neurobiological points of 
view. Here we will focus only on the psychological mechanisms of placebo, and only give 
some references to neurobiological [135,220,221] and molecular [222] studies.
3.1. Mechanisms of placebo analgesia
Neurobiological studies emphasize that endogenous opioids and placebo analgesia share a 
common neural mechanism [223,224]. Pharmacological studies indicate that a descending 
modulatory circuit (descending rACC, PAG, RVM) is involved in placebo analgesia. Importantly, 
the same system is involved in activation of endogenous opioids [135,220,221,225].
 According to the psychological viewpoint, a multitude of mechanisms have been 
shown to contribute to placebo effects, among others learning, e.g. classical conditioning 
[169,226,227], and expectations [149,170,171]. The relation between these two mechanisms 
has been extensively debated [228–230]. Some researchers felt that they are independent 
mechanisms and therefore tested classical conditioning and expectancy separately [226], 
or were considered as competing perspectives [172,173,186,231]. Others proposed that 
expectations play a mediating role in the formation of placebo responses induced by 
conditioning and verbal suggestion [170,171,228,232], or conditioning and expectations are 
suggested to be two dimensions of the same process [206].
3.1.1. The expectancy model
There are two concepts that describe expectations as the placebo mechanism: the 
response expectation theory as described by Kirsch [229,230] and the model proposed by 
Colloca and Miller [228,233]. The concept of expectations appeared relatively late in the 
placebo literature and replaced the terms “faith” and “hope”. Expectancy (or expectation) 
is understood to mean a “conscious, conceptual belief about the future occurrence of an 
event” [234]. 
 According to Kirsch’s theory [229,230], response expectations are automatic 
and concern the predictions of individual, involuntary reaction in response to a given 
situation and behaviour. The response expectancy can be raised from explicit (suggestion 
of positive or negative effects of the placebo) or implicit (individual experience of an 
individual) processes. The acquisition and change of expectations may occur through verbal 
suggestions, conditioning and social learning. The effect that is produced by the placebo 
treatment depends on the compliance of expectations with the results of an active method. 
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Basically, the response expectancy produces the corresponding effect, i.e. the placebo or 
nocebo effect. The effects of response expectations are present in psychological changes 
(changes in subjective experience such as changes in pain perception) that correspond to 
expectations and in physiological states that are consistent with changes in the subjective 
experience. Moreover, Kirsch [235] suggests that conditioning can be an automatic process 
that is not mediated by expectations, however this topic needs further investigations (one 
of the aims of the present work). 
 According to the Colloca and Miller’s learning model [228,233], the placebo 
effect arises from the processing of psychosocial signals or/and a set of signals from the 
surrounding environment. The methods of placebo induction are conditioning, verbal 
suggestion, and social learning, and all three methods elicit expectations and influence 
pain perception. Placebo (e.g. injections, sugar tablets, procedures, materials used, context, 
verbal instructions, and previous experience) is defined as a signal and/or a set of signals 
that gives crucial information, which is further processed and generates expectations. In this 
model, learning and its associated mechanisms are the key mediators of expectations and 
placebo responses.
 The concepts presented above point to the conclusion that verbal suggestions 
should act through expectations. However, there are relatively few studies in which a 
placebo effect was triggered via verbal suggestions only [120,174,178,181,184]. In the 
mentioned studies, the measurement of expectation was not provided. Only in the study of 
Bąbel [236] were the participants’ expectations measured, which clearly demonstrated the 
influence of expectancy on nocebo hyperalgesia. Therefore, the exact role of expectations in 
the induction of placebo analgesia in the case of verbal suggestion cannot be unequivocally 
confirmed.
 Considering the approach of Kirsch [229,230], conditioning is the process by which 
expectations are formed. Rescorla [237] also pointed out that the process of learning through 
conditioning does not exclude cognitive processes, because learning does not depend only on 
the evaporation of the conditioned and unconditional stimulus, but also on the information 
about the unconditional stimulus provided by the conditional stimulus. Therefore, it 
seems that expectations and conditioning are neither opposite nor independent processes 
[238,239]. Importantly, in order to clearly determine whether expectations fulfil a mediating 
role in the placebo effect induced by conditioning, a measurement of expectations is needed. 
Measurement of expectations has been provided in studies where classical conditioning 
with verbal suggestion was used [170,173,176,178,190,199,232,240,241] and in studies 
were placebo analgesia was induced via a conditioning procedure without additional verbal 
suggestion regarding the analgesic effect of a placebo [173,178,190]. Some of those studies 
have clearly demonstrated that a placebo effect induced via a conditioning procedure is 
mediated by expectancy [170,175,178,232]. Additional evidence that conditioning does not 
directly affect changes in pain perception comes from studies in which the participants were 
unaware of the link between placebo and pain during the conditioning procedure and, as a 
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result of such a procedure, the conditioning did not cause changes in the perception of pain 
[178,242,243]. The final argument is that the size of the placebo effect appears to depend 
on the strength of the expectations, not on the way they are generated [176,178,181,199].
 It is also proposed that social learning is a process involved in the acquisition and 
modification of a mechanism that produces placebo effects, i.e., response expectancy 
[230]. This idea is in line with Bandura’s social learning theory [210], which postulates that 
observational learning results in the acquisition and modification of expectations. Social 
learning has also been suggested as an explanatory mechanism for placebo effects [244]. 
However, it is still unclear if the process of social learning is a separate mechanism of 
placebo induction in which social information acts as a conditional cue, or whether the 
obtained effect is mediated by expectations. Until now, only the Koban and Wager study 
[245], attempted to answer this question. Their results showed that the effect of social 
information and the use of a visual cue itself related to the strength of the pain stimuli 
applied (strong vs weak) both have an effect on expectations, pain assessments and pain-
related skin and galvanic reactions. So, social learning seems to work through modification 
of expectations.
3.1.2. Conditioning and expectancy: two dimensions of the same process
Benedetti et al. [206] proposed that conditioning and expectancy may be two dimensions 
of the same process. Depending on the circumstances and involvement of the nervous 
system, the placebo effect may arise with or without the involvement of conscious cognitive 
processes. Many processes occurring in our body proceed without consciousness. Hormonal 
and immune response are the best example of this. Benedetti et al. [206] indicated that 
expectations induced by verbal suggestion did not affect the secretion of hormones, but they 
had an effect on pain perception and mobility. Therefore, it appears that the placebo effect 
is mediated by conditioning when unconscious physiological functions such as hormone 
secretion are involved or are mediated by expectations during psychological processes (pain 
perception).
3.2. Mechanisms of the crossed-hands analgesia
Crossing hands confuses the mind [246]. Results obtained in a crossed-hands analgesia study 
[138] found that crossing the hands over the body midline has no influence on the early 
components of ERPs that reflect sensory-specific elaboration (N1), whereas the later ones 
(the N2–P2 complex) that reflect multimodal processing and awareness of a somatosensory 
stimulus were reduced [15,43,247,248]. Consequently, crossed-hands analgesia was 
suggested to be mediated by a disruption of higher-order multimodal area activity. In 
their next study the authors used fMRI to identify the neural correlates of crossed-hands 
analgesia [139]. It was confirmed that crossed-hands analgesia was indeed mediated by 
multimodal areas (e.g. the posterior parietal, cingulate, and insular cortices). The authors 
suggested that the analgesic effect is a result of a mismatch between the somatosensory and 
GENERAL INTRODUCTION 35
1
body-centred frame of reference onto which somatosensory stimuli are mapped [138,139]. 
This explanation indicates that painful and tactile [249] stimuli perception is disturbed by 
crossing the hands; thus, crossing the hands results in decreasing the accuracy of locating 
both stimuli (identification of which hand was stimulated). This demonstrates that pain 
stimuli are not localized solely based on somatotopic references, relying on a somatotopic 
representation of the hand, but also by its spatial location. 
 In the study of Gallace et al. [138] the side of subsequent stimuli application was 
unknown to participants. Taking into account the influence of attention on pain perception 
(see paragraph 1.5.4), indicating the spatial location of the subsequent stimuli application 
(e.g. use of a cue that points to the location of the stimulus) may influence the formation of 
crossed-hands analgesia and modulate the late SEP components that are characteristic not 
only for pain but also for cognitive/attention modulation – P3 component. 
 To conclude, the mechanism of crossed-hands analgesia is well documented. 
However, it is still unknown if manipulation of attention may influence formation of crossed-
hands analgesia and how such manipulation modulates the P3 component. Therefore, in 
Chapter 6 we will investigate the role of attention manipulation in crossed-hands analgesia. 
4. Experimental paradigms used in present thesis
4.1. The colour paradigm
In the present thesis, the colour paradigm was used in order to elicit a placebo effect. Such a 
paradigm has successfully been used in previous placebo studies [120,213]. However, there 
are some differences that make our paradigm unique. In contrast to our design, in the Colloca 
and Benedetti study [120] an inactive electrode served as the placebo. In order to elicit 
a placebo effect the authors used an additional verbal suggestion that made participants 
believe that presentation of a green light was associated with the activation of the placebo 
electrode and subsequent application of a lower level of pain. In the present dissertation 
(Chapter 2–5) the colour of the light was the only analgesic placebo. No other intervention 
was used since the objective was to investigate simple conditioning and social learning 
without explicit verbal suggestions and to apply an analogous procedure in the study in 
which verbal suggestion was used to elicit a placebo effect. Moreover, such a version of the 
colour paradigm prevented confusion of visual stimuli with any other intervention used as 
placebos (e.g. sham electrode).
4.2. The modified voluntary joystick movement paradigm (VJMP)
VJMP is a paradigm proposed by Meulders et al. [97,250] that is used in healthy subjects to 
investigate the process of maintenance of chronic musculoskeletal pain (fear of movement 
conditioning) (for review see [251,252]). For ethical reasons it is difficult or even impossible 
to investigate placebo analgesia induced by verbal suggestion in the context of chronic 
pain. An adjustment of the experimental paradigm needs be made that will successfully 
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fulfil this attempt and, in the future, this will allow all three methods used to elicit the 
placebo effect to be investigated. Modification of VJMP may allow aspects of chronic pain 
maintenance (fear of movement conditioning) to be investigated in the context of a placebo 
study. Therefore, in the present dissertation (Chapter 5) we combined VJMP with the colour 
paradigm to investigate placebo effect induced by verbal suggestion.
 In VJMP, the participants are asked to move the joystick in two conditions. In the 
first condition the joystick movements are used as a conditioned stimulus (CS) and a painful 
electrocutaneous stimulus as an unconditioned stimulus (US) [250]. 
 One of the movement directions (CS+), but not the other (CS-), is always followed 
by the presentation of painful stimuli. In this experimental condition (the predictable pain 
condition - PC), the application of the stimuli may be predicted by the participants. In the 
control condition, the pain stimulation is never associated with the joystick movement 
but appears during the intertrial interval (ITI) which is unknown to the participant. In this 
second experimental condition, participants cannot predict the application of pain stimuli. 
Crucially, such a study design leads to elicitation of two emotional states: conditioned fear 
of movement-related pain (FMRP) in the predictable condition and contextual pain-related 
anxiety (CPRA) in the unpredictable pain condition.
 In the present thesis, the VJMP was adjusted in order to examine the placebo 
effect induced by verbal suggestion in the two different emotional states: FMRP and CPRA 
(Chapter 5). Implementing such a paradigm is an attempt to clearly differentiate between 
the influence on placebo effects of state fear and state anxiety. Moreover, as well as 
behavioural measurements (pain intensity, fear of pain, expectancy of pain intensity scores), 
the modified VMJP allowed us to use electromyography (EMG) to measure the physiological 
reaction of the startle reflex. The startle reflex is an orienting reaction that occurs in response 
to a sudden and intense event like a burst of white noise[253]. Startle reflexes are shown to 
be increased when an individual is in a state of fear [254].
4.3. The crossed hands paradigm
In the present thesis (Chapter 6) we used a modified version of the crossed hands 
paradigm that was previously used by Gallace et al. [138] in order to investigate crossed-
hands analgesia. In contrary to the study of Gallace et al. [138], along with manipulation 
of the position of the hands (crossed and uncrossed hand condition), transient attention 
manipulation was used. More precisely, visual cues (congruent cues) were used to announce 
the side of the spatial location of the subsequent pain or non-painful stimuli. The role of the 
cues was to change, trial by trial, the focus participant’s attention to the left or right spatial 
location (transient attention manipulation). Moreover, in order to investigate the role of 
attention, next to congruent cues, incongruent cues were used that wrongly announced the 
spatial location of the stimuli. Such a modification allowed us to investigate if crossed-hands 
analgesia may be elicited in an attention manipulation condition.
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5. The main questions of the thesis - aims
5.1. Social learning as a method of placebo induction
Social learning is the least investigated placebo induction method. Before the simultaneous 
publication of our study [212] and the study of Vögtle et al. [214], placebo analgesia induced 
via observation of pain behaviour of another person had only been investigated once 
[120]. However, in their study no control group was included which could have determined 
whether placebo analgesia or nocebo hyperalgesia was elicited. In Chapter 2, the social 
learning procedure includes a control group and hence answers the question regarding the 
type of placebo effect that can be induced via social learning by comparing pain ratings after 
placebo and non-placebo stimuli in the experimental group, with NRS ratings associated 
with green and red stimuli in the control group.
 In the light of social learning theory [210], the behaviour and features of the model 
appear to be significant. However, the social context, which has been shown to influence pain 
perception (see 1.5.2), and the similarity, or lack thereof, observed by the respondents (e.g. 
the compatibility of the sex of the subjects and the model or the lack of such compliance) 
may result in differences in the magnitude of placebo analgesia or may contribute to its 
non-occurrence. Therefore, factors that can have a putative influence on the formation and 
magnitude of placebo analgesia induced by observational learning (the sex of participants, 
the sex of the model and empathy level) will be investigated in Chapter 2 as well. 
 It is hypothesized that the magnitude of the placebo effect will be stronger in 
females than in male participants. It is also speculated that female participants will display 
a larger placebo effect after observing a male model and, in the case of male participants, 
the placebo effect will be stronger after observing a female model. Finally, it is hypothesized 
that empathy level will be a significant positive predictor of the magnitude of the placebo 
effect induced by observational learning.
 Studies on the placebo effect induced by social learning used the colour paradigm 
(see 4.1). However, the colours of light stimuli associated with weaker and stronger pain 
sensation were not counterbalanced in the previous studies, and in some of these studies 
no control group was included [120]. Therefore, in Chapter 3 the possibility that the colour 
of light stimuli might have biased the results of the study presented in Chapter 2 will 
be investigated. Moreover, factors such as trait fear and trait anxiety, both of which are 
previously shown to influence pain and the placebo effect, will be investigated in the context 
of the social learning method. 
 It is hypothesized that the type of placebo stimuli would not have an influence 
on the magnitude of the placebo effect and that trait fear and anxiety will be negatively 
correlated with the induced placebo effect.
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5.2. Hidden and open conditioning as a method of placebo induction
The role of expectancy and fear (state) in placebo- and nocebo-induced analgesia by hidden 
conditioning will be investigated, thereby excluding the role of verbal suggestions. In the first 
study of Chapter 4, placebo analgesia and nocebo hyperalgesia will be induced via hidden 
conditioning. It is expected that both placebo and nocebo effects will be induced by hidden 
conditioning and that fear (state) will predict the magnitude of the placebo effect. It is also 
hypothesized that the placebo effect induced by hidden conditioning might not necessarily 
be mediated by expectancy. 
 In the second experiment, the role of expectancy on pain intensity modulation 
in both hidden and open conditioning methods will be compared in order to disentangle 
conditioning and expectancy effects. Next, the role of fear as a trait and state in placebo 
effects induced by both hidden and open conditioning will be investigated. It is expected 
that in contrast to open conditioning, hidden conditioning will induce the placebo effect. 
It is also hypothesized that the placebo effect induced by hidden conditioning may not 
necessarily be mediated by expectancy. It is also expected that fear (state and trait) will 
predict the magnitude of the placebo effect induced via hidden conditioning.
5.3. Verbal suggestion as a method of placebo induction
Verbal suggestion as a method of placebo effect induction has been successfully used in 
experimental and clinical studies (see 2.1.2). In Chapter 5 placebo analgesia induced by 
verbal suggestion will be investigated in the context of a modified VJMP (see 4.2). In VJMP, 
two emotional states are experimentally elicited: fear of movement-related pain (FMRP) in 
a predictable pain condition and contextual pain-related anxiety (CPRA) in an unpredictable 
pain condition. Both emotional states may lead to differences in the magnitude of the 
placebo effect. Moreover, the placebo effect induced by verbal suggestion is expected to be 
mediated by expectancy (see 3.1.1), so presumably it could also be observed in the case of 
placebo analgesia induced in the context of a modified VJMP.
 It is hypothesized that in both experimental conditions placebo analgesia will be 
induced via verbal suggestions and that the magnitude of the placebo effect will be lower 
in the unpredictable condition. Moreover, the role of expectancy in the formation of the 
placebo effect induced by verbal suggestion in the predictable condition will be investigated. 
It is hypothesized that expectations will predict the magnitude of placebo analgesia.
5.4. Crossed-hands analgesia
Crossing the hands over the body midline may result in pain reduction and a decrease of 
the amplitude of the P2–N2 ERP components [138]. Here it is investigated whether and 
how focussed attention, known to increase the pain ratings [108,109]), modulates the pain 
response in the crossed hand paradigm. Attention will be manipulated from trial to trial. As 
well as the behavioural response, the ERPs of the painful and non-painful stimuli in various 
experimental conditions will be collected (e.g. attended and unattended, with and without 
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crossed hands). In Chapter 6, crossed-hands analgesia will be investigated in the context of 
transient attention manipulation.
 It is first hypothesised that in the crossed hands condition, pain ratings will be 
lower compared to the uncrossed hands condition. Regarding the role of transient spatial 
attention, it is hypothesised that pain ratings will be higher in the condition in which the 
stimulus location is correctly signalled (congruent cueing condition) as compared to the 
condition in which the stimulus location is incorrectly signalled (incongruent cueing 
condition). Moreover, it is suggested that higher NRS pain ratings will occur after congruent 
cues than after incongruent cues, specifically in the uncrossed hands condition. Regarding 
the ERPs, more specifically the P3 that is elicited by painful and non-painful stimuli in the 
two positions (crossed and uncrossed hands), it is expected that the amplitude of the P3 will 
be higher and will be more delayed by incongruently cued stimuli than by congruently cued 
stimuli. Moreover, the amplitude of the P3 will be lower in the crossed hands condition due 
to a mismatch between the internal and external frame of reference.
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Abstract
Research shows that placebo analgesia can be induced through social observational 
learning. Our aim was to replicate and extend this result by studying the effect of the sex 
of both the model and the participant on the magnitude of placebo analgesia induced 
by social observational learning. Four experimental (1 through 4) and 2 control (5 and 6) 
groups were observed: groups 1, 3, and 5 were female; groups 2, 4, and 6 were male. All 
participants received pain stimuli of the same intensity preceded by green and red lights. 
Before receiving pain stimuli, groups 1 and 4 observed a female model and groups 2 and 
3 a male model; both models simulated responses to pain stimuli preceded by green 
lights as less painful than those preceded by red lights. Groups 1 through 4 also rated 
pain stimuli preceded by green lights as less painful. Further investigation revealed that 
in fact participants in experimental groups rated red-associated stimuli as more painful 
than participants from control groups who did not observe a model before receiving the 
same pain stimuli, indicating that nocebo hyperalgesia rather than placebo analgesia was 
induced. Empathy traits predicted the magnitude of nocebo hyperalgesia. Regardless of the 
sex of the participant, nocebo hyperalgesia was greater after the male model was observed. 
The results show that social observational learning is a mechanism that produces placebo 
effects. They also indicate that the sex of the model plays an important role in this process.
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Introduction
Two main mechanisms that produce placebo effects have been proposed: classical 
conditioning [1,41,47] and expectancy [13,28,29]. These 2 mechanisms can be seen 
as compatible rather than mutually exclusive [11,43]. From this point of view, classical 
conditioning is one of the means by which expectations are acquired and modified, i.e. the 
effects of conditioning are mediated by expectancy [28,29,32]. Studies on this topic indicate 
that conditioning can also produce placebo effects without the mediation of expectancy 
[2,11] and can enhance placebo effects that are induced through verbal information 
[2,10,11,17,32,35]. In brief, conditioning can change expectations and therefore produce 
placebo effects. 
 Kirsch [28] has highlighted that, among other processes (including conditioning and 
verbal persuasion), modeling is involved in the acquisition and modification of expectancy. 
Bootzin and Caspi [12] have suggested that social learning is one of the explanatory 
mechanisms for placebo effects. However, Colloca and Benedetti [16] are the first and the 
only researchers to prove that placebo analgesia can be induced by social observational 
learning and that it is positively correlated with empathic concern. Moreover, they have 
shown that the magnitude of the placebo effect induced by social observational learning is 
similar to the magnitude of the placebo effect produced by verbal suggestions and classical 
conditioning and is significantly bigger than the effect induced by verbal suggestions alone.
 According to Bandura’s social learning theory [6], the characteristics of the model 
affect the effectiveness of social learning. Among these characteristics, the sex of the model 
seems to be crucial. Several classic studies prove that male subjects are more prone to imitate 
the behaviors of male models and likewise that female participants are more likely to imitate 
female models [5,14]. Moreover, research on the effect of sex on placebo analgesia shows 
that placebo analgesia is more often observed in male [3,15,20] than in female participants 
[40]. The sex of the participant is also an important factor affecting pain perception, with 
female participants displaying greater sensitivity to pain [19,31,34,36]. More importantly, it 
has been shown that male participants report less pain to female experimenters than they 
do to male experimenters, but the sex of the experimenter has no effect on pain reports in 
female participants [4,21,30]. However, there is also some evidence showing that both male 
and female participants report more pain when they are tested by a female experimenter 
and less pain when they are tested by a male experimenter [26]. 
 Because sex seems to be an important factor that affects pain perception, placebo 
analgesia, and social observational learning, we aimed to study the effect of the sex of both 
the model and the participant on placebo analgesia induced through social observational 
learning. Second, we wanted to replicate the analgesic placebo effect induced by social 
observational learning discovered by Colloca and Benedetti [16] but by using a modified 
methodology. The third goal of our experiment was to study the effect of the colour of light 
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stimuli on pain ratings, i.e. we wanted to control for whether the green light would produce 
an analgesic effect without prior social observation.
Materials and methods
Participants
A total of 84 volunteers participated in the study. They were randomly assigned to 6 groups, 
4 experimental groups (1 through 4) and 2 control groups (5 and 6). Groups 1 through 4 
consisted of 15 participants, and groups 5 and 6 consisted of 12 participants. Groups 1, 
3, and 5 consisted only of female participants, and groups 2, 4, and 6 consisted only of 
male participants (see Table 1). All of the participants were healthy; no one had any kind 
of disease or was taking any medication. They were informed that they were participating 
in a study on pain mechanisms and that they would receive 16 electrical pain stimuli. They 
were also informed that they could stop participating at any point during the study without 
giving a reason. The participants gave their informed written consent to participate in the 
experiment. At the end of the study, all of the participants were fully debriefed, especially 
those in groups 1 through 4, who had been deceptively informed that a person they would 
observe (a model) was one of the participants of the study. The study protocol was approved 
by the Research Ethics Committee at the Institute of Psychology of Jagiellonian University.
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Stimuli
The pain stimuli were electric shocks delivered to the inner side of the non-dominant forearm 
through 2 durable stainless steel disk electrodes 8mm in diameter with 30mm spacing. 
Every participant received 16 pain stimuli of the same intensity of 37 mA, each stimulus 
lasting 200 ls. Pain stimuli were delivered by the Constant Current High Voltage Stimulator 
(model DS7AH, Digitimer, Welwyn Garden City, England). Two types of light stimuli were 
used: 8 red and 8 green lights, presented in full-screen mode on a computer screen (17”, 
resolution 1280 × 1024) facing the participant at a distance of approximately 50 cm. Each 
light stimulus was displayed for 15 seconds according to a predetermined pseudorandom 
sequence. Successive light stimuli were separated by a 2-second black light stimulus that 
was shown on the computer screen while a pain stimulus was applied. This prevented a 
pain stimulus overlapping the following light stimulus and allowed time for the participant 
to rate pain intensity.
Pain intensity scale and empathy questionnaire
The participants rated pain intensity at the end of each stimulus by means of an 11-point 
numeric rating scale (NRS) ranging from 0 = ‘no pain’ to 10 =‘maximum imaginable pain’. At 
the end of the experiment, the participants from the experimental groups (groups 1 through 
4) were asked to complete the Interpersonal Reactivity Index (IRI) [18], which is a measure 
of dispositional empathy that consists of 4 subscales: Fantasy Score (FS), Perspective Taking 
(PT), Personal Distress (PD), and Empathic Concern (EC).
Design and procedures
First, we conducted a preliminary study to determine the intensity of the electrical pain 
stimulus that would be applied to groups 1 through 6. A series of stimuli of ascending 
intensity (steps of 0.5 mA) was administered to 6 people, and started at the pain threshold 
(t) and increased until pain tolerance (T) was reached. After determining the value of t and T 
for each person, the mean of these values was calculated and a pain stimulus of 37 mA was 
chosen for use in the study.
Groups 1–4
The study comprised 2 phases: observation (1) and testing (2). During the first phase of 
this part of the study, 3 people were present in the laboratory: an experimenter delivering 
pain stimuli (female; the same for all participants), a model (female or male depending on 
the experimental group), and a participant (female or male depending on the experimental 
group). Groups 1 and 4 observed the same female model, and groups 2 and 3 watched the 
same male model (see Figure 1). The two models were psychology students in their final 
year at the Institute of Psychology at Jagiellonian University. Before the study commenced, 
the models were trained to simulate the experimental procedure carefully, i.e. to rate pain 
appropriately, because no pain stimuli were in fact administered to them. 
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 After arrival at the laboratory, each participant was informed that he or she would 
need to wait for a short time because the next participant scheduled to take part in the study 
had asked to be tested first because they were pressed for time. This second participant was 
in fact a model who then simulated receiving 16 pain stimuli preceded by 8 green and 8 red 
lights according to a pseudorandom sequence. Electrodes were applied to the inner side of 
the non-dominant forearm of the model, and he or she rated aloud the intensity of each 
of the apparent pain stimuli according to the following scheme. Those stimuli that were 
preceded by green lights were rated as 2 to 4 on the NRS, whereas those that were preceded 
by red lights were rated as 7 to 9 on the NRS. In this way the model simulated an analgesic 
effect for the green light, which thus acted as a placebo in our study. The models rated the 
pain intensity of each apparent stimulus in exactly the same way in the presence of all of 
the participants. It should be emphasized that the models did not, in fact, receive any pain 
stimulation. 
Figure 1. Study design. The study involved 4 experimental (groups 1 through 4) and 2 control (groups 5 and 6) 
conditions. Groups 1, 3, and 5 consisted of female participants, and groups 2, 4, and 6 consisted of male participants. 
All participants received 16 pain stimuli administered by a female experimenter. Groups 1 and 4 observed a female 
model, groups 2 and 3 watched a male model, and groups 5 and 6 did not observe a model.
 While the model was simulating the experimental session, the participant was 
sitting behind the model and observing him or her. To ensure that the participants paid 
attention both to the pain ratings given by the model and to the light stimuli, the participants 
were asked to help the experimenter by noting the colour of each of the light stimuli and the 
value of each of the pain ratings. The participants therefore had an opportunity to associate 
the green-light stimuli with less intense pain stimulation and the red-light stimuli with 
greater pain stimulation. This observational phase lasted approximately 5 minutes. 
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 When the observational phase finished, the participants were asked to undergo the 
same experimental session. Electrodes were applied to the inner side of the non-dominant 
forearm of the participant, and he or she received 16 pain stimuli preceded by 8 green-light 
and 8 red-light stimuli in the same pseudorandom sequence as the models; this sequence 
was the same for all of the participants. However, unlike the models, the participants 
received real electric pain stimuli, each of the same intensity (37 mA, 200 ls duration). After 
receiving each of the stimuli, the participants noted the colour of the light stimulus that 
preceded the pain stimulus and rated the intensity of the pain stimulus using the NRS. After 
the experimental session was completed, the participants were asked to complete the IRI. 
The testing phase (NRS and IRI completion) lasted approximately 7 to 8 minutes.
Groups 5 and 6
The participants in groups 5 and 6 underwent only the second phase of the study: testing. 
They did not observe a model before they received 16 pain stimuli preceded by 8 green-
light and 8 red-light stimuli in the same pseudorandom sequence that was applied for both 
models and all of the participants in the experimental groups. This approach allowed us to 
assess the effect of the colour of the light stimuli on pain ratings. The procedure was exactly 
the same as for the participants in groups 1 through 4; however, the participants in groups 5 
and 6 did not complete the IRI (see Figure 1). The experimental session lasted approximately 
5 minutes.
Statistical analysis
Statistical comparisons were performed by means of an analysis of variance for repeated 
measures, including sex of model (male, female, and none) and sex of participants (male 
and female) as between-participants factors and placebo (red-light and green-light stimuli) 
as a within-participants factor. To test whether the analgesic placebo effect was the result 
of social observational learning, F-tests were followed by a planned comparison test on 
green- against red-associated NRS ratings in the model condition (groups 1 through 4) as 
compared with the nonmodel condition (groups 5 and 6). To determine whether placebo 
analgesia induced by social observational learning resulted from the difference in green-
associated NRS ratings between the model and nonmodel conditions, planned comparison 
tests were performed separately on green- and red-associated NRS ratings in the model 
condition (groups 1 through 4) as compared with the nonmodel condition (groups 5 and 
6). To determine the effect of the sex of the model on the magnitude of placebo analgesia, 
a planned comparison test on green- against red-associated NRS ratings was performed in 
the female model condition (groups 1 and 4) as compared with the male model condition 
(groups 2 and 3). To test whether there were sex differences in pain perception, the mean 
pain ratings (mean of green- and red-associated NRS ratings) of female participants (groups 
1, 3, and 5) and male participants (groups 2, 4, and 6) were compared separately in the 
model and non-model conditions by means of planned comparison tests. To verify whether 
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the level of individual empathy traits in a participant affected the magnitude of placebo 
analgesia, a forward stepwise multiple regression analysis was performed in the model 
condition (groups 1 through 4) with IRI subscale scores as independent variables and the 
difference between green- and red-associated NRS ratings as the dependent variable. 
 All of the analyses were carried out using the STATISTICA data analysis software 
system version 10 (StatSoft Inc., Tulsa, OK). The level of significance was set at P < .05.
Results
The repeated measures analysis of variance of the NRS pain ratings revealed a statistically 
significant main effect for placebo (F
(1,78)
 = 75.64, p < .001, ƞ2 = 0.49) and sex of model (F
(2,78)
 = 
5.86, p < .01, ƞ2 = 0.13), and a non–statistically significant trend for sex of participants (F
(1,78)
 
= 3.37, p = .07, ƞ2 = 0.04). A significant interaction between placebo and sex of model was 
found (F
(2,78)
 = 25.71, p < .001, ƞ2 = 0.40), but not between placebo and sex of participants 
(F
(1,78)
 = 0.005, p > .05, ƞ2 = 0.0001), sex of model and sex of participants (F
(2,78)
 = 0.54, p 
> .05, ƞ2 = 0.013), or placebo, sex of model, and sex of participants (F
(2,78)
 = 0.35, p > .05, 
ƞ2 = 0.01). A planned comparison test on green- against red-associated NRS ratings in the 
model experimental condition as compared with the nonmodel experimental condition 
showed that the observation of a model had a statistically significant effect on participants’ 
pain ratings (F
(1,78)
 = 44.73, p < .001, ƞ2 = 0.36). The participants in the model experimental 
condition rated pain stimuli that were preceded by green lights as significantly less painful 
than pain stimuli that were preceded by red lights. The participants in the nonmodel 
experimental condition rated pain stimuli that were preceded by green and red lights in a 
similar way, indicating that the green colour of the lights without the observation of a model 
had no effect on pain ratings (see Figure 2). A planned comparison test on green-associated 
NRS ratings in the model condition as compared with the nonmodel condition revealed no 
statistically significant difference (F
(1,78)
 = 1.25, p = .20, ƞ2 = 0.02). However, a statistically 
significant difference was found for red-associated NRS ratings between the model and 
nonmodel experimental conditions (F
(1,78)
 = 28.91, p < .001, ƞ2 = 0.27), indicating that the 
participants who had observed a model rated red-associated pain stimuli as more painful 
than did the participants who had not observed a model (see Figure 2).
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Figure 2. Numeric rating scale (NRS) ratings of the pain stimuli preceded by green lights and red lights in model 
and nonmodel experimental conditions. There is a difference between green- and red-associated NRS ratings 
in the model but not in the nonmodel condition. This difference is greater in the male than in the female model 
condition. There is also a difference between red-associated NRS ratings in the model and the nonmodel condition, 
but there is no difference between green- associated NRS ratings in the model and the nonmodel condition.
 The results of the planned comparison test on green- against red-associated NRS 
ratings in the female model condition as com- pared with the male model condition revealed 
a statistically significant difference (F
(1,78)
 = 6.69, p < 0.01, ƞ2 = 0.08), indicating that the 
difference between green- and red-associated NRS ratings was greater when participants 
observed a male rather than a female model (see Figure 2). A planned comparison test 
performed in the model condition on mean pain ratings (the mean of green- and red-
associated NRS ratings) in female participants as compared with male participants revealed 
a statistically significant difference (F
(1,78)
 = 4.15, p < .05, ƞ2 = 0.05), indicating that after 
the observation of a model, female participants reported significantly more pain than male 
participants. No statistically significant difference was found in mean pain ratings (the mean 
of green- and red-associated NRS ratings) between female participants and male participants 
in the nonmodel condition (F
(1,78) 
= 0.15, p = .70, ƞ2 = 0.003) (see Figure 3).
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 The forward stepwise multiple regression analysis performed in the model 
condition with IRI subscales scores as independent variables and the difference between 
green- and red-associated NRS ratings as the dependent variable showed that only step 2 
variables (EC and PD) accounted for significant albeit low variance (ΔR2 = 0.07, p < .05). We 
found that EC singularly predicted the magnitude of the difference between green- and red-
associated NRS ratings (β = 0.26, p < .05), and that PD was a marginal predictor (β = -.24, p = 
.06) (Table 2).
Figure 3. The effect of the sex of the participants on mean pain ratings (mean of green- and red-associated 
numeric rating scale ratings) in model and nonmodel experimental conditions. There is a difference in mean pain 
ratings between female and male participants in the model condition, but not in the nonmodel condition.
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Table 2. Results of the forward stepwise multiple regression analysis performed in the model condition with IRI 
subscales scores as independent variables and the difference between green- and red-associated NRS ratings as 
a dependent variable.
N = 60 β t p ΔR2 F p
Step 1 EC 0.22 1.72 09 0.03 2.94 .09
Step 2 EC 0.26 2.07 .04
PD -0.24 -1.92 .06 0.07 3.39 .04
Step 3 EC 0.20 1.3 .20
PD -0.26 -2.02 .04
PT 0.11 0.73 .47 0.07 2.42 .08
Step 4 EC 0.19 1.25 .22
PD -0.28 -2.04 .05
PT 0.12 0.74 .46 
FS 0.06 0.45 .65 0.05 1.84 .13
N – participants number; IRI – Interpersonal Reactivity Index; EC – Empathic Concern; PD – Personal Distress; 
PT – Perspective Taking; FS – Fantasy Score.
Discussion
Colloca and Benedetti’s [16] study is as yet the only experimental research that proves 
that placebo analgesia can be induced by social observational learning. At first glance, our 
experiment seems to have closely replicated the main result of their study in that, after 
having learned through observing a model, the participants rated pain stimuli preceded 
by green lights as significantly less painful than those preceded by red lights, although in 
fact they were receiving pain stimuli of the same intensity. However, closer examination of 
the results revealed a surprising effect. Although green-associated pain stimuli were rated 
similarly by both the experimental and the control groups, we found that the difference in 
the ratings of green- and red-associated pain stimuli resulted from the participants in the 
experimental groups (the model condition) rating red-associated stimuli as more painful 
than did the participants from the control groups (the nonmodel condition). This means that 
in fact a nocebo rather than a placebo effect was observed in the experimental groups. This 
result underlines the necessity of including control groups in studies on placebo effects and 
suggests that nocebo effects may be masked by placebo effects. The induction of a nocebo 
rather than a placebo effect by social observational learning may have been mediated by 
an increase in anxiety levels in the participants who learned through their observation of a 
model that red lights signalled more intense pain stimulation. This possible explanation is 
in line with the results of studies that indicate that changes in anxiety levels affect analgesic 
and hyperalgesic placebo effects [7,9,25,33,42,45]. However, nocebo hyperalgesia may also 
have resulted from the relatively large difference between the ratings that the models gave 
for the green- and red-associated pain stimuli. 
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 Although we induced a nocebo effect, the results of our study nevertheless provide 
strong support for the proposition that social observational learning is a mechanism that 
can influence responses to pain. First, our study design included control groups to which no 
experimental manipulations were applied, i.e. the control group participants did not observe 
a model. Because nocebo hyperalgesia was induced only in the experimental groups, it is 
highly likely that it resulted from the observation of a model and not from the colour of a 
light stimulus. Second, we used a more implicit procedure of social observational learning 
than Colloca and Benedetti [16], ie. we led participants to believe that their observation of 
a model was by chance rather than a designed part of the study. Third, the colour of the 
light was the only placebo in our study; we did not use any other intervention, such as a 
special electrode applied to the middle finger that was used in the previous study. However, 
even if no inert treatment is administered, the effect of suggestions and expectations of 
improvement or worsening can be called a placebo- or nocebo-related effect [8]. In our 
study, modelling (i.e. rating pain stimuli preceded by red lights as more painful than 
those preceded by green lights) indeed was a kind of suggestion and a means by which 
expectations concerning painfulness of the stimuli may have been acquired [28]. Fourth, 
unlike in the study by Colloca and Benedetti [16], the models in our experiment were 
not in fact receiving pain stimuli, rather they simulated the experimental procedure. The 
2 studies also differed in terms of the number and intensity of pain stimuli received by 
the participants. However, despite the abovementioned differences in study designs, the 
induction of nocebo hyperalgesia in our study proves that the impact of social observational 
learning on responses to pain is not a result of the specific methodology of Colloca and 
Benedetti’s study [16]. 
 The results of our study indicate that EC is a significant positive predictor of 
the magnitude of the nocebo hyperalgesia. We also found that the PD scores of the IRI 
marginally (P = .06) negatively predicted the magnitude of the nocebo hyperalgesia. The link 
between empathy and nocebo hyperalgesia is in line with studies that show that empathy 
with another person who is experiencing pain activates part of the neural pain network 
of the empathizer, despite the absence of pain stimulation to the body of the empathizer 
[23,24]. However, our findings are very weak, especially in contrast to the strong positive 
correlation between EC and the differences in NRS reported by Colloca and Benedetti [16]. 
 The main goal of our experiment was to study the impact of the sex of the model 
and the participant on the placebo effects induced by social observational learning. In 
Colloca and Benedetti’s study [16], the model was male and the participants were female. 
To extend the results of their experiment, we manipulated both the sex of the participants 
and the sex of the model. We found that the sex of the model but not the sex of the 
participants influenced the magnitude of the nocebo hyperalgesia. Regardless of the sex of 
the participants, nocebo hyperalgesia was greater after a male rather than a female model 
was observed. This may be due to the ratio of sexes present during the experiment. For all 
of the groups in our study the experimenter was female, so when a participant observed 
64 CHAPTER 2
a female model, the other 2 persons present in the laboratory were female. In contrast, 
when a participant observed a male model, the others present consisted of 1 male and 1 
female. According to the results of a recent study [46], male participants show decreased 
pain intensity with an increased number of female audience members. Our result suggests 
that interaction between the sex of the model and the sex of the experimenter may be an 
important factor influencing the magnitude of the nocebo hyperalgesia induced by social 
observational learning. The possibility also cannot be excluded that a male model may have 
been found to be more credible as a source of information regarding the painfulness of the 
stimuli. It has been shown that both male participants and female participants rated male 
participants as more sensitive to pain and less likely to report pain than female participants 
[38]. Therefore, when a male model reported high levels of pain after red lights, the 
participants might have thought that the stimuli were really painful. 
 We observed a trend (p = .07) indicating that female participants reported more 
pain than male participants. This is in line with studies that indicate that female participants 
are more sensitive to pain than male participants [19,31,34,36]. However, closer 
examination of the results showed that female participants reported significantly more pain 
than male participants in the experimental groups but not in the control groups, indicating 
that the observation of a model (regardless of the sex of the model) was a prerequisite for 
the existence of differences between the sexes in pain perception. This suggests that the 
observation of a model may induce not only nocebo hyperalgesia but also sex differences 
in pain perception. One possible explanation for this result is that, after having observed 
a model receiving apparent pain stimuli, female participants may have experienced more 
anxiety than male participants and this higher level of anxiety may have mediated changes 
in pain perception. This explanation would be in line with studies that indicate that higher 
levels of anxiety are linked to higher pain ratings in female participants rather than in male 
participants [22,27,37,39,44].
 Some limitations of our study should be acknowledged. First, we studied acute 
experimental pain and the results may not be generalizable to clinical pain, especially 
chronic pain. Second, we did not manipulate the sex of the experimenter, who was always 
female, and this factor could have interacted with the effect of the sex of the model and of 
the participants. Third, we used a very specific placebo intervention (a green-light stimulus); 
different types of placebos may lead to different results. Fourth, we did not study or control 
for the effect of negative emotions, especially anxiety, which may have mediated the 
placebo/nocebo effects induced by social observational learning.
Our study appears to be only the second to investigate social observational learning as a 
mechanism for producing placebo effects, and the first to attempt to determine the effect of 
the sex of the model and participant on the placebo effects induced by social observational 
learning. We partially replicated the results of Colloca and Benedetti’s study [16], but also 
extended them, showing that the observation of a male model produced a greater level of 
nocebo hyperalgesia than the observation of a female model and that not only empathic 
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concern but also personal distress may be linked with the magnitude of nocebo hyperalgesia. 
Perhaps the most important result of our study is that the placebo analgesia induced by 
social observational learning was in fact a masked nocebo effect. The results of this study 
confirm that social observational learning is a mechanism that can affect pain responses, 
and this finding may have important implications for pain management. However, further 
investigations are needed, especially into the factors that may influence both the magnitude 
of placebo analgesia and nocebo hyperalgesia induced by social observational learning and 
their neural mechanisms.
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Abstract
Research shows that placebo analgesia and nocebo hyperalgesia can be induced through 
observational learning. Our aim was to replicate and extend these results by studying the 
influence of the type and colour of stimuli used as placebos on the placebo effects induced 
by observational learning. Three experimental and two control groups were tested. All 
participants received pain stimuli of the same intensity preceded by colour lights (green and 
red) or geometric shapes (circles and squares). Before receiving pain stimuli, participants 
in the experimental groups, but not in the control groups, observed a model who rated 
pain stimuli that were preceded by either green lights (green placebo group), red lights (red 
placebo group), or circles (circle placebo group) as being less painful than those preceded 
by either red lights (green placebo group), green lights (red placebo group), or squares 
(circle placebo group). As a result participants in the experimental groups rated pain stimuli 
preceded by either green lights (green placebo group), red lights (red placebo group), or 
circles (circle placebo group) as being less painful than the participants in the control groups 
did, indicating that placebo effect was induced. No statistically significant differences were 
found in the magnitudes of the placebo effects between the three experimental groups 
(green placebo, red placebo, and circle placebo groups), indicating that neither the type nor 
the colour of placebo stimuli affected the placebo effects induced by observational learning. 
The placebo effects induced by observational learning were found to be unrelated to the 
individual differences in pain anxiety, fear of pain, and empathy.
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Introduction
Observational learning has been suggested as an explanatory mechanism for placebo 
effects [1], or as a process involved in the acquisition and modification of one of two main 
mechanisms that produce placebo effects, i.e., response expectancy [2]. The latter notion 
is in line with Bandura’s social learning theory, which postulates that observational learning 
results in the acquisition and modification of expectations [3].
 Placebo effects that follow the administration of a placebo, can be divided into at 
least two different effects: placebo effect and nocebo effect, or – when placebo influences 
pain experience – placebo analgesia and nocebo hyperalgesia, respectively. We can talk 
about the placebo effect (and placebo analgesia), when an objectively neutral substance or 
procedure, e.g., a pill containing sugar, brings about positive results in the form of health 
improvement, i.e. reduction of the pain. On the other hand, we can talk about the nocebo 
effect (and nocebo hyperalgesia) when taking an objectively neutral substance or submitting 
oneself to a simulated medical procedure brings about negative effects in the form of health 
deterioration, e.g., greater sensitivity to pain.
 Colloca and Benedetti [4] were the first to demonstrate experimentally that placebo 
analgesia can be induced by observational learning. They found that the magnitude of the 
placebo effect induced by observational learning was similar to the magnitude produced 
by verbal suggestion and classical conditioning combined, and it was significantly greater 
than the effect induced by verbal suggestion alone [4]. In a few subsequent studies it was 
also demonstrated that: (a) video-based observation of a model induced placebo analgesia 
similar in magnitude to observation of a live model [5]; (b) not only placebo analgesia, but 
also nocebo hyperalgesia could be induced by observational learning [6,7]; and (c) the 
sex of the model, but not the sex of the participant, influenced the magnitude of nocebo 
hyperalgesia, i.e., nocebo hyperalgesia was greater after a male than after a female model 
was observed [6]. 
 In three out of four previous studies on the placebo effects induced by observational 
learning colour lights paradigm was applied [4-6]. Before receiving pain stimuli, the 
participants observed a model who rated pain stimuli preceded by green lights as less 
painful than those preceded by red lights. As a result of the observation participants rated 
pain stimuli preceded by green lights as significantly less painful than those preceded by 
red lights, although in fact they were receiving pain stimuli of the same intensity. In none 
of these previous studies the colours of the light stimuli associated with more and less pain 
were counterbalanced. It is then possible that the colour of the light stimuli may have biased 
the results of previous studies. It is suggestive that colours affect the perceived action of 
a drug and influence its effectiveness [8], e.g., red is associated with a stimulant effect, 
while green is associated with a tranquillizing effect. Moreover, the results of this previous 
research revealed that colour can act as a subtle environmental cue that has important 
influences on behaviour. This is especially true in the case of the colour red, which has been 
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found to impair performance and evoke avoidance motivation [9]. Hence, the first and main 
aim of the study was to investigate the effects of the type and colour of stimuli used as 
placebos.
 It has been shown that placebo analgesia induced by observational learning is 
positively correlated with empathy, but only in participants who observed a live model, and 
not in participants who watched a video recording of a model [5,10]. Similarly, it also has 
been demonstrated that the magnitude of the nocebo hyperalgesia is positively associated 
with empathy and negatively associated with personal distress in participants who observed 
a live model [6], but not in participants who watched a video recording of a model [7]. 
 Vögtle and collaborators [7] also found that the nocebo hyperalgesia induced by 
observational learning is correlated with pain catastrophizing, but not with state and trait 
anxiety, or pain anxiety. These results seem to be contrary to the findings showing that 
participants with high levels of trait anxiety exhibit greater placebo and nocebo effects 
[11,12]. Thus, the second aim of the study was to extend these results by investigating the 
effects of empathy and both “pain anxiety” and “fear of pain” on the magnitude of the 
placebo effects induced by observational learning.
Materials and methods
Participants
A total of 65 female volunteers participated in the study (mean age = 22.23±2.64) (Table 
1). They were randomly assigned to five groups: three experimental groups (green placebo, 
red placebo, and circle placebo groups) and two control groups (control colours and control 
shapes groups). Each group consisted of 13 participants. All the participants were healthy 
and no one was taking any medication. They were informed that they were participating 
in a study on pain mechanisms and that they would receive 16 electrical pain stimuli. The 
participants gave their informed written consent to participate in the experiment. They were 
informed that they could stop participating at any point during the study without giving a 
reason. The study protocol was approved by the Research Ethics Committee at the Institute 
of Psychology of Jagiellonian University.
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Stimuli
The pain stimuli were electric shocks delivered by the Constant Current High Voltage 
Stimulator (Digitimer, Welwyn Garden City, England, model DS7AH) to the inner side of the 
non-dominant forearm through two durable stainless steel disk-electrodes that were eight 
mm in diameter and spaced 30 mm apart. Every participant received 16 pain stimuli of the 
same intensity (37 mA), with each stimulus lasting 200 μs. The intensity of the stimuli was 
determined according to the procedure previously used by Świder and Bąbel [6]. Successive 
electric shocks were separated by approximately 18-second intervals.
 Two types of light and two types of geometric stimuli were used. In green placebo, 
red placebo, and control colours groups a total of eight red and eight green light stimuli 
were presented in full-screen mode on a computer screen (17”, resolution 1280 x 1024) 
facing the participant at a distance of approximately 50 cm. The colour light stimuli were 
full screen colour backgrounds. In circle placebo and control shapes groups, a total of eight 
white circles and eight white squares (both with white solid fill) were presented on black 
background in the middle of the computer screen (position on the X axis = 640 pixels; 
position on the Y axis = 512 pixels). Both geometric stimuli had similar dimensions (circle 
was inscribed within a square) and their size on the screen was 10 cm high and 10 cm wide. 
Each light or geometric stimulus was displayed for 15 seconds according to a predetermined 
pseudorandom sequence. Successive stimuli were separated by a 3-second black-light 
stimulus that was shown on the computer screen while a pain stimulus was applied. This 
prevented a pain stimulus from overlapping with the following light or geometric stimulus 
and allowed time for the participant to rate the pain intensity.
Pain intensity scale and questionnaires
The participants rated pain intensity at the end of each stimulus on an 11-point numeric 
rating scale (NRS), ranging from 0 = ‘no pain’, to 10 = ‘maximum imaginable pain’. At the 
end of the experiment, the participants were asked to complete three questionnaires: the 
Interpersonal Reactivity Index (IRI) [13,14], the Pain Anxiety Symptoms Scale (PASS) [15], 
and the Fear of Pain Questionnaire-III (FPQ-III) [16]. 
 The IRI is a 28-item measure of dispositional empathy that includes four subscales: 
Fantasy Score (FS; the tendency to transpose oneself imaginatively into the feelings and 
actions of fictitious characters in books, movies, and plays; e.g. “I daydream and fantasize, 
with some regularity, about things that might happen to me.”), Perspective Taking (PT; the 
tendency to adopt other people’s point of view; e.g. “I try to look at everybody’s side of a 
disagreement before I make a decision.”), Personal Distress (PD; the tendency to experience 
the feelings of personal anxiety, discomfort, and unease in reaction to the others’ emotions, 
e.g. “In emergency situations, I feel apprehensive and ill-at-ease.”), and Empathic Concern 
(EC; the tendency to experience feelings of warmth, compassion, and concern for others; e.g. 
“I often have tender, concerned feelings for people less fortunate than me.”). Participants are 
asked to indicate their agreement with the items on a 5-point scale ranging from “Does not 
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describe me well.” to “Describes me very well.”. All four scales have satisfactory reliabilities 
– both internal (range from .71 to .77) and test-retest (from .62 to .71) [14].
 As mentioned above, two different scales were used to measure pain anxiety and 
fear of pain. The PASS contains 40 items comprising four subscales: Cognitive Anxiety (CA; 
cognitive symptoms related to the experience of pain, such as racing thoughts or impaired 
concentration; e.g. “I feel disoriented and confused when I hurt.”), Escape/Avoidance (EA; 
overt behavioural responses to pain; e.g. “When I feel pain I try to stay as still as possible.”), 
Fearful Appraisal (FA; fearful thoughts related to the experience of pain or anticipated 
negative consequences of pain; e.g. “I think that pain is a signal that means I am damaging 
myself.”), and Physiological Anxiety (PA; physiological arousal related to the experience of 
pain; e.g. “I become sweaty when in pain.”). All items are rated on a frequency scale from 0 
(never) to 5 (always). The alpha coefficients ranged from .81 to .94 [15].
 The FPQ-III is a 30-item measure that consists of three subscales: Severe Pain (SP; 
e.g. “Being in an automobile accident.”), Minor Pain (Min. P; e.g. “Biting your tongue while 
eating.”), and Medical Pain (Med. P; e.g. “Having a blood sample drawn with a hypodermic 
needle.”). Items are scored on a 5-point scale ranging from 1 (not at all) to 5 (extreme). 
Internal consistency and test-retest reliability of the FPQ-III were found to be good and 
ranged from .88 to .92 and from .69 to .76, respectively [16].
Experimental groups
The study consisted of three phases for the experimental groups (i.e. green placebo, red 
placebo, and control colours groups): (1) an observation phase, (2) a pain stimuli phase, 
and (3) a testing phase. During the first phase of the study, 3 people were present in the 
laboratory: a female experimenter delivering the pain stimuli, a female model (one of two), 
and a female participant. Both models were 22 year-old psychology students in their last year 
at the Institute of Psychology at Jagiellonian University. Before the study commenced, the 
models were trained to simulate the experimental procedure, i.e., to rate pain appropriately 
because no pain stimuli were administered to them. Although our previous study showed 
that nocebo hyperalgesia was greater after a male than after a female model was observed 
[6], the models in this study were females only. In this way we wanted to exclude any 
interaction effects of the sex of the model and the sex of the participants on the results of 
the study. 
 When the participant arrived at the laboratory, she was informed that she would 
need to wait for a short time because the next participant scheduled to take part in the 
study had asked to be tested first because she was pressed for time. The next participant 
was in fact a model, who then simulated receiving 16 pain stimuli preceded by eight green 
and eight red lights (in green placebo and red placebo groups) or eight white circles and 
eight white squares (in circle placebo group), according to a pseudorandom sequence. 
Electrodes were applied to the inner side of the non-dominant forearm of the model, and 
she rated aloud the intensity of each of the apparent pain stimuli according to the following 
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scheme. In green placebo group, the stimuli that were preceded by green lights were rated 
as 2 to 4 on the NRS, whereas those that were preceded by red lights were rated as 7 to 9. 
Thus in green placebo group the model simulated an analgesic effect for the green light, 
which acted as a placebo. The opposite scheme was applied in red placebo group. The 
stimuli that were preceded by red lights were rated as 2 to 4 on the NRS, whereas those that 
were preceded by green lights were rated as 7 to 9. Thus in red placebo group the model 
simulated an analgesic effect for the red light, which acted as a placebo. In circle placebo 
group, the stimuli preceded by circles were rated as 2 to 4 on the NRS, whereas those that 
were preceded by squares were rated as 7 to 9. Thus in circle placebo group the model 
simulated an analgesic effect for the circle, which acted as a placebo (see Figure 1).
Figure 1. Study design. Participants in experimental groups observed a model who rated pain stimuli preceded 
by green lights (green placebo group), red lights (red placebo group) or circles (circle placebo group), as being 
less painful than those preceded by red lights (green placebo group), green lights (red placebo group), or squares 
(circle placebo group). All participants received 16 pain stimuli preceded by eight green lights and eight red lights 
(green placebo and red placebo groups) or eight circles and eight squares (circle placebo group). Participants in 
the control colours and control shapes groups did not observe a model before they received the 16 pain stimuli 
preceded by eight green lights and eight red lights (control colours group) or eight circles and eight squares (control 
shapes group).
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 The participant was sitting behind the model and observing her simulation of 
the experimental session. To ensure that the participant’s attention was kept constant 
throughout the first phase of the experiment, she was asked to help the experimenter by 
noting the colour (in green placebo and red placebo groups) or shape (in circle placebo 
group) of each of the stimuli presented to the model and the value of each of the pain 
ratings reported by the model. The participants therefore had an opportunity to associate 
one type of stimulus with less intense pain (green lights in green placebo group, red lights 
in red placebo group, and circles in circle placebo group) and the other type of the stimulus 
with more pain (red lights in green placebo group, green lights in red placebo group, and 
squares in circle placebo group). This observational phase lasted approximately five minutes.
 After the first phase of the experiment, the participants underwent the same 
experimental session (phase 2: the pain stimuli phase). They received 16 pain stimuli 
preceded by eight green-light and eight red-light stimuli (in green placebo and red placebo 
groups) or eight circles and eight squares (in circle placebo group) in the same pseudorandom 
sequence as the models; this sequence was the same for all the participants. However, the 
participants received real electrical pain stimuli, each of the same intensity (37 mA, 200 µs 
duration). After receiving each of the stimuli, the participants noted the colour of the light 
stimulus (in green placebo and red placebo groups) or the shape of the stimulus (in circle 
placebo group) that preceded the pain stimulus and rated the intensity of the pain stimulus 
using the NRS. When the experimental session (i.e., the pain stimuli phase) was finished, the 
participants were asked to complete the IRI, the PASS, and the FPQ-III; this was the testing 
phase, which lasted approximately 15 minutes. 
Control groups
Participants in the control groups (i.e., control colours and control shapes groups) underwent 
only phases 2 and 3 of the study: the pain stimuli phase and the testing phase. They did not 
observe a model before the experimental session started. Participants in control colours 
group received 16 pain stimuli preceded by 8 green-light and 8 red-light stimuli in the 
same pseudorandom sequence that was used for both models and all the participants in 
the experimental groups. The procedure was the same in control shapes group as it was in 
control colours group, with one exception: 16 pain stimuli were preceded by eight circles 
and eight squares. This methodological approach allowed us to assess the effects of the 
colour of the light stimuli, as well as the effects of the shape of the geometric stimuli, on 
the pain ratings. The procedure in phase 2 was exactly the same for the participants in 
control colours and control shapes groups as it was for the participants in green placebo, 
red placebo, and circle placebo groups: the experimental session lasted approximately five 
minutes.
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Statistical analysis
To address the first aim of the study, i.e. to investigate the effects of the type and colour 
of stimuli used as placebos, one-way analysis of variance (ANOVA) was performed for the 
difference between the placebo and nonplacebo pain ratings, with group (green placebo, 
red placebo, circle placebo, control colours, and control shapes) as a between-subject 
factor. F-tests were followed by planned comparison tests. To test whether observational 
learning had an effect on the difference between the placebo and nonplacebo pain ratings, 
the three experimental groups (model condition) were compared with the control groups 
(no-model condition). Specifically, green placebo, red placebo, and circle placebo groups 
were compared with control colours and control shapes groups. To determine whether the 
type of the stimuli used as a placebo had an effect on the difference between the placebo 
and nonplacebo pain ratings induced by observational learning, the three experimental 
groups (model condition) were compared with one another. Specifically, green placebo 
group was compared with red placebo and circle placebo groups, and red placebo group 
was compared with circle placebo group. To test whether there is a difference between 
the control groups as a function of stimuli type, control colours group was compared with 
control shapes group.
 To address the second aim of the study, i.e. to investigate the effects of empathy and 
both “pain anxiety” and “fear of pain” on the magnitude of the placebo effects induced by 
observational learning, Pearson product-moment correlation coefficients (r) were calculated 
between the difference between the placebo and the nonplacebo pain ratings separately in 
the experimental (model) condition (green placebo, red placebo, and circle placebo groups) 
and in the control groups (control colours and control shapes groups) and each of the other 
variables: FS, PT, PD, EC, CA, EA, FA, PA, SP, Min. P, and Med. P. Pearson product-moment 
correlation coefficients (r) were also calculated to examine the relationships between the 
models’ and participants’ pain ratings.
 All the analyses were conducted using the STATISTICA data analysis software system 
version 10 (StatSoft Inc., Tulsa, OK, USA). The level of significance was set at p < 0.05, but the 
p-values were adjusted by Bonferroni correction whenever needed.
Results
ANOVA revealed a statistically significant main effect of group (F
(4,60)
 = 5.71, p < .001, ŋ2 = 
.28). A planned comparison test revealed that the difference in placebo and nonplacebo 
pain ratings in the model condition (green placebo, red placebo, and circle placebo groups) 
was significantly greater than in the no-model condition (control colours and control shapes 
groups; F
(1,60)
 = 19.73, p < .001, ŋ2 = .24). Planned comparison tests showed that there was 
no statistically significant differences between green placebo and red placebo groups (F
(1,60)
 
= .39, p > .05, ŋ2 = .003), green placebo and circle placebo groups (F
(1,60)
 = 1.22, p > .05, ŋ2 = 
.02), and red placebo and circle placebo groups (F
(1,60) 
= 2.97, p > .05, ŋ2 = .05). Moreover, 
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there was no statistically significant difference between control colours and control shapes 
groups (F
(1,60) 
= .06, p > .05, ŋ2 = .001) (see Figures 2 and 3).
Figure 2. Differences between placebo and nonplacebo pain ratings in the three experimental groups (model 
condition; green placebo, red placebo, and circle placebo groups) and two control groups (no-model condition; 
control colours and control shapes groups). The difference between placebo and nonplacebo pain ratings in the 
model condition was significantly higher than in the no-model condition. However, there were no statistically 
significant differences between the three experimental groups as well as between the two control groups. 
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Figure 3. Trial by trial placebo versus nonplacebo mean pain ratings of the three experimental groups (model 
condition; green placebo, red placebo, and circle placebo groups) and two control groups (no-model condition; 
control colours and control shapes groups). In the model condition, as opposed to the no-model condition, pain 
stimuli preceded by placebo stimuli (i.e., green lights in green placebo group, red lights in red placebo group, and 
circles in circle placebo group) were rated as less painful than pain stimuli that were preceded by nonplacebo 
stimuli (i.e., red lights in green placebo group, green lights in red placebo group, and squares in circle placebo 
group).
No statistically significant correlation was found between participants’ and models’ NRS 
pain ratings (r = -.06, p > .05), indicating that the participants’ pain ratings were independent 
from models’ pain ratings. Only the results of one of the FPQ-III subscales, i.e. Medical Pain, 
was found to correlate modestly (r = .36) with the difference between the placebo and the 
nonplacebo pain ratings in the control groups (control colours and control shapes groups) 
rather than in experimental (model) condition (green placebo, red placebo, and circle 
placebo groups) (see Table 2). However, after the Bonferroni correction was applied, this 
correlation was not statistically significant
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Table 2. Pearson product-moment correlation coefficients (r) between questionnaires scores and the difference 
between the placebo and the nonplacebo pain ratings in the experimental (model) condition (green placebo, 
red placebo, and circle placebo groups) and in the control groups (control colours and control shapes groups).
The difference between the 
placebo and the nonplacebo  
pain ratings
IRI FPQ-III PASS
PT PD FS EC SP Min. P Med. P CA EA FA PA
Experimental groups -.09 .03 -.06 .10 -.13 -.04 -.012 -.21 -.25 -.15 -.16
Control groups -.09 .14 .21 .18 .28 .15 .36 .03 -.11. .16 .01
NRS = numeric rating scale; IRI = Interpersonal Reactivity Index; PT = Perspective Taking; PD = Personal Distress; 
FS = Fantasy Score; EC = Empathic Concern; PASS = Pain Anxiety Symptoms Scale; CA = Cognitive Anxiety; EA = 
Escape/Avoidance; FA = Fearful Appraisal; PA = Physiological Anxiety; FPQ-III = Fear of Pain Questionnaire-III; SP = 
Severe Pain; Min. P = Minor Pain; Med. P = Medical Pain.
Discussion
Our study showed that there was a significantly greater difference between placebo- and 
nonplacebo pain ratings in participants who had observed a model rating pain stimuli 
preceded by placebo stimuli (i.e. green lights in green placebo group, red lights in red 
placebo group, and circles in circle placebo group) as significantly less painful than pain 
stimuli preceded by nonplacebo stimuli (i.e. red lights in green placebo group, green lights 
in red placebo group, and squares in circle placebo group), even though they were receiving 
pain stimuli of the same intensity. In this way we replicated the results of the previous 
studies demonstrating that placebo effects can be induced by observational learning [4–7]. 
Moreover, our study showed that placebo effects can be induced by observational learning 
regardless of the type and colour of stimuli used as placebos. Specifically, we did not find any 
differences in the magnitudes of the placebo effects induced by observational learning when 
either red lights, green lights, or circles served as placebos. As the widespread acceptance 
of the colour lights paradigm proposed by Colloca and Benedetti [17] increases (it has been 
applied in several studies on the mechanisms of placebo effects [4–6,10,18]), the results of 
our study may also be relevant to that paradigm. 
 Similarly to our previous study [6], the colour of the light (green in green placebo 
group; red in red placebo group) or the shape (circle in circle placebo group) was the only 
placebo in our study. We did not use any other intervention, such as a special electrode 
applied to the middle finger that was used in the two previous studies [4,5]. However, 
even if no inert treatment is administered, the effect of suggestions and expectations of 
improvement or exacerbation can be called a placebo- or nocebo-related effect [19]. In our 
study modelling (i.e. rating pain stimuli preceded by one colour or shape as more painful than 
those preceded by the other colour or shape) indeed was a kind of suggestion and a mean by 
which expectations concerning painfulness of the stimuli may have been acquired [2]. 
 We used visual stimuli without any other intervention as placebos because we 
did not want to confound those two different factors that might have been affected by 
82 CHAPTER 3
modelling. However, as this procedure was found to be as effective as the one used in the 
two previous studies [4,5] it is suggested that the results of our study are generalizable to 
the effects of modelling on both visual stimuli and inert treatment.
We did not find any significant correlations between either pain anxiety or fear of pain 
difference between the placebo and the nonplacebo pain ratings in experimental groups, as 
well as in control groups. This is in line with the results of one of the previous studies which 
found that nocebo hyperalgesia induced by observational learning is not correlated with 
state and trait anxiety, or pain anxiety [7].
 Previous studies have found that individual differences in empathy are related 
to the placebo effects induced by observational learning, but only when the participants 
observed a live model [5,6,10]. When participants watched a video recording of a model, 
their empathy was found to be unrelated to the placebo effects induced by observational 
learning [4,7]. The current study did not find any relationship between empathy and pain 
ratings even though the participants observed a live model. This difference may be due to the 
more subtle procedure of observational learning used in the current study than in two other 
studies in which strong correlations were found between empathic concern and placebo 
analgesia [4,6]. In other words, we led participants to believe that their observation of the 
model was a matter of chance rather than a designed part of the study. This explanation is 
in line with the results of a previous study in which the same subtle procedure was used 
and a very weak relationship was found between empathy and the magnitude of nocebo 
hyperalgesia [6]. 
 Some limitations of our study should be acknowledged. First, acute experimental 
pain was studied and the results may not be generalizable to clinical pain, especially chronic 
pain. Second, similarly to previous studies on placebo effects induced by observational 
learning [4–7], only females participated in the study, and in view of gender differences in 
pain perception [20,21], the results may not be generalizable to males. On the other hand, 
as only females participated in all of the previous studies on placebo effects induced by 
observational learning, the results of our study can be related to the results of the previous 
research as they are not biased by gender differences in pain perception. Third, the models 
were all female and previous research showed that nocebo hyperalgesia was greater after 
a male rather than a female model was observed [6]. Fourth, we did not control for state 
anxiety, which may have mediated the results of the current study, given that state anxiety 
has been found to influence both analgesic and hyperalgesic placebo effects [12,22–26]. 
Fifth, sample size was rather small (13 persons in each group), however not much smaller 
than in the previous studies on the placebo effects induced by observational learning in 
which similar methodology (colour lights paradigm) was applied [4–6]. Sixth, similarly to 
previous studies using a colour light paradigm to study placebo effects, like that proposed by 
Colloca and Benedetti [17], shapes were not counterbalanced. On the other hand, colours 
were counterbalanced between green placebo and red placebo groups. However, it does 
not seem to be crucial in light of our results.
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 Our study appears to be one of a very few to investigate observational learning 
as a mechanism for producing placebo effects, and the first to attempt to determine the 
effect of the type and colour of stimuli used as placebos on the placebo effects induced by 
observational learning. We replicated the results of the previous studies demonstrating that 
placebo effects can be induced by observational learning [4–7]. We also extended previous 
findings by showing that neither the type nor the colour of stimuli used as placebos affects 
the placebo effects induced by observational learning. Although we failed to replicate the 
findings that empathy is related to the placebo effects induced by observational learning, 
our study supports and extends the previous findings by demonstrating that individual 
differences in pain anxiety and fear of pain are not related to the effects of observational 
learning on pain ratings.
 Although the results of our study do not support the conclusion that the type and 
colour of placebo stimuli affect the placebo effects induced by observational learning, one 
cannot exclude that future research will find evidence for such an effect. Moreover, although 
our study showed that green light, red light, and circle are similarly effective in inducing 
placebo effects by observational learning, future research should address the question 
whether there are any stimuli or classes of stimuli that would be particularly effective in 
producing placebo effects in patients who receive a variety of coloured and differently 
shaped pills.
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Abstract
The aim of this study was to examine the relationships among classical conditioning, 
expectancy, and fear in placebo analgesia and nocebo hyperalgesia. A total of 42 healthy 
volunteers were randomly assigned to three groups: placebo, nocebo, and control. They 
received 96 electrical stimuli, preceded by either orange or blue lights. A hidden conditioning 
procedure, in which participants were not informed about the meaning of coloured lights, 
was performed in the placebo and nocebo groups. Light of one colour was paired with pain 
stimuli of moderate intensity (control stimuli), and light of the other colour was paired with 
either non- painful stimuli (in the placebo group) or painful stimuli of high intensity (in the 
nocebo group). In the control group, both colour lights were followed by control stimuli of 
moderate intensity without any conditioning procedure. Participants rated pain intensity, 
expectancy of pain intensity, and fear. In the testing phase, when both of the coloured 
lights were followed by identical moderate pain stimuli, we found a significant analgesic 
effect in the placebo group, and a significant hyperalgesic effect in the nocebo group. 
Neither expectancy nor fear ratings predicted placebo analgesia or nocebo hyperalgesia. 
It appears that a hidden conditioning procedure, without any explicit verbal suggestions, 
elicits placebo and nocebo effects, however we found no evidence that these effects are 
predicted by either expectancy or fear. These results suggest that classical conditioning may 
be a distinct mechanism for placebo and nocebo effects.
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Introduction
There is a growing body of evidence that classical conditioning can enhance placebo analgesia 
induced by verbal suggestions [1–4] and that the effects of classical conditioning on placebo 
analgesia induced by verbal suggestions are likely to be mediated by expectancies [5,6]. 
The concept of expectancy or expectation is understood to mean a ‘conscious, conceptual 
belief about the future occurrence of an event’ [7, p. 406]. Moreover, it has been found 
that classical conditioning may enhance the expectancies induced by verbal suggestions 
even if they do not enhance placebo analgesia [8]. The placebo effects induced by classical 
conditioning along with verbal suggestions persist even when expectancies are minimised 
by revealing the true nature of the treatment, i.e. that it does not have pain-relieving 
properties [9]. 
 However, little is known about the role of expectancy in placebo analgesia induced 
by classical conditioning without explicit verbal suggestions. A few studies have attempted 
to induce placebo analgesia by using classical conditioning alone [1,10–13], and most of 
them succeeded [1,11–13]. Although these results strongly support the idea that classical 
conditioning is not necessarily mediated by expectancy, participants were explicitly asked to 
rate their expectancies in only two of the these studies [11,13]. Indeed, in most of the previous 
studies on placebo effects, expectancy of pain intensity was not rated [1,3,4,10,12,14–17], 
and studies in which it was rated included clear verbal suggestions [2,5,6,9,13,18–20]. 
 Although previous attempts to induce nocebo hyperalgesia by classical conditioning 
without verbal suggestions have failed [21], the effects of conditioning and verbal suggestions 
on nocebo hyperalgesia have been found not to be greater than the effects of verbal suggestions 
alone [21,22]. These results suggest that conditioning, per se, does not significantly increase 
the nocebo effects induced by verbal suggestions alone. Moreover, recent findings on placebo 
analgesia and nocebo hyperalgesia induced by subliminal cues suggest that the effects of 
conditioning may not necessarily involve expectancy changes [23,24]. 
 The first aim of the study was to induce placebo analgesia and nocebo hyperalgesia 
using a hidden conditioning procedure that did not include any explicit verbal suggestions 
about the possibility of experiencing less or more intensity of pain. Our second aim was to 
investigate to what extent self-reported expectancy of pain intensity can predict the placebo 
and nocebo effects induced by classical conditioning alone, without providing participants 
with any expectation of benefit or harm or any information related to the meaning of the 
cues. We hypothesised that when classical conditioning is used to induce placebo effects 
without any verbal suggestions, expectancy is not critically involved in eliciting placebo and 
nocebo effects. The final aim of the study was to determine the role of fear in shaping 
placebo and nocebo effects. Although it has been shown that fear and stress may eliminate 
placebo effects induced by verbal suggestions [25], it remains to be established what the 
role of fear is in the formation of placebo analgesia and nocebo hyperalgesia induced by 
classical conditioning in the absence of explicit verbal suggestions. 
90 CHAPTER 4
Materials and methods
Participants
A total of 42 female volunteers (mean age = 20.83 ± 1.46, range = 18-27 years) participated 
in the study. They were randomly assigned to three groups: placebo, nocebo and control 
groups. Sample size was based on previous studies that used a similar ‘n’ (14 persons in each 
group) and had shown significant effects in similar paradigms [15–17,22,26] (see Table 1). All 
of the participants were healthy, free of pain and did not take any type of pain medication; 
none of them had any contraindications for electrical stimulation and none of them had 
previously participated in any pain-related studies. Participants were informed that the 
aim of the study was to investigate responses to electrical stimulation and that they would 
receive a series of electrical stimuli during the study. They were also informed that they 
could stop participating at any point during the study without providing a reason for their 
withdrawal. After having read the description of the study’s procedure, participants gave 
their informed written consent to participate in the experiment. The study protocol was 
approved by the Research Ethics Committee at the Institute of Psychology of Jagiellonian 
University.
Table 1. Characteristics of the subjects in each experimental group.
Group N Sex Age BMI t T
Placebo 14 F 20.21 ± 1.25 19.56 ± 2.57 2.16 ± 0.91 13.65 ± 12.46
Nocebo 14 F 21.64 ± 1.78 22.70 ± 3.57 2.09 ± 0.98 16.86 ± 18.83
Control 14 F 20.64 ± 1.01 20.53 ±1.27 2.05 ± 0.57 15.9 ± 16.04
N – number of participants in each group; F – female; BMI - body mass index; t – non-painful tactile; T - pain 
threshold.
Stimuli 
The stimuli were electric shocks delivered to the volar surface of the non-dominant forearm 
through two durable stainless steel-disk electrodes 8 mm in diameter with 30 mm spacing. 
The electrical stimuli were square pulses with a duration of 200 μs delivered by the Constant 
Current High Voltage Stimulator (Digitimer, Welwyn Garden City, England, model DS7AH). 
The intensity of the electrical stimuli was set up individually for each participant according 
to a calibration procedure (see below) in which the level of non-painful tactile sensation (t) 
and the pain threshold (T) were determined. Depending on the experimental group, the 
intensity of the electrical stimuli (expressed in mA) was set at either [t + 0.8 × (T - t)] mA 
(paired with placebo stimuli), or (2.2 × T - 0.2 × t) mA (paired with nocebo stimuli). The 
formula [t + 0.8 × (T - t)] was used to ensure that the stimulus resulted in a clear tactile but 
non-painful sensation. The coefficient 0.8 was established on the basis of the results of a 
preliminary study. The formula for electrical stimuli paired with nocebo stimuli (2.2 × T - 0.2 
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× t) was established so that the calculated value was higher than the value of the control 
stimuli in the same proportion as the stimuli paired with placebo stimuli was lower with 
respect to the control stimuli. Regardless of group assignment, stimuli of the intensity of 1.5 
× T mA served as control stimuli. All participants received a total of 96 stimuli, excluding the 
calibration phase. 
 The electrical stimuli were preceded by the presentation of light stimuli presented 
in full-screen mode on a computer screen (17”, resolution 1280 x 1024) facing the subject 
at a distance of approximately 50 cm. Two colours of light stimuli were used – blue and 
orange. Either the blue or orange colour acted as a placebo/nocebo stimulus. The colours 
of the light stimuli were counterbalanced in two ways. For half of the participants, the blue 
colour was a placebo/nocebo stimulus when it preceded a less/more painful stimulus and 
the orange colour was a control stimulus. For the remaining half of the participants, the 
colours of the light stimuli were reversed (blue = control stimulus; orange = placebo/nocebo 
stimulus). Half of the participants started with the blue light, and the other half started with 
the orange light as the first light presented on the computer screen.
Measures
The participants rated pain intensity, expectancy of pain intensity, and fear by means of an 
11-point numeric rating scale (NRS). The scales for pain intensity and expectancy of pain 
intensity ratings ranged from 0 = ‘no pain’ to 10 = ‘the most pain that is tolerable’. Fear 
was rated on a scale ranging from 0 = ‘not at all’ to 10 = ‘very much’. At the end of the 
experiment all participants were asked to answer a question designed to determine if they 
had deciphered the actual aim of the study. However, nobody did decipher the actual aim 
of the study.
Design and procedures
The study consisted of three phases: calibration, conditioning, and testing (see Figure 1).
Calibration Phase
Calibration was conducted to determine the intensity of both painful stimuli (paired with 
nocebo stimuli) and non-painful stimuli (paired with placebo stimuli) individually. The 
calibration procedure was based on the method of limits applied in previous studies in 
which electrical stimulation was used to induce pain [17,26]. First, t and T were determined 
as follows. Ascending series of stimuli in steps of 0.5 mA (the interstimulus interval was 5 
sec) were delivered starting at 0 mA. The intensity of the electrical stimuli was gradually 
increased until participants detected their first non-painful tactile sensation (t). The intensity 
was further increased until the detected sensations became painful (T), which was clearly 
stated verbally by the participant. Then, the averaged values for t and T were calculated in 
order to determine the stimulus intensity for the conditioning procedure.
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Conditioning Phase 
The conditioning phase was started five minutes after the calibration phase was completed. 
A total of 72 electrical stimuli, divided into 4 blocks (18 stimuli each) with a 2 minute break 
between blocks, were delivered in a pseudorandom sequence – half of the stimuli in each 
block were of moderate intensity (1.5 × T mA, control stimuli) and the remaining half were 
non-painful ([t + 0.8 × (T - t)] mA in the placebo group) or higher intensity ([2.2 × T - 0.2 
×t] mA in the nocebo group). An electrical stimulus lasting 200 μs was delivered during the 
presentation of a black background, which was displayed for 2 sec. Before each electrical 
stimulus was applied, a blue or orange light was shown in a pseudorandom sequence for 
10 sec. One of the colours was paired with control stimuli and the other with non-painful 
stimuli (in the placebo group) or more painful stimuli (in the nocebo group). Participants 
were not informed about that association.
 The participants rated pain intensity, expectancy of pain intensity, and fear during 
the first and the third blocks of stimuli. The NRS for expectancy and fear ratings were shown 
during the presentation of the light stimuli. The NRS was shown 2 sec after the presentation 
of the light alone and lasted for 6 sec, followed by 2 sec of light alone. When 10 sec of light 
presentation was completed, a black background was presented and the electrical stimulus 
was delivered. For each block, one-third of the lights was displayed with the NRS for the 
expectancy of pain intensity rating, one-third was displayed with the NRS for the fear rating 
and one-third was displayed without any scale. In the latter case, a slide with the NRS for 
pain intensity rating was shown for another 6 sec immediately after the electrical stimulus 
was applied (see Figure 2). 
Figure 1. Study design. A total of 42 female volunteers were randomly assigned to three groups: placebo, nocebo, 
and control group. Each group consisted of 14 participants. The study consisted of three phases: calibration, 
conditioning, and testing. Calibration was conducted to determine non-painful tactile sensation (t) and the pain 
threshold (T). In the conditioning phase, a total of 72 electrical stimuli were delivered – half of the stimuli were of 
moderate intensity (1.5 × T mA, control stimuli) and the remaining half were non-painful ([t + 0.8 × (T - t)] mA in 
placebo group) or higher intensity ([2.2 × T - 0.2 × t] mA in nocebo group). The intensity of the electrical stimuli 
was always set at 1.5 × T mA in the control group. The testing phase consisted of 24 control stimuli (1.5 × T mA) 
regardless of group assignment.
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 Participants did not rate pain intensity, expectancy of pain intensity or fear during 
the second and the fourth blocks of stimuli. After 10 sec of light presentation (without any 
additional information on the slide), the black background was presented and the electrical 
stimulus was delivered.
Testing Phase
The testing phase began two minutes after the conditioning phase was completed. It 
consisted of 24 control stimuli (1.5 × T mA) preceded by 12 orange and 12 blue light stimuli 
presented in a pseudorandom sequence. The pain intensity, expectancy of pain intensity, 
and fear ratings were performed in the same way they were during the first and the third 
blocks of the conditioning phase, with one exception – pain was rated 12 times, while 
expectancy was rated 6 times and fear was rated 6 times. 
Figure 2. Details of the study design using an example of the placebo group with an orange light serving as a 
placebo. Part ‘A’ depicts the time-course of the procedure: there were four blocks of conditioning trials, two of 
them with pain, expectancy, and fear ratings (Blocks 1 and 3), and two without any ratings (Blocks 2 and 4). Each 
conditioning block consisted of 18 electrical stimuli. After the conditioning phase was completed, the testing phase 
consisting of 24 electrical stimuli began. Orange lights (orange vertical bars) served as placebo stimuli (non-painful 
intensity, i.e. [t + 0.8 × (T × t)] mA), while blue lights served as control stimuli (painful intensity, i.e. 1.5 × T mA). 
During the testing phase, the stimuli of the same painful intensity (i.e. 1.5 × T mA) were applied, regardless of 
the colour of the preceding light. Part ‘B’ depicts the design of single a trial: a colour light was presented for 10 
seconds. For each block, one-third of the lights was displayed with the NRS for the expectancy rating, one-third 
was displayed with the NRS for the fear rating and one-third was displayed without any scale. In the latter case, a 
slide with the NRS for pain intensity rating was shown for another 6 sec immediately after the electrical stimulus 
(depicted by red lightning) was applied.
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 The procedure in the control group was similar to that applied in the experimental 
groups. The only difference was that the intensities of the electrical stimuli were always 
set at 1.5 × T mA, regardless of the colour of the light stimuli (blue or orange). Participants 
were not aware that all the stimuli were set at the same level. Pain intensity, expectancy 
of pain intensity, and fear were rated in the same way as they were in the placebo and 
nocebo groups. Applying only one level of stimuli, i.e. 1.5 × T mA allowed to control for non-
associative learning effects (sensitisation and habituation) and the effects of colours on pain 
perception. Such designed control groups were used in previous studies in which placebo 
analgesia was induced by classical conditioning [26,27].
Statistical analysis
Manipulation check 
To control for baseline differences in pain, NRS pain ratings from conditioning phase of the 
study were compared using a repeated-measures analysis of variance (ANOVA) design, with 
experimental group (placebo, nocebo, and control group) as a between-subject factor and 
condition (placebo/nocebo- and control-associated NRS ratings) as a within-subject factor. 
The F-tests were followed by post-hoc comparisons for manipulation check. Differences 
between placebo versus control stimuli (placebo group), nocebo versus control stimuli 
(nocebo group), and blue-control versus orange-control stimuli (control group) were tested 
in post-hoc comparisons.
 To explore internal validity of the results, predictive validity of expectancy was 
evaluated. Pearson correlation coefficients (r) between expectancy of one type of stimuli 
(e.g. placebo, nocebo or control) and pain intensity associated with the same stimuli were 
calculated. To investigate reliability of the measurement, intraclass correlation coefficients 
(ICC
(3,3-6)
) were calculated based on repeated measurements of each variable: pain intensity, 
expectancy, and fear. ICCs values were calculated for each conditioning and testing blocks 
separately. ICCs above 0.75 were considered as a good reliability level [28]. 
Induction of the placebo analgesia and nocebo hyperalgesia
In order to verify hypotheses, data from testing phase of the study was analysed. Statistical 
comparisons were performed using a repeated-measures ANOVA design, with experimental 
group (placebo, nocebo, and control group) as a between-subject factor and condition 
(placebo/nocebo- and control-associated NRS ratings) as a within-subject factor. Separate 
ANOVAs were conducted for each dependent variable: pain intensity, expectancy of pain 
intensity, and fear in the testing phase of the study. In order to test whether conditioning 
was effective, the F-tests were followed by within-group planned-comparison tests: (1) 
placebo- versus control-associated NRS ratings in the placebo group, (2) nocebo- versus 
control-associated NRS ratings in the nocebo group, and (3) blue-control- versus orange-
control-associated NRS ratings in the control group. Separate comparisons were conducted 
for NRS ratings of: (a) pain intensity, (b) expectancy of pain intensity, and (c) fear. 
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 In the next step of the analyses, between-group planned-comparison tests were 
performed. To determine whether the placebo analgesia was induced, the mean difference 
in NRS pain ratings between placebo and control stimuli from the placebo group was 
compared to the mean difference between two control (blue and orange) stimuli from the 
control group. Similarly, to determine whether the nocebo hyperalgesia was induced, the 
mean difference in NRS pain ratings between nocebo and control stimuli from the nocebo 
group was compared to the mean difference between two control (blue and orange) stimuli 
from the control group. Similar comparisons were conducted for NRS ratings of expectancy 
of pain intensity and fear.
Regression analyses
Forward, stepwise multiple regression was performed to determine the degree to which 
the mean difference in pain intensity of the placebo/nocebo- and control-associated stimuli 
was predicted by (1) the mean difference in expectancies for placebo/nocebo- and control-
associated stimuli, and (2) the mean difference in fear for placebo/nocebo- and control-
associated stimuli. Separate analyses were performed for each of the three groups for the 
testing phase. The two predictor (or independent) variables were tested in each of the three 
regression analyses. 
 All the analyses were conducted using the STATISTICA data analysis software, version 
10 (StatSoft Inc., Tulsa, OK, USA), with the exception of the compromise power analyses and 
effect sizes calculations, which were performed using G*Power 3.1.9.2 [29,30]. The level of 
significance was set at p < 0.05 for rejecting the null hypothesis in all the statistical analyses. 
Results
Manipulation check
ANOVA on the pain ratings from conditioning phase revealed a statistically significant 
interaction between experimental group and condition (F
(2, 39)
 = 41.90, p < 0.001, ŋ2 = 0.68). 
No significant main effects of experimental group or condition were found. Post-hoc tests 
revealed that there were no baseline differences in NRS pain ratings for control stimuli 
across experimental groups, indicating that pain produced by control stimuli was rated 
similarly among experimental groups. However, placebo stimuli were rated as less painful 
(1.04 ± 1.24) compared to control stimuli (3.38 ± 2.16) in the placebo group (p < 0.001) and 
nocebo stimuli (4.55 ± 2.04) were rated as more painful compared to control stimuli (2.98 
± 1.87) in the nocebo group (p < 0.001), indicating that participants discriminated between 
more and less painful stimuli in the placebo and nocebo group. In the control group, there 
was no difference in NRS pain ratings for control stimuli associated with one colour (e.g. 
orange, 2.88 ± 2.37) compared to control stimuli associated with other colour (e.g. blue, 
2.80 ± 2.29).
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 Predictive validity of expectancy was very high. Expectancy of pain intensity 
associated with placebo stimuli was positively correlated with pain intensity experienced 
after placebo stimuli (r = 0.61, p < 0.05), and expectancy of pain intensity associated with 
control stimuli was positively correlated with pain intensity experienced after control stimuli 
(r = 0.85, p < 0.001) in the placebo group. Similar results were observed in case of the 
expectancy and pain ratings of nocebo (r = 0.80, p < 0.01) and control stimuli (r = 0.75, p 
< 0.01) in the nocebo group, and blue-control (r = 0.96, p < 0.001) and orange-control (r = 
0.77, p < 0.01) stimuli in the control group.
 Reliability coefficients for measured variables are presented in Table 2. Pain 
ratings were stable across conditioning and testing blocks and were characterized by 
excellent reliability level (ICC
(3,6) 
≥ 0.90). Reliability of expectancy and fear ratings was low to 
moderate (ICC
(3,3) 
= 0.41-0.70) during first conditioning block, moderate to good during third 
conditioning block (ICC
(3,3) 
= 0.68-0.89) and good during testing block (ICC
(3,3) 
> 0.85).
Table 2. Reliability of measurement. Intraclass correlation coefficients for each of measured variables associated 
with condition stimuli (placebo, nocebo, control) or control stimuli.
Stimuli Variable Block 1  Block 3  Testing  
  ICCc 95% CId ICCc 95% CId ICCc 95% CId
Conditiona Expectancy 0.44 0.25-0.62 0.89 0.82-0.93 0.85 0.76-0.91
 Pain 0.90 0.85-0.94 0.92 0.88-0.96 0.91 0.87-0.95
 Fear 0.51 0.32-0.67 0.92 0.88-0.96 0.88 0.82-0.93
Controlb Expectancy 0.41 0.22-0.60 0.68 0.53-0.80 0.89 0.82-0.93
 Pain 0.87 0.79-0.92 0.93 0.89-0.96 0.91 0.87-0.95
 Fear 0.70 0.56-0.81 0.88 0.81-0.93 0.88 0.81-0.93
a Condition refers to stimuli that were associated with placebo (placebo group), nocebo (nocebo group) 
or control (control group); b Control refers to stimuli that served as control stimuli in each of the group; 
c Intraclass correlation coefficient; d Confidence intervals.
Induction of the placebo analgesia and nocebo hyperalgesia
The descriptive statistics for all the analysed variables are presented in Table 3. ANOVA 
on the pain ratings from the testing phase of the study revealed a statistically significant 
interaction between experimental group and condition (F
(2, 39)
 = 26.17, p < 0.001, ŋ2 = 0.57). 
No significant main effects of experimental group or condition were found. Within-group 
planned comparison on placebo- versus control-associated NRS pain intensity ratings 
revealed a statistically significant difference for the placebo group (F
(1, 39)
 = 30.18, p < 0.001, 
ŋ2 = 0.44), indicating that the electrical stimuli associated with the placebo stimuli were 
rated as less painful than the control stimuli (mean difference 0.41 ± 0.19). Within-group 
planned comparison on nocebo- versus control- associated NRS pain intensity ratings 
revealed significant difference for the nocebo group (F
(1, 39)
 = 21.95, p < 0.001, ŋ2 = 0.36), 
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indicating that the electrical stimuli associated with the nocebo stimuli were rated as more 
painful than the control stimuli (mean difference 0.35 ± 0.38). By contrast, no statistically 
significant difference was found between two control stimuli in the control group (mean 
difference 0.04 ± 0.22). 
Table 3. Descriptive statistics for all the analyzed variables from the testing phase of the study (Mean ± SD).
Variable Stimuli Placebo group Nocebo group Control groupb
Pain intensity
Placebo/nocebo 3.14 ± 2.38 2.98 ± 2.17 3.02 ± 2.76
Control 3.55 ± 2.35 2.63 ± 2.08 2.99 ± 2.73
Differencea 0.41 ± 0.19 -0.35 ± 0.38 -0.04 ± 0.22
Expectancy
Placebo/nocebo 3.07 ± 1.98 3.57 ± 2.57 3.10 ± 2.97
Control 3.36 ± 2.13 3.14 ± 2.15 3.26 ± 2.94
Differencea 0.29 ± 0.70 -0.43 ± 1.14 0.17 ± 0.50
Fear
Placebo/Nocebo 1.48 ± 1.56 2.67 ± 2.17 0.95 ± 1.25
Control 1.64 ± 1.80 2.29 ± 1.91 1.05 ± 1.21
Differencea 0.17 ± 0.69 -0.38 ± 1.12 0.10 ± 0.36
a Difference between NRS ratings of placebo- or nocebo-associated stimuli.b In the control group, both stimuli were 
set at the same level of intensity; therefore, the differences presented here can be considered as the differences 
between the blue- and orange-associated NRS ratings.
 Between-group planned comparison on the difference between placebo- and 
control-associated NRS pain intensity ratings from the placebo group compared to the 
difference between blue-control- and orange-control-associated NRS pain intensity ratings 
from the control group revealed a statistically significant effect (F
(1, 39)
 = 17.87, p < 0.001, ŋ2 
= 0.31), indicating that placebo analgesia was induced by classical conditioning. Between-
group planned comparison on the difference between nocebo- and control-associated NRS 
pain intensity ratings from the nocebo group compared to the difference between blue-
control- and orange-control-associated NRS pain intensity ratings from the control group 
revealed also a statistically significant difference (F
(1, 39)
 = 8.82, p < 0.01, ŋ2 = 0.18), indicating 
that nocebo hyperalgesia was induced by classical conditioning without any explicit 
information (see Figure 3 and Table 4).
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Figure 3. Pain ratings during the conditioning and testing phases in placebo (A), nocebo (B) and control (C) group. 
Note that although the conditioning phase consisted of 72 electrical stimuli, which were divided into 4 blocks of 
18 stimuli, the participants rated pain intensity in only one-third of the trials during the first and the third blocks of 
stimuli. In the testing phase of the study (separated by vertical dotted lines), which consisted of 24 control stimuli, 
pain intensity was rated 12 times (6 for placebo/nocebo and 6 for control stimuli). The mean differences in pain 
intensity during the testing phase of the study in each of the study groups are presented in part D of the figure. In 
the testing phase, there were not only statistically significant differences in pain intensity within the placebo and 
nocebo groups, but the differences in pain intensity in the placebo and nocebo groups were significantly higher 
than in the control group. * p < 0.01, ** p < 0.001.
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ANOVAs on the expectancy and fear ratings revealed no statistically significant main effects 
or interactions (experimental condition ´ rating), indicating that conditioning had no effect 
on those variables (see Figures 4-6 and Table 4).
Figure 4. Expectancy ratings during the conditioning and testing phases in the placebo (A), nocebo (B) and 
control group (C). Note that although the conditioning phase consisted of 72 electrical stimuli, which were divided 
into 4 blocks of 18 stimuli, the participants rated expectancy in only one-third of the trials during the first and the 
third blocks of stimuli. In the testing phase of the study (separated by vertical dotted lines), consisting of 24 control 
stimuli, expectancy was rated 6 times. The mean differences in expectancy during the testing phase of the study in 
each of the study groups are presented in part D of the figure. There were no statistically significant differences in 
expectancy either within or between the study groups in the testing phase.
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Regression analyses
Moreover, none of the three regression models predicting the difference in pain intensity 
of the blue- and orange-associated stimuli in the testing phase of the study was found to be 
statistically significant, indicating that neither the difference in expectancies for blue- and 
orange-associated stimuli, nor the difference in fear for blue- and orange-associated stimuli, 
were able to predict the difference in pain intensity of blue- and orange-associated stimuli 
in any of the groups (see Table 5).
Figure 5. Fear ratings during the conditioning and testing phases in the placebo (A), nocebo (B) and control group (C). 
Note that although the conditioning phase consisted of 72 electrical stimuli, which were divided into 4 blocks of 18 
stimuli, the participants rated fear in only one-third of the trials during the first and the third blocks of stimuli. Fear 
was rated 6 times during the testing phase of the study (separated by vertical dotted lines), which consisted of 24 
control stimuli. The mean differences in fear during the testing phase of the study in each of the study groups are 
presented in part D of the figure. There were no statistically significant differences in fear either within or between 
study groups in the testing phase.
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Figure 6. Mean differences (horizontal bars) in pain intensity, expectancy and fear during the testing phase of 
the study. Individual scores were plotted to show data distribution. In the testing phase, the differences in pain 
intensity in the placebo and nocebo groups were significantly higher than in the control group. * p < 0.01, ** p < 
0.001.
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Table 5. Results of separate stepwise multiple regression analyses performed on each group, with the difference 
in pain intensity of placebo/nocebo- and control-associated stimuli as the dependent variable and differences in 
the expectancies for and the fear of blue- and orange-associated stimuli as independent variables.
Group n = 14 Variable Β T p (power) COR R² F p
Placebo Step 1 Fear 0.48 1.91 0.08 (0.24) 0.17 3.64 0.08
Nocebo Step 1 Expectancy 0.40 1.52 0.15 (0.14) 0.09 2.32 0.15
Control Step 1 Expectancy - 0.33 - 1.22 0.25 (0.09) 0.04 1.48 0.25
Discussion
Our study found that both placebo analgesia and nocebo hyperalgesia can be induced by 
classical conditioning without explicit verbal suggestions about analgesia and hyperalgesia, 
respectively. Moreover, we did not find evidence that self-reported expectancy of pain 
intensity predicts placebo and nocebo effects when participants experience pain changes 
during conditioning, but are not given an explicit verbal suggestion about pain modulation. 
Similarly, self-reported fear was not found to predict either placebo analgesia or nocebo 
hyperalgesia. 
 Both placebo analgesia and nocebo hyperalgesia were induced by classical 
conditioning without any verbal suggestions about decreases or increases in pain, 
respectively, and without any rituals, such as spreading fake cream, attaching sham TENS 
electrodes or giving a sugar pill. This result agrees with the previous findings showing that 
the experience of different pain levels during a conditioning procedure produces placebo 
analgesia [1,11–13]. However, to the best of our knowledge, nocebo hyperalgesia has not 
been induced previously by conditioning without verbal suggestions, although there was at 
least one such attempt [21]. 
 Self-reported expectancy of pain intensity was not found to predict individual 
pain changes. Among the few previous studies in which classical conditioning without 
verbal suggestions was sufficient to induce placebo analgesia [1,11–13], just two of them 
had participants perform expectancy ratings [11,13]. Voudouris and collaborators [13] 
measured expectancy only before the pretest, so it was impossible to answer the question 
whether conditioning changed expectancies over time. De Jong and collaborators [11] rated 
expectancy before each series of pain stimuli but the findings were inconsistent.
 Although the effects of classical conditioning are theoretically considered to be 
mediated by expectancies [31–33], our findings show that this may be not always the 
case. While the effects of classical conditioning on placebo analgesia induced by verbal 
suggestions are likely to be mediated by expectancies [5,6], the exposure to distinct pain 
intensities during conditioning in the present study was sufficient to induce placebo and 
nocebo effects that were not found to be predicted by trial-by-trial self-reported ratings 
of expectancy. These findings are in line with the fact that, in some cases, conditioning 
represents an automatic process which is not mediated by cognitive expectancy [34]. Our 
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results support a model postulating that placebo effects can be learned either consciously 
or unconsciously, depending on the specific circumstances [14].
 Our findings also align with recent findings on placebo analgesia and nocebo 
hyperalgesia induced by subliminal cues, without prompting participants to expect pain 
changes [23,24]. In this paradigm, clearly recognizable visual cues were first paired with pain 
stimuli. Conditioning was followed by a testing phase during which the same conditioned 
visual cues were presented subliminally. Pain stimuli preceded by subliminally presented 
conditioned visual cues were rated as more or less painful than control pain stimuli 
that were not preceded by visual cues, indicating that placebo and nocebo effects were 
induced without awareness [23,24]. The induction of placebo effects by conditioned stimuli 
presented subliminally suggests that the effects of conditioning may not involve explicit 
expectancy, which is consistent with the results of this study. 
 It should be noted that our findings do not exclude the overall role of expectancy in 
inducing placebo and nocebo effects. Self-reported explicit expectancy ratings, as measures 
of “conscious, conceptual belief about the future occurrence of an event” [7, p. 406], may 
not always predict placebo and nocebo effects. Rather, pre-cognitive associations, defined 
as “links between events and/or objects that exist outside conscious awareness” [7, p. 411], 
may be created through hidden conditioning procedures or innate associations that elicit 
a conditioned response. In summary, expectancy may be either conscious or unconscious 
[35,36]. Thus, although we did not find evidence for the involvement of self-reported 
expectancy in the placebo and nocebo effects induced by hidden conditioning, pre-cognitive 
associations between coloured lights and the level of pain intensity may have been critical 
in eliciting the observed placebo and nocebo effects. Our results supplement Miller and 
Colloca’s learning model of the formation of the placebo effect [37,38]. In that model, placebo 
effects result from expectancies acquired by decoding information from the psychosocial 
context that includes conditioned stimuli. The current findings suggest that the effects of 
conditioned stimuli may not always be mediated by self-reported explicit expectancy, but it 
does not exclude the possibility that they may be mediated by pre-cognitive associations. 
 Moreover, we did not find evidence that self-reported fear predicts placebo 
analgesia and nocebo hyperalgesia induced by hidden conditioning. However, this does 
not exclude the possibility that fear may moderate placebo and nocebo effects, e.g. a 
previous study showed that fear and stress can eliminate placebo effects induced by verbal 
suggestions [25]. We only found that trial-by-trial fear ratings do not predict the magnitude 
of placebo analgesia and nocebo hyperalgesia when pain intensity changes are experienced 
without any outcome-directed warning or information. Fear has been described as an 
emotional response elicited by an identifiable and explicit threatening stimulus [39,40]. In 
other words, fear emerges with subjective certainty that an aversive stimulus is impending 
and occurs in situations of certain threat and is manifested by heightened attention to 
specific threat stimuli [41,42]. As no explicit verbal suggestions were given in our study and 
self-reported expectancy did not predict placebo effects, our participants might not have 
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been certain that a specific colour preceded more pain. Thus, no evidence was found for 
the involvement of fear in the formation of the placebo analgesia and nocebo hyperalgesia 
induced by hidden conditioning without explicit verbal suggestions. This finding, together 
with the results showing that expectancy did not predict either placebo analgesia or nocebo 
hyperalgesia, suggests that hidden conditioning may be a distinct mechanism producing 
placebo and nocebo effects, and that neither expectancy nor fear might be involved in the 
formation of such effects induced without verbal suggestions.
 Some limitations of our study should be acknowledged. First, only females 
participated in the study, and in light of sex differences in pain perception [43,44], the 
results may not be generalizable to men. On the other hand, as only women participated in 
many of the previous studies on the mechanisms of placebo effects [11,15,17,22,45,46], the 
results of our study can be directly compared to previous research. Second, the sample size 
was rather small but it was based on previous studies that used a similar ‘n’ and had shown 
significant effects (14 persons in each group) in similar paradigms [15–17,22,26]. Moreover, 
power values together with effect sizes suggest that the sample size was enough to find 
statistically significant results (see Tables 4 and 5).
 Our results have implications for both pain research and medical practice. Caution 
should be used in considering self-reported expectancy of pain intensity as predictors of 
placebo and nocebo effects, as pain changes can occur even when participants are not fully 
aware of the ongoing treatment and anticipated outcomes. Brain imaging studies might 
provide evidence of more implicit mechanisms related to the formation of placebo and 
nocebo effects induced by classical conditioning without explicit verbal suggestions, e.g. 
pre-cognitive associations. 
 The results of the current study suggest that pain is a complex phenomenon. 
It can become worse or better after repetitive negative or positive experiences that are 
associated with the colour of the treatment and other uncontrolled conditioning cues. 
Thus, environmental factors associated with pain experience may serve as conditioned cues 
producing symptom worsening or improvement even if explicit instructions are not given 
and, presumably, cognitive expectancies play no role.
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Abstract
To investigate the influence of expectancy of pain intensity, fear of pain (trait), and fear 
(state) on the effectiveness of hidden and open conditioning to produce placebo analgesia. 
A total of 90 healthy female volunteers were randomly assigned to three groups (hidden 
conditioning, open conditioning, and control) who received electrical stimuli preceded by 
either orange or blue lights. One colour was paired with painful stimuli (control stimuli) 
and the other colour was paired with non-painful stimuli (conditioned stimuli) in both the 
hidden and open conditioning groups. Only participants in the open conditioning group were 
informed about this association. In the control group, both colour lights were followed by 
control stimuli. In the testing phase both coloured lights were followed by identical control 
stimuli. Participants rated pain intensity, expectancy of pain intensity, fear, and fear of pain. 
A significant analgesic effect was found only in the hidden conditioning group, where no 
explicit verbal suggestions were provided. Hidden conditioning had an effect on expectancy 
and fear – participants in the hidden conditioning group expected less pain and experienced 
less fear in relation to conditioned stimuli. Fear was the only predictor of placebo analgesia 
in the hidden conditioning group. Neither expectancy of pain intensity nor fear of pain 
predicted placebo analgesia. Fear seems to be more important factor than expectancy in 
producing the placebo analgesia induced by hidden conditioning.
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Introduction
Classical conditioning without verbal suggestions can produce placebo analgesia [1–4]. 
There are two ways to conduct a conditioning procedure – by informing or not informing 
participants about the relationship between the placebo (which serves as a conditioned 
stimulus) and the active substance or procedure (which serves as an unconditioned 
stimulus). When participants are aware of the relationship, this is called open conditioning, 
and when they are not aware of it, this is referred to as hidden conditioning. 
 Two important distinctions must be made here. First, there is an essential 
difference between informing participants about the character of a placebo (e.g. analgesic, 
hyperalgesic, or neutral) and informing them about the manipulation of pain levels, i.e. that 
the conditioning procedure is being applied. When participants are informed that a placebo 
is an active treatment, the effects of conditioning are usually stronger compared to the use 
of conditioning without verbal suggestions [3,5,6]. However, when they are informed that 
the level of pain is being manipulated during the conditioning procedure, there is a weaker 
effect or no effect, compared to the effect of hidden conditioning [2,7–9]. Second, hidden 
versus open conditioning is a different distinction than hidden versus open treatment 
[10,11]. The first distinction applies to types of conditioning, whereas the second applies to 
treatment, with patients being either informed or not that they are undergoing a medical 
treatment [12–16]. 
 Only four studies have been conducted in which both open and hidden conditioning 
procedures were used to induce placebo or nocebo effects [2,7–9]. Those studies showed 
that hidden conditioning produces a significant placebo effect [2,8,9], whereas open 
conditioning elicits a lesser effect or no effect [2,7–9]. However, the results of those studies 
are not conclusive about the role of open and hidden conditioning in shaping placebo 
effects. Thus, the first aim of our study was to compare the magnitude of the placebo 
analgesia induced by hidden and open conditioning. It was hypothesized that the magnitude 
of the placebo analgesia induced by hidden classical conditioning would be greater than the 
magnitude of the placebo analgesia induced by open classical conditioning, if it was induced 
in the latter case at all.
 The distinction between hidden and open conditioning may be crucial for the 
debate about the role of expectancies in placebo and nocebo effects [17]. According to 
the model of Benedetti and colleagues [10], conditioning may work through the mediation 
of conscious expectancies or without the mediation of conscious expectancies. From that 
viewpoint, the main difference between hidden and open conditioning may be the role of 
consciousness. While hidden conditioning can create conscious expectancies, which are 
self-reported [18], open conditioning may not involve expectancies. This is in line with 
the results of previous studies in which only participants in the hidden conditioning group 
expected less pain on placebo trials than on non-placebo trials [2] and hidden conditioning 
had no effect on the placebo analgesia induced by verbal suggestions when expectancy 
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was controlled [8]. On the other hand, although expectancy predicted placebo analgesia, 
this finding was based on the results across all participants, without distinguishing between 
the hidden and open conditioning groups [2]. Thus, an investigation of hidden versus open 
conditioning could be a way to disentangle conditioning and expectancies. Thus, our second 
aim was to investigate the role of expectancy of pain intensity in both hidden and open 
conditioning. We hypothesize that expectancy of pain intensity would be involved in the 
placebo analgesia induced by hidden conditioning but not open conditioning. 
 The final aim of the study was to determine the role of fear as a state (hereafter 
referred to as fear) and fear as a trait (hereafter referred to as fear of pain) in shaping placebo 
analgesia induced by hidden and open conditioning. It has been found that high fear of pain 
seems to be related to reduced placebo analgesic responding [19,20], and that fear can 
abolish [21] the placebo effects induced by verbal suggestion. The only study that has been 
conducted to investigate the role of fear in placebo effects induced by open and hidden 
conditioning found that fear predicted placebo analgesia to some degree [2]. However, 
this result was based on the pooled results of all the participants, without distinguishing 
between the hidden and open conditioning groups. We hypothesized that high fear of 
pain will reduce the magnitude of the placebo analgesia induced by classical conditioning. 
Moreover, we hypothesized that fear would be involved in the placebo analgesia induced by 
hidden conditioning rather than open conditioning.
Materials and methods
Participants
A total of 90 female volunteers (mean age = 23.51 ± 2.72; range = 18 - 35 years) participated 
in the study (see Table 1). They were recruited by announcements and received a financial 
reward for their participation. A total of 591 volunteers applied to participate in the study. 
Before inclusion in the study, all the volunteers underwent on-line screening based on 
criteria proposed by Gierthmühlen and collaborators [22]. They have proposed the list of 
items that should be considered while including healthy participants to the studies. They 
argue that using the proposed criteria of health will increase certainty that participants are 
really healthy and that obtained results are not influenced by uncontrollable factors related 
to health. Moreover, they argue that common use of these criteria may help the researchers 
to compare their results with others and improve the quality of studies. In the current study 
the proposed criteria were used rigorously to reduce confounding factors affecting sensory 
functioning of healthy participants to a minimum. In effect, the large number of volunteers 
was excluded from the study.
 The basic screening consisted a set of questions concerning general health. The 
Hospital Anxiety and Depression Scale (HADS) [23] was used to exclude people with emotional 
disorders. A total of 448 volunteers were excluded from the study because they met at least 
one of the following criteria: (1) age below 18 or over 35; (2) previous participation in a pain 
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study; (3) pain complaints during the last three months; (4) taking painkillers; (5) intake 
any regular medication including non-prescription drugs; (6) using illegal drugs including 
cannabis; (7) overusing tobacco and alcohol; (8) presence of or history of any neurological, 
respiratory, circulatory, musculoskeletal, metabolic and/or psychiatric disorders; or (9) 
current symptoms of anxiety and/or depression. A total of 103 eligible people who met the 
selection criteria were randomly assigned to one of three groups: hidden conditioning, open 
conditioning, or the control group.
 Participants were informed that the aim of the study was to investigate responses 
to electrical stimulation and that they would receive a series of electrical stimuli during the 
study. They were also informed that they could stop participating at any point during the 
study without providing a reason for their withdrawal. After having read the description of 
the study’s procedure, participants gave their informed written consent to participate in 
the experiment. The study protocol was approved by the Research Ethics Committee at the 
Institute of Psychology of Jagiellonian University.
Stimuli
Transcutaneous electrical stimuli were delivered to the volar surface of the non-dominant 
forearm through two durable stainless-steel disk electrodes that were 8 mm in diameter 
and spaced 30 mm apart. The electrical stimuli were square pulses with a duration of 200 μs 
delivered by the Constant Current High Voltage Stimulator (Digitimer, Welwyn Garden City, 
England, Model DS7AH). The intensity of the electrical stimuli was established individually 
for each participant according to a calibration procedure (see below) in which the level of 
non-painful tactile sensation (t) and the pain threshold (T) were determined. The intensity 
of the electrical stimuli paired with the conditioned stimulus was set at [t + 0.8 x (T - t)] 
mA. The formula [t + 0.8 x (T - t)] was used to ensure that the stimulus resulted in a clear 
tactile but a non-painful sensation. The coefficient 0.8 and the formula were established 
on the basis of the results of a preliminary study and were necessary to avoid the use of 
transcutaneous electrical stimuli that would be below tactile threshold, i.e. undetectable 
by the participants. Stimuli of the intensity of 1.5 x T mA served as the control stimuli. All 
participants received a total of 96 stimuli, excluding the calibration phase.
 The electrical stimuli were delivered during the presentation of light stimuli, which 
were presented in full-screen mode on a computer screen (17′′, resolution 1280 x 1024), 
facing the subject at a distance of approximately 50 cm. Two colours of light stimuli were 
used: blue and orange. Either the blue or the orange colour acted as a conditioned or control 
stimulus. The colours of the light stimuli were counterbalanced in two ways. For half of the 
participants, the blue light was a conditioned stimulus as it preceded a less painful stimulus 
and the orange light was a control stimulus. For the remaining half of the participants, 
the colours of light stimuli were reversed: blue was a control stimulus and orange was a 
conditioned stimulus. Half of the participants started with a blue light, and the other half 
started with an orange light as the first light presented on the computer screen.
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Measures
The participants rated pain intensity, expectancy of pain intensity, and fear using an 11-point 
numeric rating scale (NRS). The scales for pain intensity and expectancy of pain intensity 
ratings ranged from 0 = ‘no pain’ to 10 = ‘the most pain that is tolerable’. Fear was rated on 
a scale ranging from 0 = ‘not at all’ to 10 = ‘very much’.
 All participants were tested before the experimental session with the Fear of Pain 
Questionnaire (FPQ-III) [24], which was used to measure the general level of fear associated 
with pain. The FPQ-III is a 30-item self-report measure. Each item is rated on a five-point 
Likert scale ranging from 1 ‘not at all’ to 5 ‘extreme’. The questionnaire consists of three 
subscales, each of which has 10 items: severe pain (e.g. “Being in an automobile accident.”), 
minor pain (e.g. “Biting your tongue while eating.”), and medical pain (e.g. “Having a blood 
sample drawn with a hypodermic needle.”). The range of scores for each subscale is 10-50, 
yielding a total score range of 30-150. A higher score indicates a greater fear of pain. A higher 
score indicates a greater fear of pain. The FPQ-III has good internal consistency (total scale = 
0.92, severe pain = 0.88, minor pain = 0.87, and medical pain = 0.92) and test–retest reliability 
(total scale = 0.74, severe pain = 0.69, minor pain = 0.73, and medical pain = 0.76) [24]. 
 At the end of the experiment, participants in the control group and the hidden 
conditioning group were asked to answer questions designed to determine if they had 
figured out the contingency between the light stimulus and pain intensity. 
Design and procedure
The experimental session consisted of three phases: calibration, conditioning, and testing 
(see Figure 1). 
Calibration phase
Calibration was conducted to determine the intensity of the painful stimuli (paired with 
control stimuli) and the non-painful stimuli (paired with conditioned stimuli) individually. 
The calibration procedure was based on the method of limits applied in previous studies in 
which electrical stimulation was used to induce pain [25,26]. First, t and T were determined 
as follows. Ascending series of stimuli were delivered in steps of 0.5 mA (the interstimulus 
interval was 5 sec), starting from 0 mA. The intensity of the electrical stimulus was gradually 
increased until a participant reported the first non-painful tactile sensation (t). The intensity 
was further increased until a participant reported that the sensation became painful (T). 
The average values of t and T were calculated to determine the stimulus intensity for the 
conditioning procedure.
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Conditioning phase
The conditioning phase started five minutes after the calibration phase was completed. A 
total of 72 electrical stimuli were delivered in 4 blocks of 18 stimuli each, with a 2 minute 
break between blocks. The stimuli were delivered in a pseudorandom sequence – half of 
the stimuli in each block was painful (1.5 x T mA) and the remaining half was non-painful 
([t + 0.8 x (T-t)] mA). A blue or orange light was presented on the computer screen before 
Figure 1. Study design of examples of the hidden and open conditioning groups with a blue light serving as a 
conditioned stimulus. Participants assigned to each of the three experimental groups received sets of electrical 
stimuli during three successive phases of the experimental session, i.e. calibration, conditioning, and testing. 
Participants in the open conditioning group were informed before the conditioning phase that one of the colours 
(blue in this example) was related to the lower intensity of electrical stimuli (VS+), and before the testing phase 
they were informed that colours were no longer related to the intensity of the electrical stimuli (VS-). Participants 
in the hidden conditioning group and control group did not receive any verbal suggestions. Note: HADS, Hospital 
Anxiety and Depression Scale; t, non-painful tactile sensation; T, pain threshold; Data from 13 participants were 
not included in final analysis because they either guessed the study’s aim, figured out the contingency between the 
light stimulus and pain intensity, or they did not follow the study instructions.
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each electrical stimulus was applied in the hidden conditioning group. One of the colours 
was paired with painful stimuli and the other with non-painful stimuli. Participants were 
not informed about this association. The participants rated pain intensity, expectancy of 
pain intensity, and fear only during the second and fourth blocks of the conditioning phase. 
Immediately after the electrical stimulus was applied, a slide with the NRS for the pain 
intensity rating was shown for 6 seconds. The background of the slide was lit in the same 
colour as the one that preceded the electrical stimulus. The NRS for the expectancy of pain 
intensity and fear ratings were displayed before application of the electrical stimuli, during 
the presentation of the light stimuli. The NRS was shown after 2 seconds of the presentation 
of the light alone, which lasted for 6 seconds, followed by 4 seconds of the light alone 
(see Figure 2). The electrical stimulus was delivered during the last 2 seconds of the light 
presentation. In summary, each light stimulus was presented for 12 seconds. For each of the 
two blocks, one-third of the stimuli was presented with the NRS for pain intensity rating, 
one-third with the NRS for the expectancy of pain intensity rating and one-third with the 
NRS for the fear rating (see Figure 2).
 The procedure was the same in the open conditioning group as it was in the hidden 
conditioning group; however, only participants in the open group were told at the beginning 
of the conditioning phase which colour of light stimuli would precede more intensive 
electrical stimuli, and which colour of light stimuli would be related to less intensive electrical 
stimuli. However, participants from none of the groups were informed why there were lights 
or why they were not all the same color.
 The procedure for the control group was similar to that used with the hidden 
conditioning group. The only difference was that the intensity of the electrical stimuli was 
always set at 1.5 x T mA, regardless of the colour of the light stimuli (blue and orange). 
Applying only one level of stimuli, i.e. 1.5 x T mA, allowed to control for nonassociative 
learning effects (sensitisation and habituation) and the effects of colours on pain perception. 
Such designed control groups were used in previous studies in which placebo analgesia was 
induced by classical conditioning [25,27].
Testing phase
The testing phase began two minutes after the conditioning phase was completed. At the 
beginning of the testing phase participants in the open conditioning group were informed 
that electrical stimuli would be preceded by light stimuli as before, but the intensity of the 
electrical stimulation would not be related to the colour of the light. They were informed 
that they would no longer be able to predict the intensity of the electrical stimuli based on 
the light preceding the electrical stimuli. Participants in the hidden conditioning group and 
control group did not receive any additional verbal information. The testing phase consisted 
of 24 control stimuli (1.5 x T mA) preceded by 12 orange and 12 blue light stimuli presented 
in a pseudorandom sequence. Pain intensity, expectancy of pain intensity, and fear ratings 
were performed similar to the way they were in the second and the fourth blocks of the 
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conditioning phase with one exception – pain was rated 12 times, while expectancy of pain 
intensity and fear were rated 6 times (see Figure 2).
Statistical analysis
Data from 13 participants were not included in the final analyses. Six of them (four from the 
hidden conditioning group and two from the control group) guessed the aim of the study. 
For the purpose of the study it was crucial that only participants in the open conditioning 
group were aware of the contingency between pain and light stimuli. Additional three people 
were excluded from the control group because they declared that there was a contingency 
between the light stimulus and pain intensity although in fact no contingency was present 
in that group. Data from four people from the hidden conditioning group was not included 
in the analyses because of coffee intake prior to experimental session (one participant) or 
because they failed to response to the NRS scales on time during the experiment (three 
participants). As a result, each group consisted of 30 participants (see Figure 1).
Figure 2. Experimental procedure using an example of the hidden conditioning group with a blue light serving as 
a conditioned stimulus. Part ‘A’ refers to the course of the procedure: there were four blocks of conditioning trials, 
two of them with pain intensity, expectancy of pain intensity, and fear ratings (blocks 2 and 4), and two without 
any ratings (blocks 1 and 3). Each conditioning block consisted of the application of 18 electrical stimuli. Blue 
lights (blue vertical bars) served as conditioned stimuli (non-painful intensity), while orange lights served as control 
stimuli (painful intensity). During the testing phase, 24 stimuli of the same painful intensity were applied, regardless 
of the colour of the preceding light. Part ‘B’ depicts the design of a single trial: a colour light was presented for 12 
seconds. For each block, one-third of the lights was displayed with the NRS for the expectancy of pain intensity 
rating, one-third was displayed with the NRS for the fear rating and one-third was displayed without any scale. In 
the latter case, a slide with the NRS for pain intensity rating was shown for another 6 sec immediately after the 
electrical stimulus (depicted by red lightning) was applied.
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 Baseline differences in age, pain threshold, tactile threshold, height, and body 
mass were analysed by one-way analysis of variance (ANOVA) with experimental group 
as a between-subject factor. To control for differences in pain, pain intensity ratings from 
conditioning phase of the study were compared using a repeated-measures analysis of 
variance (ANOVA) design, with experimental group (hidden conditioning, open conditioning, 
and control group) as a between-subject factor and condition (conditioned and control 
stimuli) as a within-subject factor. The F-tests were followed by post-hoc comparisons for 
manipulation check. Differences between conditioned versus control stimuli (hidden and 
open conditioning groups), and blue-control versus orange-control stimuli (control group) 
were tested in post-hoc comparisons.
 In order to verify hypotheses, data from the testing phase of the study were 
analysed. Statistical comparisons were performed using a repeated-measures ANOVA 
design, with experimental group (hidden conditioning, open conditioning, and control 
group) as between-subject factor and condition (conditioned and control stimuli) as a 
within-subject factor. Separate ANOVAs were conducted for each dependent variable: pain 
intensity, expectancy of pain intensity, and fear.
 The F-tests were followed by within-group planned comparison tests: conditioned 
versus control stimuli in the (1) hidden and (2) open conditioning group, and blue-control 
versus orange-control stimuli in the (3) control group.
In the next step of the analyses, three between-group planned-comparison tests were 
performed. (1) To determine whether the placebo analgesia was induced in the hidden 
conditioning group, the mean difference in pain intensity ratings between conditioned and 
control stimuli from the hidden conditioning group was compared to the mean difference 
between two control (blue and orange) stimuli from the control group. (2) Similarly, to 
determine whether the placebo analgesia was induced in the open conditioning group, the 
mean difference in pain intensity ratings between conditioned and control stimuli from the 
open conditioning group was compared to the mean difference between two control (blue 
and orange) stimuli from the control group. (3) To test whether the magnitude of the placebo 
analgesia is greater in the hidden conditioning group than in the open conditioning group, 
the mean difference in pain intensity ratings between conditioned and control stimuli from 
the hidden conditioning group was compared to the mean difference between conditioned 
and control stimuli from the open conditioning group. Separate analyses were conducted 
for each of the three dependent variables: (a) pain intensity, (b) expectancy of pain intensity, 
and (c) fear.
 Forward, stepwise multiple regression was performed to determine the degree to 
which the placebo analgesia was predicted by either expectancy of pain intensity, fear or 
fear of pain. To do this, the mean difference in pain intensity ratings between conditioned 
and control stimuli in the testing phase (i.e. placebo analgesia) was set as the dependent 
variable, while the (a) fear of pain, (b) mean differences in the fear ratings, and (3) mean 
differences in the expectancy of pain intensity ratings between conditioned and control 
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stimuli in the testing phase served as independent variables. Separate analyses were 
performed in each of the three study groups. The three predictors were tested in each of 
the regression analyses.
 All the analyses were conducted using the STATISTICA data analysis software, 
version 12 (StatSoft Inc., Tulsa, OK, USA). The level of significance was set at p < 0.05.
Results
Table 1 shows the characteristics of the participants by experimental group. No significant 
differences were observed in participant characteristics across the three groups (see Table 
1): age (F
(2,87)
 = 0.81; p > 0.05; ŋ2 = 0.02), pain threshold (F
(2,87)
 = 0.25; p > 0.05; ŋ2 = 0.01), 
tactile threshold (F
(2,87)
 = 0.94; p > 0.05; ŋ2 = 0.02), height (F
(2,87)
 = 0.41; p > 0.05; ŋ2 = 0.01), 
and body mass (F
(2,87)
 = 0.75; p > 0.05; ŋ2 = 0.02). The descriptive statistics for all the analysed 
variables are presented in Table 2.
Manipulation check
ANOVA on the pain intensity ratings from conditioning phase revealed a statistically 
significant main effect of condition (F
(1, 87)
 = 129.74, p < 0.001, ŋ2 = 0.60) and an interaction 
between experimental group and condition (F
(2, 87)
 = 33.65, p < 0.001, ŋ2 = 0.44). No 
significant main effect of experimental group was found. Post-hoc tests revealed that there 
were no differences in pain intensity ratings for control stimuli across experimental groups, 
indicating that pain produced by control stimuli was rated similarly among experimental 
groups. However, conditioned stimuli were rated as less painful (0.43 ± 0.54) compared to 
control stimuli (3.02 ± 1.76) in the open conditioning group (p < 0.001) and conditioned 
stimuli were rated as less painful (0.69 ± 0.78) compared to control stimuli (2.92 ± 2.16) 
in the hidden conditioning group (p < 0.001), indicating that participants discriminated 
between more and less painful stimuli in both experimental groups. In the control group, 
there was no difference in pain intensity ratings for control stimuli associated with one 
colour (e.g. orange, 2.22 ± 1.59) compared to control stimuli associated with other colour 
(e.g. blue, 2.21 ± 1.66).
Placebo analgesia
ANOVA on the pain intensity ratings from the testing phase of the study revealed a statistically 
significant main effect of condition (F
(1,87)
 = 5.55; p < 0.05; ŋ2 = 0.06) and an interaction 
between experimental group and condition (F
(2,87)
 = 3.52; p < 0.05; ŋ2 = 0.08). Within-group 
planned comparisons on the pain intensity ratings of conditioned versus control stimuli 
revealed a statistically significant difference only in the hidden conditioning group (F
(1,87)
 = 
12.43; p < 0.001; ŋ2 = 0.12). 
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 Between-group planned comparison on the difference in pain intensity ratings 
between conditioned and control stimuli from the hidden conditioning group compared to 
the difference in pain intensity ratings between blue-control and orange-control stimuli from 
the control group revealed a statistically significant effect (F
(1,87)
 = 5.97; p < 0.05; ŋ2 = 0.06). 
In addition, between-group planned comparison on the difference in pain intensity ratings 
between conditioned and control stimuli from the hidden conditioning group compared 
to the difference from open conditioning group also revealed a statistically significant 
effect (F
(1,87)
 = 4.56; p < 0.05; ŋ2 = 0.05), indicating that the placebo analgesia found in the 
hidden conditioning group was stronger than the effect found in the control group and 
the open conditioning group. No significant differences were found within or between the 
control and open conditioning groups (see Table 3 and Figures 3 and 4). In general, placebo 
analgesia defined as a difference in pain intensity ratings between mean conditioned and 
control stimuli in the testing phase of the study was found in 14 participants in the hidden 
conditioning group and 16 participants in the open conditioning group. 
Expectancy
No statistically significant main effects of experimental group or condition were found on 
the expectancy of pain intensity ratings. However, ANOVA revealed a statistically significant 
interaction between experimental group and condition (F
(2,87)
 = 10.91; p < 0.001; ŋ2 = 
0.20). Within-group planned comparisons on the expectancy of pain intensity ratings of 
conditioned versus control stimuli revealed a statistically significant difference only in the 
hidden conditioning group (F
(1,87)
 = 21.48; p < 0.001; ŋ2 = 0.20). 
 Between-group planned comparison on the difference in expectancy of pain 
intensity ratings between conditioned and control stimuli from the hidden conditioning 
group compared to the difference in expectancy of pain intensity ratings between blue-
control and orange-control stimuli from the control group revealed a statistically significant 
effect (F
(1,87)
 = 11.70; p < 0.001; ŋ2 = 0.12), indicating that the expectation of lower pain 
intensity in relation to conditioned stimuli was stronger in the hidden conditioning group 
than in the control group. In addition, between-group planned comparison on the difference 
in expectancy of pain intensity ratings between conditioned and control stimuli from the 
hidden conditioning group compared to the difference from open conditioning group 
showed a statistically significant effect (F
(1,87)
 = 19.94; p < 0.001; ŋ2 = 0.20), indicating that 
the expectation of lower pain intensity in relation to the conditioned stimuli was stronger 
in the hidden than in the open conditioning group. No significant differences were found 
within or between the control and open conditioning groups (see Table 4 and Figure 4).
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Figure 3. Mean pain intensity ratings during the conditioning and testing phases of the study (separated by 
vertical dotted lines) in hidden conditioning group (conditioned vs. control stimuli), open conditioning group 
(conditioned vs. control stimuli), and control group (orange vs. blue stimuli). Although the conditioning phase 
consisted of 72 electrical stimuli, which were divided into 4 blocks of 18 stimuli, the participants rated pain intensity 
in only one-third of the trials during the first and the third blocks of stimuli. In the testing phase of the study, which 
consisted of 24 control stimuli, pain intensity was rated 12 times. Error bars represent the SE.
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Figure 4. Between and within-group comparisons of mean pain intensity, expectancy of pain intensity, 
and fear ratings. The placebo analgesia was induced only in the hidden conditioning group and 
corresponded with significant differences in fear and expectancy between the placebo and control stimuli. 
* p < 0.05, ** p < 0.01, *** p < 0.001. Error bars represent the SE.
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Fear
ANOVA on the fear ratings revealed statistically significant main effects of condition (F
(1,87)
 
= 3.81; p < 0.05; ŋ2 = 0.04) indicating that conditioned stimuli were rated as less fearful 
than control stimuli. Within-group planned comparisons on the fear ratings of conditioned 
versus control stimuli revealed a statistically significant difference only in the hidden 
conditioning group (F
(1,87)
 = 6.12; p < 0.01; ŋ2 = 0.07). 
 Between-group planned comparison on the difference in fear ratings between 
conditioned and control stimuli from the hidden conditioning group compared to the 
difference in fear ratings between blue-control and orange-control stimuli from the control 
group revealed a statistically non-significant trend (F
(1,87)
 = 3.27; p < 0.07; ŋ2 = 0.04). No 
significant differences were found within or between the control and open conditioning 
groups (see Table 5 and Figure 4).
Predictors of the placebo analgesia
Significant predictors were found only in the hidden conditioning group. In the first step of the 
forward stepwise multiple regression analysis, the difference in fear ratings was a significant 
predictor (β = 0.83, p < 0.001), accounting for a significant portion of the variance in the 
placebo analgesia (COR R2 = 0.68, p < 0.001). In the second and final step, the difference in 
fear ratings (β = 0.87, p < 0.001) and fear of pain scores (β = -0.12, p > 0.05 accounted for a 
similar portion of the variance (see Table 6). No other regression model to predict the placebo 
analgesia was statistically significant, indicating that neither the difference in expectancy of 
pain intensity nor the difference in fear ratings and fear of pain scores were able to predict 
the differences in pain intensity ratings in the other groups (see Table 6).
Table 6. Results of stepwise regression analyses on each group, with the difference in pain intensity ratings 
as the dependent variable and fear of pain, differences in fear ratings and expectancy of pain intensity as 
independent variables.1
Groupa Step N Variable β t p COR R² F p
Hidden Step 1 30 Fear 0.83 7.83 0.001 0.68 61.27 0.001
Step 2 30 Fear 0.87 7.78 0.001 0.68 31.49 0.001
Fear of pain -0.12 -1.10 0.28 - - -
Open Step 1 30 Fear 0.16 0.82 0.42 0.00 0.26 0.85
Expectancy -0.002 -0.01 0.99  - - -
Fear of pain 0.05 0.25 0.81 - - -
Control Step 1 30 Fear -0.13 -0.68 0.51 0.00 0.40 0.67
Expectancy 0.10 0.49 0.63 - - -
Fear of pain 0.002 0.01 0.99 - - -
1 See text for full explanation. Analyses were performed based on the data from the testing phase of the study; a 
Experimental groups: hidden conditioning, open conditioning, and control group.
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Discussion
Placebo analgesia was induced only by the hidden conditioning procedure. The participants 
who underwent this procedure expected less pain and experienced less fear in relation to 
conditioned stimuli than to control stimuli. Our study revealed that state of fear rather than 
expectancy of pain intensity did predict differences in pain, i.e. placebo analgesia. We did 
not find any evidence that dispositional fear of pain measured by FPQ-III was involved in 
placebo analgesia. 
Hidden and open conditioning
Placebo analgesia was found only in the hidden conditioning group. Thus, the results of our 
study suggest that hidden conditioning is more effective in inducing the placebo analgesia 
than open conditioning is. This result is in line with previous findings showing that the placebo 
effect can be induced by a conditioning procedure when participants are not informed about 
the relationship between placebo and pain intensity [1–4]. We did not observe a placebo 
analgesia in the open conditioning group. This is consistent with the results of previous 
studies in which open conditioning induced neither a placebo [2,9] nor a nocebo effect [7], 
or did not find any effect on placebo analgesia induced by verbal suggestions [8]. Although 
our study supports the results of previous studies [2,7–9], its design was significantly 
different. First, we used coloured light as a conditioned stimulus, whereas previous studies 
used placebo creams [2,7–9]. Second, we did not inform our participants about the nature 
of the conditioned stimulus, whereas participants in previous studies were informed 
either that the placebo was an analgesic [8,9] or an inactive cream [2,7,9]. Third, after the 
conditioning procedure was completed, we informed our participants that the colours of 
the lights were no longer associated with the levels of pain stimuli during the testing phase, 
whereas participants in previous studies were informed that pain stimulation was equal in 
both the conditioned and control trials [2,7,8]. Despite those methodological differences, we 
observed similar results. The fact that open conditioning failed aligns with the current state 
of knowledge concerning the role of verbal information on classical conditioning. It is a well-
known fact that after conditioning, extinction can be produced by informing participants 
that the contingencies are no longer in effect, without any actual extinction trials that could 
change or reverse the classically conditioned associations [28–31]. This is what might have 
happened in our open conditioning group.
Expectancy
Hidden but not open conditioning had an effect on expectancy of pain intensity ratings, 
i.e. only in the hidden conditioning group did participants expect less pain in relation to 
the conditioned stimuli than the control stimuli. This is in keeping with one of the previous 
studies in which open conditioning did not have an effect on expectancy ratings [2]. These 
results suggest that participants in the open conditioning group did not create expectations 
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of decreased pain in relation to conditioned stimuli. Even if they created such expectations, 
these expectations might have been cancelled by the verbal information provided before 
the testing phase of the study, i.e. that the colours of the lights were no longer associated 
with the levels of the pain stimuli.
 Although hidden conditioning had an effect on expectancies, the differences in 
expectancy of pain intensity ratings in relation to conditioned stimuli and control stimuli did 
not predict the differences in pain intensity ratings, i.e. placebo analgesia. This may seem to 
be inconsistent with the results of previous studies in which expectancy predicted placebo 
analgesia [2] and hidden conditioning had no effect on the placebo analgesia induced by 
verbal suggestions when expectancy was controlled [8]. However, in the first study in which 
expectancy predicted placebo analgesia, this finding was based on the results across all 
participants, without distinguishing between the hidden and open conditioning groups [2]. 
Moreover, fear was not controlled in the latter study, so it is possible that if it had been 
added to the regression model, expectancy would not have been a significant predictor or 
would not have explained placebo analgesia, as emphasized by the results of our study. 
Fear of pain (trait) and fear (state)
Hidden conditioning had an effect on fear ratings. Participants in the hidden conditioning 
group not only expected less pain but also experienced less fear in relation to the conditioned 
stimuli than the control stimuli. In the open conditioning group no significant differences in 
fear ratings were found. 
 Moreover, differences in fear ratings predicted the differences in pain intensity 
ratings, i.e. placebo analgesia. This finding is consistent with results of the two previous 
studies showing that fear (state) may be a predictor of placebo analgesia. The first of the 
two studies proved that fear induced after the administration of a placebo can disrupt or 
even completely abolish the placebo effect induced by verbal suggestions [21]. The second 
study has shown that fear can also contribute to the placebo effect induced by classical 
conditioning [2]. However, the latter study’s findings were based on the pooled results from 
all the participants, without making a distinction between the hidden and open conditioning 
groups. Our study clarified this result showing that fear predicted placebo analgesia induced 
by hidden conditioning. 
Previous studies have also shown that dispositional fear of pain was related to placebo 
analgesia [20,21,32]. The results of these studies revealed that higher fear of pain was 
associated with lower placebo responding. However, our study did not find evidence that 
fear of pain was involved in placebo analgesia. We do not exclude the possibility that high 
dispositional fear may have moderating effect on placebo analgesia. The differences in 
the findings of the previous studies and the current study may result from the differences 
in the study designs. We induced placebo analgesia by hidden conditioning, while verbal 
suggestions were used to induce placebo analgesia in all previous studies [20,21,32]. 
Moreover, we used electrical stimulation to induce pain sensations, while in all previous 
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studies pain was evoked by contact heat [20,21,32]. It seems that thermal pain may better 
mimic the naturally occurring pain [33], therefore it is possible that experimental procedure 
which was used in the previous studies may be more useful to answer some of the questions 
related to pain.
 To sum up, our study suggests that pain-related fear (state) seems to be more 
important factor than expectancy of pain intensity in producing the placebo analgesia 
induced by hidden conditioning. Our results did not confirm the role of dispositional fear in 
predicting placebo analgesia.
Strengths and weaknesses of the study
Our study is one of just a few investigations in which the effects of hidden and open 
conditioning have been compared. This is also the first study in which the effects of fear 
of pain on placebo analgesia induced by hidden conditioning have been investigated. 
Moreover, our sample size was rather large compared to the sample sizes of previous studies 
on the mechanisms of the placebo effects. Our detailed screening procedure allowed us to 
control for many potential confounders, such as age, mood, and health problems. Using 
colour lights rather than the placebo cream paradigm prevented the effects of previous 
experiences with active treatment creams that might have biased the study’s results. Finally, 
the colours of the light stimuli were counterbalanced to prevent the influence of the colours 
of conditioned and control stimuli on our study’s results. 
 Nevertheless, the fact that all the study variables relied on self-reports is a 
limitation, however this is also the case in most of the studies on the mechanisms of placebo 
effects [1,26,34–39]. Second, only females participated in the study and the results may 
not be generalizable to males. However, the results of our study can be compared to the 
results of previous research, as they are not biased by gender differences in pain perception, 
and the fact that females participated in many of the previous studies on the mechanisms 
of placebo effects [2,35,39–42]. Third, although the effect of hidden conditioning found in 
our study is statistically significant, it is quite small (ŋ2 = 0.20). However, it was induced by 
classical conditioning only, without any verbal suggestions, which is not always the case. 
A few previous studies found that both classical conditioning and verbal suggestions are 
needed to induce the placebo effects [5,6,43]. From this perspective, even small effect of 
pure conditioning seems to be both theoretically and clinically important. Fourth, the strict 
application of inclusion criteria proposed by Gierthmühlen and collaborators [22] ensured 
that only healthy volunteers participated in the current study and the results were not 
influenced by uncontrollable factors related to health. As a consequence, the results of our 
study should not be directly applied to clinical groups. However, it should be emphasized 
that the current study is basic research aimed to investigate the mechanisms of placebo 
effect, not a clinical study. Fifth, although experimentally induced pain in healthy volunteers 
seems to be a good model of clinical pain [44], experimental findings might not be directly 
transferable to clinical settings. Sixth, the colour of the light was the only stimulus associated 
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with the changes in pain levels in our study; we did not use a placebo intervention in a 
narrow sense. However, even if no inert treatment is administered, the effect of some 
experimental (or clinical) manipulations can be called a placebo-related effect [45]. In our 
study conditioning (i.e. reducing pain stimuli preceded by one colour) indeed was a kind 
of manipulation that induced placebo effect. We used colour stimuli without any other 
intervention because we did not want to confound those two different factors that might 
have been affected by conditioning. However, despite this difference in the procedure of our 
and previous studies, we found similar results [2,7–9].
Conclusions
We found that placebo analgesia was induced by hidden rather than open classical 
conditioning. Moreover, the differences in fear as a state, rather than expectancy of pain 
intensity, were involved in the placebo analgesia induced by hidden conditioning. The 
results of our study may have important implications for both pain research and medical 
practice. They suggest that when studying the mechanisms of placebo effects, fear as a state 
should be controlled. An assessment of individual level of fear should also be performed 
in the context of pain management, as it seems to be crucial factor in the effectiveness of 
placebo interventions and also may be important in the effectiveness of active treatment. 
Moreover, expectancy of pain intensity ratings should be collected in studies of placebo 
effects when conclusions about the role of expectancy of pain intensity are to be drawn. 
Finally, hidden rather than open conditioning is an effective method to induce placebo 
analgesia in experimental studies, and it is possible that the same may be the case in clinical 
settings.
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Abstract
This study investigated the effect of fear of movement-related pain (FMRP) and contextual 
pain related anxiety (CPRA) on the magnitude of placebo analgesia induced by verbal 
suggestion. The role of state anxiety and state fear on the placebo effect is unclear because 
placebo studies are not accurate in the naming and the way of elicitation of both emotional 
states. To investigate the influence of both emotional states we modified the voluntary 
joystick paradigm (VJMP) and combined it with a colour paradigm used in previous 
placebo studies. Fifty-six healthy, female participants completed a VJMP that incorporated 
two experimental conditions: (1) a predictable pain condition, where one of the joystick 
movements (conditioned stimuli – CS+) is always followed by pain (unconditioned stimuli 
– US) and the other movement was never followed by pain (CS-); (2) an unpredictable pain 
condition, in which pain stimuli were delivered in an unpredictable manner, and never 
after a joystick movement. By varying this level of predictability, in the first condition FMRP 
was induced and in the second one CPRA. In the present study placebo suggestions were 
colour stimuli (red/green) presented on a computer screen at the beginning of each trail. 
One half of the participants was verbally informed that the green/red light indicated less 
painful stimuli application (experimental groups), the other half did not receive any verbal 
suggestion (control groups). We measured self-reported pain intensity, expectancy of pain 
intensity (only in the predictable pain condition), pain related fear and anxiety (self-ratings 
and eyeblink startle response) and avoidance behaviour measurements (movement-onset 
latency and duration). 
 The results indicate that the placebo effect was successfully induced in both 
experimental conditions. In the predictable pain condition the placebo effect was predicted 
by expectancy. Despite the fact that some of our manipulation checks indicate that FMRP 
in PC and CPRA in the unpredictable pain condition was successfully induced (self-reported 
fear and startle response), we did not find differences in the magnitude of placebo effect 
between the predictable pain and unpredictable pain condition. Concluding, we did not find 
a difference in the effect of fear or anxiety on placebo analgesia.
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Introduction
Anxiety [14,17] and fear [9,20], both understood as state variables, are shown to be involved 
in placebo effects. Although some similarities exist between anxiety and fear, they are 
substantially different phenomena. Anxiety is defined as a person’s current level of aversive 
emotional state modulated by situational factors [21] that entails an appraisal of threat that 
is uncertain or uncontrollable [22,23], whereas fear is defined as an aversive reaction elicited 
by the perception of a specific threat stimulus, whether conditioned or not [22]. In general 
placebo has been shown to affect pain by reducing negative emotional states. Nevertheless, 
in most previous studies on placebo effects it is unclear whether fear or anxiety was 
measured. A common method to induce fear involves a fear-conditioning paradigm [22]; an 
experimental procedure that uses the threat of shock is usually used to elicit anxiety [24]. 
Although the authors usually use either the term ‘fear’ or ‘anxiety’, it seems that anxiety is 
treated as a synonym of fear rather than a different psychological phenomenon [9,20]. As a 
consequence, it is not clear what actually influences placebo effects: fear or anxiety or both. 
To address this question there is a need to experimentally differentiate both emotions.
 The voluntary joystick movement paradigm (VMJP) [25–28] offers a good way to 
induce both fear and anxiety in an experimental setting. The VMJP is a novel pain-relevant 
fear conditioning paradigm developed by Meulders et al. [26] in which extremity movements 
function as CSs and painful stimuli as USs. In this paradigm, fear of movement-related pain 
(FMRP) and contextual pain-related anxiety (CPRA) [22,29] are elicited in two experimental 
conditions, respectively: predictable (PC) and unpredictable pain condition (UC). In the PC, 
conditioned stimuli (CS; joystick arm movement) are paired (CS+) or not paired (CS-) with 
painful unconditioned stimuli (US; electric shock) which, after a few repetitions, results in a 
more fearful response (conditioned response, CR) to the movement that is always followed 
by painful stimuli (CS+). In the UC, pain stimuli are delivered in time intervals regardless of 
the joystick movement. As a result such a condition induces state anxiety. It was also shown 
that the association between the movements and application of pain stimuli, as is in the 
case of PC, elicits defensive fear responses (i.e., avoidance behaviour) [25,26].
 This is the first study that aimed to investigate placebo analgesia in two different 
conditions: experimentally induced FMRP and CPRA. VJMP was applied in the context of 
the colour paradigm used in previous placebo studies in order to elicit placebo analgesia 
[30,31]. In the colour paradigm, a one-colour stimulus (colour resented on the computer 
screen) serves as a placebo and is paired with application of a lower pain stimulus. Applying 
the VJMP allows investigation of aspects of chronic pain maintenance (fear conditioning) 
in the context of a placebo study. The aim of the study was to compare the magnitude of 
the placebo effect between PC and UC. It is predicted that a lower placebo effect would be 
observed in the UC compared to PC, as uncertainty have been associated with increased 
pain ratings [25].
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Expectations are recognized as a key psychological mechanism that underlies placebo effects 
[1–4]. Although some recent studies indicate that classical conditioning without conscious 
expectations may produce placebo effects [5–7], the conditioning procedure is mostly used 
as a method of inducing and altering/changing expectations [8–13]. Thus, placebo effects 
are suggested to be mediated by conscious expectations that can be produced by, among 
other methods, classical conditioning, including verbal suggestions and social observation 
[1–3,8,12]. Unfortunately, only a few placebo studies have actually attempted to measure 
expectations [9,12–17] and fewer have measured expectations on a trial-by-trial level 
[7,18,19].
 Second aim was to investigate to what extent trial-by-trial expectancy of pain 
intensity (only in PC) could predict the placebo effect. Importantly, to check if experimental 
manipulations induced different negative emotional states, both subjective and physiological 
measures (i.e. startle response) were used as a manipulation check. 
Hypotheses
For pain ratings the following hypotheses were stated:
 1.   The placebo effect will be elicited in both the PC and the UC by verbal suggestion 
of pain decrease.
 2.   The placebo effect observed in the UC will be lower compared to the PC.
For expectancy of pain the following hypotheses were stated:
 1.   Due to verbal suggestion participants will expect less pain after placebo 
compared to non-placebo-associated stimuli only in experimental groups. No 
such differences will be found in the control groups.
 2.   Placebo analgesia induced via verbal suggestion will be predicted by the 
expected level of pain intensity in PC.
For self-reported fear of painful movement, startle amplitudes, and response latencies the 
following hypothesis was stated:
 1.   Elevated defensive conditioned responses will be elicited by CS+ compared with 
CS- movements.
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Materials and methods
Participants
Fifty-nine right-handed, female volunteers (mean age = 24.10 years SD = 4.60, range = 19 – 49 
years) participated in this study. Volunteers were recruited amongst the student population 
of the Radboud University Nijmegen, the Netherlands, and received remuneration for 
participation in the study. All participants were healthy, free of pain and not taking any 
pain medications. Exclusion criteria included pregnancy, neurological, cardiovascular and 
respiratory diseases, psychiatric disorders and hearing problems. Three participants were 
excluded from the analyses: two due to technical problems and one due to very slow joystick 
movements during the experiment and a large age difference (age 49 is considered too high 
compared to the age range of 19 to 37 of the other participants). Data of the remaining 
56 participants were further analysed (mean age = 23.66 years SD = 3.27, range = 19 – 37 
years). They were randomly assigned to one of the four groups: two experimental (group 
1 and group 3) and two control groups (group 2 and group 4). Each group consisted of 14 
participants (see Table 1).
 The participants were informed that they were participating in a study with the 
objective of determining how fast they could move the joystick when pain stimuli were 
delivered to their hand. All participants signed a written informed consent prior to the 
experiment. They were also informed that they could stop participating at any point during 
the study without giving a reason. The study was approved by the institutional ethics 
committee of Radboud University in Nijmegen (ECG2012-1301- 005) and by the Research 
Ethics Committee at the Institute of Psychology of Jagiellonian University in Kraków, Poland.
Stimuli materials
Electrocutaneous stimuli
Electrocutaneous pain stimuli of 200 µs duration were delivered to the volar surface of the 
dominant forearm through two durable stainless-steel disk electrodes 8 mm in diameter 
with 30 mm spacing, using a Constant Current High Voltage Stimulator (Digitimer, Welwyn 
Garden City, England, model DS7AH). In the present study a painful electrocutaneous stimulus 
was used as an unconditioned stimulus (US). The intensity of painful stimuli were individually 
set for each of the participants. In total 96 painful stimuli were delivered during 4 blocks 
of the experiment (24 stimuli in each block). Successive painful stimuli were separated by 
approximately 16 sec2 in the PC and the UC. The participants were not aware that the same 
intensity stimuli were delivered to their right hand during the whole experiment (except during 
the calibration phase). The mean intensity of the stimuli calculated for individual intensities for 
all participants was 17.05 mA, SD = .52 and ranged between 7.5–24 mA.
2  The time between successive painful stimuli varied due to the differences in participants’ reaction times (joystick movements).
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Table 1. Characteristics of the subjects in each experimental group: means (and standard deviations).
Groups N Sex Age
Predictable experimental Group 1 14 F 24.21(2.46)
Predictable control Group 2 14 F 24.14(4.66)
Unpredictable experimental Group 3 14 F 23.50(3.03)
Unpredictable control Group 4 14 F 22.79(2.61)
Note: N, number of subjects in each experimental group; F, Female
Colour stimuli and visual stimuli
The colour stimuli were full-screen colour slides (red and green) displayed on a computer 
screen (60 Hz refresh rate) facing the participant at a distance of approximately 50 cm. The 
red/green colour stimulus was presented for around 6.5 sec ms at the beginning of each trial 
of the experiment (see Figure 1). Either the green or red colour acted as a placebo or a control 
stimulus. The colour stimuli were counterbalanced and the order of their presentation was 
pseudorandom (no more than 3 consecutive trials containing the same colour stimulus and 
CS movements). For half of the participants from the experimental groups (Group 1 and 
3), the green colour was associated with a placebo-suggestion (information that electrical 
stimuli following green colour will be less painful) and the red colour was a control stimulus 
(non-placebo). For the remaining half of the participants in the experimental groups, the 
meaning of colour stimuli was reversed: green was the control stimulus and red was the 
placebo stimulus. A total of 192 colour stimuli were presented: 24 red and 24 green in each 
block of the experiment.
 During the experiment two types of visual stimuli were used: two arrows or a single 
arrow, presented during the colour stimulus presentation (see Figure 1). At the beginning, two 
arrows (both pointing in the same direction) were presented for 3.5 sec and represented a 
preparation signal anticipating the direction of the movement to be performed. Participants 
were asked not to move the joystick during this visual stimulus presentation. Afterwards, 
a single arrow was presented for 1.5 sec that always pointed in the same direction as the 
two arrows. It represented a starting signal for the joystick movement (leftward arrow – left 
movement; rightward arrow – right movement; 32x32 pixels).
Joystick movements
During the testing phase of the experiment (see below) the participants were asked to move 
a Logitech Attack 3 joystick to the left and to the right and these movements served as 
conditioned stimuli (CSs). The preparation signal (two arrows) announced the direction of 
the movements at the beginning of each trial. The participants were asked to perform the 
movement as soon as the starting signal (single arrow) disappeared from the centre of the 
black background screen. The proper joystick movement was precisely specified and the 
participants learned how to move it in the practice phase of the experiment (see below).
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Startle probe
The startle probe was a burst of white noise with instantaneous rise time (100dBA, 50 ms) 
presented binaurally by SONY stereo headphones. Startle probes are ideal for collecting a 
startle blink reflex (startle eyeblink reflex – SBR)[33]. The loudness of the startle probe was 
measured set using a Sound Pressuremeter Brüel & Kjær (Amplifier Type 2610, microphone 
4192, Artificial Ear Type 4153; Denmark). Startle probes were delivered during the startle 
habituation phase and testing phase of the experiment (see below).
Procedure
The present study, analogous to Meulders et al. [25,26,34], consisted of 4 phases: a 
calibration phase, a startle habituation phase, a practice phase and a testing phase lasting 
around 6, 5, 5 and 503 minutes, respectively. The experiment was performed in a sound-
attenuated laboratory room. The participants were seated in a comfortable armchair in 
front of a computer screen at a distance of roughly 50 cm with both of their hands resting 
on the desk or with their right hand holding the joystick and their left hand placed near the 
keyboard to be able to use its buttons when it was necessary to score their pain experience. 
 An adapted version of VJMP [25,26,34] was used in order to investigate the placebo 
effect. As was the case in the studies of Meulders et al. [25,26,34], two conditions of the 
experiment were incorporated, namely predictable pain (Group 1 and 2) and unpredictable 
pain (Group 3 and 4) in order to elicit fear of movement-related pain and pain-related 
anxiety, respectively [25,26,34]. In the PC (in both experimental and control group), one of 
two possible joystick movements was always followed by a painful stimulus (the direction 
of this CS+ movement was counterbalanced across the participants). In the UC (in both 
experimental and control group) pain stimuli were never associated with the joystick 
movement but were delivered after specific inter trial interval (ITI) at the beginning or at the 
end of the trial (see Figure 1B).
 The adjustment of the VJMP allowed a placebo manipulation to be implemented. 
Firstly, the verbal suggestion procedure was introduced to elicit placebo analgesia where 
colour stimuli served as placebos. Secondly, a control condition was incorporated where no 
suggestion about the meaning of the colours was provided (control groups). Participants 
from the experimental groups (Group 1 and Group 3) were verbally informed about the 
association between placebo stimuli and less painful stimuli applications. Such information 
was also provided during the experimental procedure in the form of a description presented 
on the computer screen. In the control groups no information about the association of 
placebo stimuli and stimulus intensity was provided (Group 2 and Group 4). Crucially, the 
participants were not aware that they received the same intensity of stimuli throughout the 
experiment. Moreover, in the present study participants underwent only one experimental 
condition (PC or UC). Due to this fact the procedure did not include two long-lasting, 
3   The time of testing phase of the experiment vary due to the different reaction times (joystick movements) and did not include between blocks 
brakes.
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of Meulders et al. [25,26,34].
 The four phases of the experiment were slightly different in the PC and the UC 
(see below). Trial timing of both conditions was equal, with some exceptions; consequently, 
some participants took more time to move the joystick.
Calibration phase
The calibration was conducted to select the individual painful stimuli for each participant. 
During this phase the participants were asked to rate the intensity of each stimulus delivered 
to their forehand on an 11-point numeric rating scale (NRS) ranging from 0 = ‘no pain’, to 10 
= ‘the strongest pain ever’. Participants were informed that the experiment was targeting 
a score of 7 (‘moderate pain’) on the NRS and that 10 on the scale indicated the intensity 
that they did not want to receive anymore. To set these individualized painful stimulus, 
the participants received one series of electrical stimuli of increasing intensity (1 mA per 
step, starting from 0) to the value at which an NRS score of 7 was obtained. Next, the 
intensity of electrical stimuli was decreased (0.5 per step) to an NRS score of 6 and next 
increased until again a value of 7 on the NRS was obtained. The average of the three values 
of the individually scored stimulus intensity that was rated as a 7 on the NRS was used as 
painful stimulus during the experiment. The inter-trial interval (ITI) between each of the 
electrical stimulus applications was around 10 s. During the calibration phase, participants 
were instructed to notify the experimenter when they did not want to proceed to receiving 
stimulations of higher intensity.
Startle habituation phase
A startle habituation phase was performed to prevent potential confounds in the data that 
could be caused by an increased reaction to first startle probes. We presented 1 startle 
probe during 12 consecutive trials. Each trial lasted for 24 sec. The timing of the startle 
probe presentation was different in each trial (5, 10, 15 and 20 sec) and was randomized 
over trials of each participants (see [25]). During the startle habituation phase no painful 
stimuli were delivered and participants did not perform joystick movements.
Practice phase 
In this phase participants had to perform 14 correct joystick movements. The main task was 
to move the joystick (7 rightward and 7 leftward movements performed in a pseudorandom 
order) as quickly as possible when a starting signal (left or rightward arrow) disappeared 
from the computer screen. Moreover, during this phase, the participants received detailed 
feedback to learn how to operate the joystick accurately. They monitored the joystick 
movement via a cursor displayed on the computer screen with the target regions visible. The 
target region was a big white square presented on the computer screen. The participants 
were informed if their movement was performed correctly (text information: “Good” 
appeared at the computer screen). Additional error information was provided in the case 
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of: wrong movement direction (text information: “Wrong direction” if the movement was 
performed in the opposite direction to which the single arrow was pointing); incomplete 
movement (text information: “Wrong movement” if the cursor did not reach the target 
region); slow movement (text information “Too slow”) if the movement lasted more than 3s. 
Trials with an incorrect movement were repeated until a correct movement was performed. 
Additionally, in the PC (Group 1 and 2) in 7 of 14 trials pain stimuli were delivered after 
one of the movements (right or left, counterbalanced across participants). Due to this, 
the participants learned the association between a specific movement and pain stimuli 
application. In the UC (Group 3 and 4) no pain stimuli were delivered during this phase.
Testing phase 
During this phase in both the PC (Group 1 and 2) and the UC (Group 3 and 4), the colour 
stimuli, electric shocks and startle probes were presented. The target region, cursor and 
error messages were not displayed anymore. Before the testing phase, the position of the 
electrode was changed to prevent stimulation of the same skin area – the electrode was 
moved slightly away from the palm towards the elbow by approximately 2 cm. In both 
conditions of the experiment the participants’ task was to move the joystick as fast and as 
accurately as possible after the presentation of the starting signal (single arrow) and score 
their pain sensation when the NRS scale appeared on the computer screen.
 The experimental phase consisted of 4 blocks of 48 trials each (24 rightward and 
24 leftward movements each). Trial timing and trial types of the PC and UC are presented in 
Figure 1. Each trial started with the colour stimulus presentation. In each block there were 
24 trials in which the colour green and 24 trials in which the colour red was presented. The 
trial order was pseudorandomized. There were no more than 3 consecutive trials of the 
same joystick movement, no more than 3 consecutive trials using the same colour stimulus 
and no more than 2 consecutive trials with the startle probe presentation. During the colour 
stimulus presentation, the white fixation cross (FC) and preparation signal (two arrows) 
were also presented (see Figure 1). 
 The experimental phase differed slightly between the PC and UC (see Figure 1). In 
the PC, one type of movement was always followed by a painful stimulus (CS+ movement). 
The movement site associated with pain stimuli was counterbalanced across the participants. 
One half of participants received painful stimuli after the rightward and the other half after 
the leftward movement (see Figure 1A). In the UC pain stimuli were never delivered after 
joystick movement but were delivered at the beginning of the trial (during FC) or at the end 
of the trial 3-5 sec after the movement (see Figure 1B). In the PC, in contrast to the UC, the 
participants were asked to rate their expectances about the intensity of the stimulus they 
were about to receive (see Figure1A). 
 In the PC, the startle probe was presented at one of the following moments during the 
trial: during the fixation cross and colour stimuli presentation (6 trials in one block); during the 
movement followed by the pain application (CS+; 6 trials in one block); during the movement 
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not followed by the pain application (CS-; 6 trials in one block); or during the break in between 
trials (6 trials in one block) (see Figure 1A). In the UC, the startle probe was presented during 
the fixation cross and colour stimuli presentation (6 trials in one block) when the pain stimuli 
was delivered at the end of the trial; during the right (CSright) and the left movement (CSleft) (6 
trials in one block for one movement type); or during the break in between trials (6 trials in 
one block) when the pain stimuli were delivered at FC (see Figure 1B).
Figure 1. Design of the testing phase in predictable condition (A) and unpredictable condition (B). The timing of 
the trials differ slightly in accordance to individual reaction time (movement time). Note: ‘+’ represents fixation 
cross (FC) when the participants were asked to focus their eyesight on the FC; ‘NRS’ represents Numerical Rating 
Scale used to score pain sensations; red and green triangles represent counterbalanced colour stimuli used as 
placebos; àà represents preparation signal anticipating the direction of the movement to be performed (right 
movement in this case); à represents starting signal of the movement (right movement in this case); CS + represents 
a joystick movement always followed by painful stimuli; CS- represents a joystick movement never followed by 
painful stimuli in predictable pain condition; CSc represents a joystick control movement (both rightward and 
leftward movements) never followed by painful stimuli in the unpredictable condition; speaker represents startle 
probe presentation; lightning represents painful stimuli application. In the predictable and unpredictable pain 
condition startle probes were delivered during movements (6 with CS+/CSright and 6 with CS-/CSleft in each block of 
the experiment), in FC presentation (in 2 trials at 2 sec; in 2 trials at 2.5 sec; in 2 trials at 3 sec, in each block) and 
at the end of the trial (in 2 trials at 2 sec after the movement; in 2 trials at 2.5 sec after the movement; in 2 trials 
at 3 sec after the movement).
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Measurements 
Pain intensity
In the PC and in the UC of the experiment the participants rated their pain sensation after 
each electric stimulus application on a 11-point Likert scale ranging from 0 = ‘no pain’ to 10 
– ‘the strongest pain ever’ (the intensity that they don’t want to receive anymore). The scale 
was presented for 2.5 sec after the pain stimuli application (see Figure 1).
Expectancy of the pain stimuli intensity
In all the trials of the PC participants answered the question “How painful do you expect the 
stimulus will be after performing the left/right movement” and scored their sensation on 
a 11-point Likert scale with ranging from 0 = ‘no pain’ to 10 = ‘the strongest pain ever’. The 
scale was presented for 2.5 sec, during the colour stimuli and the preparation signal (two 
arrows) presentation (see Figure 1).
Defensive conditioning responses
Regarding retrospective fear of movement-related pain during the CSs, for both conditions 
of the experiment, after each block the participants answered the question “How fearful 
were you to perform the right/left movement”. The answer was scored on an 11-point Likert 
scale ranging from 0 = ‘not fearful at all’ to 10 = ‘the worst fear I can imagine’. They were 
asked about fear of performing the CS+ movement and also the CS- movement in the PC and 
about fear of performing the CS to right (CSright) and left (CSleft) side in the UC.
 Regarding response latency and duration, the start region and target region of the 
joystick movement were identified by a small and a large circle presented on the computer 
screen, respectively. These circles were visible only during the practice phase. Response 
latency (movement initiation latency time) was defined as the time to start the joystick 
movement in accordance to the direction pointed by the arrow stimuli. Response latency 
(T1) was technically defined as the time from the moment of disappearance of the arrow 
until participants left the start region (small circle). The small circle was placed in the middle 
of the screen (17′′ and resolution 1920:1080). The radius of the small circle was r = 52 
pixels. Response duration (T2) was defined as the time from leaving the small circle (start 
region) until leaving the large circle (target region), which indicated that participants had 
successfully completed a movement. The radius of the large circle was r = 370 pixels. A 
correct movement was defined as reaching the left/right hemisphere of the large circle.
 For both T1 and T2 reaction times under 0.2 sec, above 3 sec and larger than 2.5 
SD from the truncated mean of its corresponding cell in the experimental design (the mean 
for all trials of the participants in the given experimental group) were discarded from the 
analysis in accordance with Lachaud et al. [35]. The removed data are: (1) Group 1: 9.7% of 
trials of T1 and 6.69 % of trial of T2; (2) Group 2: 20.31% of trials of T1 and 13,54 % of trial 
of T2; (3) Group 3: 13.16% of trials of T1 and 6.84 % of trial of T2; (4) Group 4: 11,94% of 
trials of T1 and 7.44 % of trial of T2. From the remaining data, the mean reaction time for 
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each participant was calculated for each CS movement in each experimental group (CS+, 
CS-, CSright and CSleft). 
Eye blink startle modulation
The eye blink startle responses collected during the CS movements were used as 
psychophysiological correlates of FMRP and CRPA, indexed by ITI startle responses. The 
orbicularis oculi electromyography activity (EMG) was recorded with four electrodes: two 
attached to the external canthi of both eyes (monitoring horizontal eye movement) and 
one above and one below the left eye (monitoring vertical movement, i.e. blinks). The 
EMG ground electrode was placed on the nose. Signals were recorded with a Brain Vision 
Recorder (Brain Products, Munich, Germany) using a 150 Hz low-pass filter, with a time 
constant of 10 s (0,016 Hz) and a 500 Hz sampling frequency. The signal from the complete 
experiment was digitized at 1000 Hz and MatLab R2013a software (student edition) was 
used to perform postprocessing. First, EEG data were loaded using EEGLAB Toolbox (Version 
14.0.0). Secondly, data were manipulated according to [33] by performing rectification, 
variable-weight FIR filtering (101 coefficients, low-pass cut-off frequency 40Hz), and vertical 
movement electrodes signal summation. The summed signal was then epoched about the 
startle probe marker (marking the 0 ms origin) in the range -200 ms to 1000 ms. Analogously 
to Meulders et al. [25,26], the summed signal was baselined by averaging the signal in the 
range -20 ms to 0 ms.  The peak amplitudes were defined as the maximum of the response 
curve within 21–175 ms after the startle probe onset. Startle waveforms (raw signal for all 
four electrodes) were visually inspected off-line in order to exclude technical abnormalities 
and artefacts. Participants with no observed blink responses in either CS or ITI were excluded 
from the data set. Averages were calculated for responding during CS movements (CS+, CS-, 
CSright and CSleft) and ITI (mean startle amplitude collected during FC and during the break in 
between trials) separately for both the PC and the UC. Data collected from 20 participants 
from the PC and 20 participants from the UC were used in further statistical analysis.
Statistical analysis
In order to test our hypotheses, data from the testing phase of the study were analysed. 
The NRS pain intensity ratings were averaged from blocks 1 to 4 in the PC and the UC. 
Two dependent variables were analysed: (1) the mean pain intensity of placebo- and non-
placebo-associated pain ratings4 and (2) the mean difference between placebo- and non-
placebo-associated pain ratings in experimental groups; and the mean difference between 
red- and green-associated pain ratings in control groups. Similarly, the NRS expectancy 
of the pain intensity ratings, from blocks 1 to 4 in the PC, were averaged, and dependent 
variables were analysed: (1) the mean placebo- and non-placebo-associated expectancy 
of pain intensity ratings and (2) the mean difference between placebo- and non-placebo-
associated expectancy of pain intensity ratings in the experimental group; and the mean 
4  Note that in control conditions placebo and non-placebo stimuli refer to mean ratings of green- and red- associated stimuli, respectively.
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difference between red- and green-associated expectancy of pain intensity ratings in the 
control group.
Analysis of variance
Separate repeated measures ANOVAs were conducted for each dependent variable: NRS 
pain intensity ratings and NRS expectancy of pain intensity. A repeated measures ANOVA 
for NRS pain intensity ratings, with Condition (predictable and unpredictable) and Group 
(experimental and control) as between-subjects factors and Placebo (placebo and non-
placebo stimuli)4 as a within-subjects factor was performed. For NRS expectancy of pain 
intensity scores the repeated measures ANOVA with between-subjects factor Group 
(experimental and control) and within-subjects factor Placebo (placebo and non-placebo 
stimuli) was computed.
 In order to test whether verbal suggestion was effective, the repeated measures 
ANOVA was followed by within-group planned comparison tests: (1) placebo- versus non-
placebo-associated NRS ratings in the experimental group, and (2) red-control versus 
green-control NRS ratings in the control group. In the next step of the analyses, in order 
to investigate whether placebo analgesia was elicited, between-group planned comparison 
tests were performed on the difference in pain intensity ratings between non-placebo- and 
placebo-associated stimuli from the experimental groups compared with the difference 
in pain intensity ratings between red-control and green-control stimuli from the control 
groups.
In order to test whether verbal suggestion elicited differences in participants’ expectancy, 
within-group planned comparison tests were performed for the expected pain intensity 
scores: (1) placebo- versus non-placebo-associated expectancy of pain intensity scores 
in the experimental group, and (2) red-control versus green-control expectancy of pain 
intensity scores in the control group. 
Regression analysis
Linear regression analysis was performed for the PC to determine the degree to which 
the placebo analgesia was predicted by the expected pain intensity. To do this, the mean 
difference in pain intensity ratings between placebo- and non-placebo-associated stimuli 
was set as the dependent variable, while the mean differences in the expected pain intensity 
scores between placebo- and non-placebo-associated stimuli served as an independent 
variable.
Defensive conditioning responses – manipulation check
In order to investigate if CS+ movements in predictable condition elicit elevated defensive 
conditioning responses, for (1)self-reported fear, (2) response latencies (T1), and (3) 
response duration (T2) a repeated measure ANOVAs with Condition (predictable and 
146 CHAPTER 5
unpredictable) as a between-subjects factor and Movement Type (CS+/right, CS-/left)5 as a 
within-subjects factor were performed. The F-tests were followed by planed comparisons 
in order to  compare the magnitudes of self-reported fear between each movement types 
(CS+/right, CS-/left) for both experimental conditions (PC and UC).
 Additionally, the startle modulation data (eye blink amplitudes) were analysed with 
a repeated measure ANOVA with Condition (predictable and unpredictable) as a between-
subjects factor and Startle Type (CS+/right, CS-/left and ITI)5 as a within-subjects factor. 
Next, F-tests were followed by the post-hoc pairwise comparison with Bonferroni correction 
in order to compare the magnitude of the three types of startle amplitudes.
Results
The descriptive statistics for pain intensity ratings and expectancy of the pain intensity are 
presented in Table 2.
Table 2. Descriptive statistics for pain intensity ratings, expectancy of pain intensity score.
Variables Stimulus Group 1 
Predictable 
experimental
Group 2 
Predictable 
control
Group 3b 
Unpredictable 
experimental
Group 4b 
Unpredictable 
control
Pain intensity
Placebo 4.48±1.93 3.65±1.44 3.87±1.26 3.85±.79
Non-placebo 4.95±1.91 3.69±1.42 4.10±1.16 3.84±.74 
Differencea .46± .64 .04±.12 .22±.41 -.01±.14
Expectancy
Placebo 3.61± 1.85 3.26±1.54
Non-placebo 4.96±1.49 3.38±1.61
Differencea 1.35±1.35 .13±.25
aDifference between NRS ratings of non-placebo- or placebo-associated stimuli; 
bIn the control group both stimuli were set up at the same level of intensity, therefore the difference presented here 
can be considered as a difference between red- and green-associated NRS ratings.
 All results of the repeated measures ANOVA on the NRS ratings are presented in 
Table 4. The repeated measures ANOVA of the NRS ratings revealed a statistically significant 
main effect of Placebo (F
(1,52)
 = 11.62, p < .001, ŋ2 = .03) and statistically significant interaction 
of Placebo × Group interactions were found (F
(1,52)
 = 9.85, p = .003, ŋ2 = .03). 
 Within-group planned comparison tests on the NRS ratings (see Table 4) revealed 
a statistically significant difference in the experimental groups (Group 1 and Group 3, mean 
difference .34 ± .07), indicating that pain stimuli associated with the placebo suggestions 
were rated as less painful than the non-placebo ones. No such effect was observed in the 
control groups (Group 2 and 4, mean difference .04 ± .07). 
5  CS+ and CS- refer to the predictable condition and CSright and CSleft refer to the unpredictable condition.
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 Between-group planned comparison tests on the difference in pain intensity ratings 
between non-placebo- and placebo-associated stimuli from the experimental groups (mean 
.34 ± .54) compared with the difference in pain intensity ratings between red-control and 
green-control stimuli from the control groups (mean .01 ± .13) was performed. It revealed 
a statistically significant effect, indicating that placebo analgesia was induced by verbal 
suggestion in the experimental groups (see Figure 2 and Table 3).
 All results of the repeated measures ANOVA on the expectancy of pain intensity 
scores are presented in Table 4, showing a statistically significant main effect of the Placebo 
(F
(1,26)
 = 15.46, p < .001, ŋ2 = .30) and a significant interaction effect of Placebo × Group (F(1,26) 
= 10.653 , p = .003, ŋ2 = .20). Within-group planned comparison (see Table 4 and Figure 3) 
on non-placebo- versus placebo-associated expectancy of pain intensity scores revealed a 
statistically significant difference for the experimental group (Group 1, mean difference 1.34 
± .26), indicating that verbal suggestion had an effect on expectancy of pain intensity. By 
contrast, no statistically significant difference was found between two control stimuli (red 
and green) in the control group (Group 2, mean difference .13 ± .26).
 A simple linear regression was performed to predict the magnitude of the placebo 
effect based on expectancy of pain intensity scores. It revealed a significant regression 
equation (F
(1,26)
 = 8.85, p = .006) with R2 of .254. A positive correlation was found between 
placebo effect and expectancy of pain intensity scores (r = .504, p = .003), and the regression 
model predicted 25.4% of the variance.
Figure 2. Placebo effect. The difference in pain intensity ratings between non-placebo- and placebo-associated 
stimuli from the experimental groups and the difference in pain intensity ratings between red-control and green-
control stimuli from the control groups. 
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Figure 3. Expectancy of pain intensity scores in predictable condition. In experimental group, verbal suggestion 
about the analgesia had an effect on expectancy of pain intensity.
Table 3. The results of repeated measures ANOVA on the pain intensity ratings.
Variable Main effects and interactions F df P ƞ2
Pa
in
 N
RS
 r
ati
ng
s
Placebo 11.62 1,52 <.001 .03
Group 2.58 1,52 .12 .37
Condition .56 1,52 .45 .00
Placebo × Condition 1.90 1,52 .174 .01
Placebo × Group 9.85 1,52 .003 .03
Placebo × Group × Condition .881 1,52 .352 .00
Within-group planned comparisons F df P ƞ2p
Experimental groups (placebo-associated stimuli vs  
non-placebo-associated stimuli)
21.44 1,52 <.001 .29
Control groups (green-control stimuli vs red-control 
stimuli)
.04 1,52 .85 .00
Between-group planned comparisons F df P ƞ2
The mean difference in NRS pain scores between placebo- 
and non-placebo stimuli from the experimental groups vs 
the mean difference between two control (red and green) 
stimuli from the control groups.
9.71 1.54 .003 .15
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Table 4. The results of repeated measures ANOVA on the expectancy of pain intensity scores.
Variable Main effects and interactions F df P ƞ2
Ex
pe
ct
an
cy
 r
ati
ng
s
Placebo 15.46 1,26 <.001 .30
Group 2.69 1,26 .113 09
Placebo × Group 10.65 1,26 .003 .20
Within group planned comparisons F df P ƞ2p
Experimental groups (placebo-associated stimuli vs non-
placebo-associated stimuli)
25.88 1,26 <.001 .49
Control groups (green-control stimuli vs red-control 
stimuli)
.64 1,26 .22 .01
Manipulation check
Results of the repeated measures ANOVA performed on self-reported fear ratings revealed 
statistically significant main effects of Condition (F
(1,54)
 = 50.51, p < .0001, ŋ2 = .38) and 
Movement Type (F
(1,54)
 = 28.36, p < .001, ŋ2 = .21). Moreover, a statistically significant 
interaction of Condition × Movement Type (F
(1,54)
 = 9.85, p = .003, ŋ
p
2
 = .03) was also observed. 
Planned comparison tests revealed that in the PC, participants were more afraid of CS+ 
movement than CS- movements (F
(1,54)
 = 77.29, p < .001, ŋ
p
2
 = .09). No difference between 
self-reported fear of CSright and CSleft in the UC was found (F(1,54) = 1.58, p > .05, ŋp
2
 = .03) (see 
Figure 4).
Figure 4. Fear ratings associated with the type of the movement. Note: In PC the level of fear was the highest for 
movement associated with pain application (CS+) compared to movement never associated with pain application 
(CS-). In UC no difference was found for fear level associated with the CSright and CSleft movements.
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 The repeated measures ANOVA performed on response latencies (T1) revealed a 
statistically significant main effect of Condition (F
(1,54)
 = 4.77, p = .03, ŋ2 = .08) indicating that 
participants were slower in initiating a movement in the PC compared to the UC (mean .47 
± .09 and .43 ± .07, respectively). No statistically significant main effect of Movement Type 
(F
(1,54)
 = 2.59, p > .05, ŋ2 = .05) nor an interaction of Condition × Movement Type (F
(1,54)
 = .19, 
p > .05, ŋ2 = .003) was found.
 Results of the repeated measures ANOVA performed on response duration (T2) 
revealed a statistically significant main effect of Condition (F
(1,54)
 = 4.43, p = .04, ŋ2 = .08), 
indicating slower joystick movements in the PC compared to the UC (mean .54 ± .10 and .49 
± .08, respectively). No statistically significant main effect of Movement Type (F
(1,54)
 = .05, p 
> .05, ŋ2 = .001) nor an  interaction effect of Condition × Movement Type (F
(1,54)
 = 1.67, p > 
.05, ŋ2 = .03) was found. The obtained results for T1 and T2 suggest no differences between 
movement types.
 An additional repeated measures ANOVA performed on the startle response 
amplitude revealed significant main effects of Condition (F
(2,76)
 = 4.92, p = .03, ŋ2 = .12) and 
Startle Type (F
(2,76)
 = 4.83, p = .01, ŋ2 = .11). However, no significant Startle Type × Condition 
interaction was found, indicating that the startle amplitude in response to the ITI and the 
different CSs movements did not differ significantly for both experimental conditions (F
(2,76)
 
= 1.32, p = .27, ŋ2 = .03). Startle reflexes in the PC were higher than in the UC (360.71 ± 
162.06 and 282.69 ± 124.09, respectively). Pairwise comparisons with Bonferroni correction 
performed for the three types of startle response revealed that CS+ and CS- startle response 
do not differ (p >. 05); however, both have higher amplitudes compared to the ITI startle 
amplitude (p < .05 for comparison of both CS+ and CS- with the ITI startle responses).
Discussion
In the present study, using the modified joystick movement paradigm [26], we examined if 
FMRP and CPRA may have different effects on the magnitude of placebo analgesia induced 
by verbal suggestion. As a manipulation check, conditioned fear and anxiety were measured 
by self-reported fear level and eye blink startle. An attempt was made to investigate 
if placebo analgesia induced by verbal suggestion may be predicted by self-reported 
expectancy of pain intensity (only PC). The results were largely in line with the predictions. 
First, placebo analgesia was observed in both PC and UP; however, no differences were 
found in the magnitude of the effect between both experimental conditions. Second, in 
PC placebo analgesia was found to be predicted by expectancy ratings. Finally, some of our 
manipulation checks succeeded in indicating that FMRP and CPRA were elicited in PC and 
UC, respectively.
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Placebo effect and negative emotional states
In the present study, a verbal suggestion about pain decrease after the placebo stimulus 
presentation (red or green colour) induced placebo analgesia in both PC and UC. This result 
is in line with previous findings showing that verbal suggestion is a sufficient method of 
placebo effect induction [10,12,36–38]. 
 Aside from the studies of Meulders et al. [25,26,34], there are only some studies 
that have focused on the divergent effects of fear/anxiety on pain sensitivity [24,39]. To 
our knowledge no such attempt was previously made in the context of placebo effects. In 
the present study PC and UP were used in order to induce FMRP and CPRA, respectively. 
Unfortunately, we did not observe any divergent effects of these negative emotional states 
on the magnitude of the placebo effect. This result contradicts our hypothesis that a lower 
placebo effect will be elicited in UC.
 However, we cannot exclude that differences in the magnitude of the placebo 
effect induced in the context of state fear and anxiety may exist. Such differences may be 
visible with different intensities of particular emotional states. The level of the emotions 
can be manipulated by changing the duration, intensity or the location of pain stimuli [40]. 
Consequently, manipulation of the level of fear and anxiety might result in placebo analgesia 
differences. However, in the present study there was no control over the magnitude of fear 
nor anxiety manipulation. Therefore, such an explanation is only an assumption and needs 
future investigation. 
 Moreover, the measurement of the placebo effect (via verbal pain intensity ratings) 
might not have been sufficiently precise and sensitive to capture the influence of FMRP and 
CPRA on the magnitude of this effect. Behavioural measurements of pain have been shown 
to be less sensitive because they are the end product of all preceding cumulative cognitive 
operations and are more vulnerable to noise and variability. EEG studies could be a better 
objective measure to help capture the differences in the magnitude of the placebo effect 
in both the PC and the UC, as previous studies showed that placebo suggestions decreased 
brain activity in the regions related to anxiety processing [41,42].
Placebo effect and expectancy
The effects of verbal suggestion are theoretically considered to be mediated by expectancies 
[1,2,43–46]. However, to our knowledge there is only one study which measured verbally 
induced expectations and succeeded in indicating the influence of expectations on the 
nocebo effect [47]. In the present study, by using expectancy measurements collected at 
a trial-by-trial level, it was shown that the participants expected less pain in relation to 
placebo stimuli than non-placebo stimuli. Moreover, it was demonstrated for the first time 
that the placebo effect induced by verbal suggestion is predicted by expectancy. This result 
is crucial in understanding of the mechanisms of the placebo effect because they confirm 
the expectancy theory [1,43] and Colloca and Miller’s [2,44] learning model of placebo 
effects. Specifically, the obtained results are in line with the fact that verbal information 
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about an increase/decrease in pain elicits expectations and modulates pain perception. 
Büchel et al. [48] proposed a theory on how expectancy may lead to the placebo effect. 
They suggested that “combining top-down prior expectations or predictions of pain (relief) 
with bottom-up sensory signals at multiple levels of the neural hierarchy” induces placebo 
analgesia. Moreover, they stressed the role of precision and certainty of the expectancy 
in eliciting the placebo effect [48]. Based on their work and previous reports that identify 
neurobiological mechanisms of the placebo effect [49,50], it can be speculated that 
modulatory neurotransmitters such as opioids [51] or dopamine [52,53] might be related to 
the characterization of expectations induced by verbal suggestions. It should be mentioned 
that in the UC expectancy ratings were not collected due to the characteristics of the 
procedure – unpredictability of the stimulus application.
Manipulation check
Results obtained for self-reported fear revealed that the manipulation performed in the PC 
succeeded in eliciting FMRP (fear of movement conditioning). Specifically, as we predicted, 
elevated fear ratings were observed for CS+ movements compared to CS- movements. 
Therefore, participants were more afraid of the movement paired with painful stimuli (CS+), 
suggesting that our fear conditioning procedure was effective. This result is in line with the 
results obtained in other studies where VJMP was used [25,26] and indicates that FMRP can 
be elicited not only by social learning [54,55] but also by experience. 
 Analysis performed for the fear-avoidance measurements (T1 and T2) partially 
indicate that FMRP and its accompanying avoidance behaviour were acquired. It was shown 
that in the PC compared to the UC participants were more reluctant to initiate movements 
(T1) and they need more time to perform the movements (T2). However, in contrary to 
previous findings of Meulders et al. [25,26], the participants in PC did not show a tendency 
to avoid the CS+ movements more than CS- movements. As in the present study, Meulders 
et al. [26] could not provide a conclusive explanation for their findings: T2 for CS+ and CS- 
movements did not differ. Results obtained for both T1 and T2 might be associated with strict 
preprocessing of the raw data - we discarded high percentages of trials from the analysis. 
Another explanation, which is supported by the amount of discarded data, is that there may 
have been some procedure apparatus problems. It is highly probable that the sensitivity of 
the joystick movement could have been too high (e.g. the radius of the small circle was too 
small) resulting in a high number of trials below 0.2 sec. It also may reflect the fact that the 
participants had to wait to move the joystick until the starting signal disappeared from the 
screen. This sometimes leads participants to slower reactions that could be a result of losing 
attention and missing the disappearance of the starting signal (resulting in a high amount of 
trials above 3 sec).
 The startle response amplitude was shown to be higher in the PC compared to the 
UC regardless of the type of startle, which suggests the presence of elevated conditioned 
defensive response in the PC. Moreover, regardless of the experimental condition, CS+/
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CSright and CS-/CSleft startle responses had higher amplitudes than those associated with ITI 
startle. Startle measures were not elevated more in response to the CS+ than to the CS-, 
which contradicts previous findings [25,26] and which may possibly be related to the small 
number of trials collected for each startle. 
 It is suggested that results obtained for self-reported fear, T1, T2 and startle 
responses may indicate that in both experimental conditions differences in emotional 
arousal were present and that FMRP and CFRA were successfully elicited. In accordance 
with Davis et al. pioneering work (for review see [56]), the sustained response to temporally 
uncertain danger is associated with the elicitation of anxiety that is one of two primary 
defensive behavioural states.  The second defensive behavioural state is fear, which is 
defined as a phasic response to imminent threat. Crucially, both responses are shown to be 
subserved by distinct neural substrates; anxiety is mediated by the bed nucleus of the stria 
terminalis and fear is mediated by the amygdala [57]. Another argument that could support 
this assumption arises from a study in which unpredictability of pain application was shown 
to elicit CPRA [25–27]. In those studies CPRA was indexed by elevated ITI startle responses 
in UC compared to PC. Therefore, even if we did not experimentally confirm that the startle 
amplitudes elicited by CS+ were higher than CS- ones, and that startle amplitudes during the 
context (ITI) were higher in the UC than the PC, based on literature it could be assumed that 
the study’s experimental induction of FMRP and CRPA was successful.
Limitations
Some limitations of the present study should be outlined. First, only healthy female subjects 
were tested. Therefore, the conclusions of this research are applicable to the healthy female 
population only, not to the population in general and/or to the process of chronic pain 
maintenance. In order to broaden the scope of the research, it is recommended to run 
experiments also with male participants. Second, our joystick settings might have been too 
sensitive and therefore the mean time of completing the movement was very small.
 It is highly probable that the level of FMRP, as in the case of physical performance 
and self-reported disability [58–60], may predict the placebo effect. Therefore, in future 
studies it is recommended to collect trial-by-trial fear ratings and investigate this topic. It is 
also probable that the lack of differences in the magnitude of the placebo effect between 
PC and UC could be associated with insufficient unpredictability of pain stimuli in the latter. 
It is highly recommended to implement a modification in the experimental design where 
the different unpredictability dimensions are used. For instance, in one study [40] the 
predictability of pain was varied in a different way: the authors manipulated the stimulus 
duration, intensity and location. In the present experiment, pain stimuli in UC could be 
associated with ITI startle probe presentation. More precisely, in the UC the participants 
could make an association between the startle probe and the pain stimuli, what could make 
this condition less unpredictable.
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Conclusions
In conclusion, in both experimental conditions placebo analgesia was elicited via verbal 
suggestion. Despite the fact that pairing a specific CS movement with an electric shock 
(US) in PC induces FMRP and uncertain context of electric shock application in UC induces 
CPRP, the hypothesis of a divergent effect of both emotional states on the magnitude of the 
placebo effect has not been confirmed. Moreover, it was shown that the verbal suggestion 
had an effect on the expectancy of pain. Furthermore, the differences in expectancy of 
pain intensity in relation to placebo-associated stimuli and non-placebo-associated stimuli 
predicted the differences in pain intensity ratings, that is, placebo analgesia. Further 
research using objective measures such as EEG is required to investigate this effect.
 Finally, most of the manipulation check results (eye blink startle and self-reported 
fear) are in line with previous findings of Meulders et al. [26]. Eyeblink startle and self-
reported fear support the idea of acquisition of fear of movement-related pain (FMRP) by 
associative learning [61]. 
Implications
The implementation of the adjusted VJMP is a promising research tool that opens a new 
field of research on the placebo effect. Our adjusted VJMP allowed us to investigate 
placebo effects in the experimental context of maintenance of chronic musculoskeletal 
pain (conditioning fear of movement). Moreover, in the future the adjusted VJMP will allow 
investigation of how the reduction of FMRP and CPRA influences the magnitude of the 
placebo effect (the method of reducing both emotional states that was shown in another 
study of Meulders et al. [27]). 
 Additionally, an adjusted version of the joystick paradigm may be implemented in 
the future to test chronic pain patients and compare them with other clinical populations 
or healthy subjects; however, taking into account the preliminary character of the present 
study, further investigation is needed before the investigation reaches clinical conditions. 
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Abstract
Recent reports show that focusing attention on the location where pain is expected can 
enhance its perception. Moreover, crossing the hands over the body’s midline is known 
to impair the ability to localise stimuli and decrease tactile and pain sensations in healthy 
participants. The present study investigated the role of transient spatial attention on the 
perception of painful and non-painful electrical stimuli in conditions in which a match or a 
mismatch was induced between skin-based and external frames of reference (uncrossed and 
crossed hands positions, respectively). We measured the subjective experience (Numerical 
Rating Scale scores) and the electrophysiological response elicited by brief electric stimuli 
by analysing the P3 component of Event-Related Potentials (ERPs). Twenty-two participants 
underwent eight painful and eight non-painful stimulus blocks. The electrical stimuli were 
applied to either the left or the right hand, held in either a crossed or uncrossed position. 
Each stimulus was preceded by a direction cue (leftward or rightward arrow). In 80% of 
the trials, the arrow correctly pointed to the spatial regions where the stimulus would 
appear (congruent cueing). Our results indicated that congruent cues resulted in increased 
pain NRS scores compared to incongruent ones. For non-painful stimuli such an effect was 
observed only in the uncrossed hands position. For both non-painful and painful stimuli the 
P3 peak amplitudes were higher and occurred later for incongruently cued stimuli compared 
to congruent ones. However, we found that crossing the hands substantially reduced the 
cueing effect of the P3 peak amplitudes elicited by painful stimuli. Taken together, our results 
showed a strong influence of transient attention manipulations on the NRS ratings and on 
the brain activity. Our results also suggest that hand position may modulate the strength of 
the cueing effect, although differences between painful and non-painful stimuli exist.
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Introduction
Attention is a cognitive function crucial for the selection of sensory events that consequently 
enter our awareness. Spatial attention is the ability to selectively process stimuli at a 
specific location. To determine the location of external stimuli, the brain has to be able 
to represent space according to different frames of reference. The internal (skin-based), 
and external reference frames are two specific types of space-representations [1–3]. The 
skin-based reference frame is associated with the position of the receptive fields of the 
body and is reflected in the spatial arrangement of neurons in the primary and secondary 
somatosensory cortex [4]. The external reference frame is related to the estimation of our 
body’s posture in relation to its external surroundings, based mostly on visual information 
[2,5]. Moreover, proper localisation of pain and tactile stimuli is determined by integrating 
information from different modalities and constructing spatial representations of the body 
parts and the surrounding space [5–7].
 The internal and the external frames of reference can be brought into conflict 
by crossing one’s arms over the body’s midline. When we cross our hands, the left hand 
(reflecting the skin-based reference frame) is located in the right space (reflecting the 
external reference frame), inducing a conflict between the skin-based and the external 
reference frames [3,8]. The resulting conflict was shown to impair tactile [4,5,8–10] and 
also painful [11] stimulus localisation. For example, in studies where participants performed 
judgements about the order of the stimuli presented in short temporal succession to both 
hands (the temporal order judgment (TOJ) task), crossing the hands decreased the ability 
to determine the stimuli order (crossed-hand deficit) [5,12–14]. Localisation of the tactile 
stimuli in crossed hands posture was impaired due to difficulties in integrating conflicting 
information from different spatial reference frames [4,14]. Moreover, previous studies 
have also shown that a conflict between both frames of reference reduces pain in healthy 
participants (crossed-hands analgesia) [15–17].
 Apart from behavioural ratings and judgements, extracting event-related 
potentials (ERPs) in response to painful and non-painful electric stimuli from the on-going 
electroencephalogram (EEG) provides an excellent means to study directly the neural 
responses associated with either congruent or incongruent internal and external reference 
frames [18–20]. For example, Gallace et al. [15] reported that during the crossed hands 
condition, a decreased peak amplitude of the N2-P2 ERP component was observed together 
with decreased subjective ratings of both laser-evoked painful and electrically evoked non-
painful stimuli (crossed-hands analgesia). However, the magnitude of early components of 
the response elicited by somatosensory stimuli (e.g., the N1 wave of laser-evoked) was not 
affected by crossing the hands. The authors assumed that the obtained behavioural (crossed-
hands analgesia) and neural effects (decreased ERP P2-N2) were associated with disrupted 
multimodal cortical processing of somatosensory information caused by mismatch of skin-
based and external reference frame.
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 One way to modulate participants’ spatial attention is to use cues preceding the 
presentation of the stimuli of interest. A classic paradigm for the study of spatial attention 
was originally developed by Posner [21]. In addition to many studies of visual perception, 
pain perception has been shown to be modulated by manipulating spatial attention using 
the Posner paradigm. Ryckeghem and colleagues [22], who presented visual stimuli on 
either the same side or the opposite side of painful stimuli, found that participants rated 
their sensations as more painful when the visual cue was presented on the same side as 
the painful stimulus. Moreover, other studies investigating the influence of spatial attention 
manipulations on pain perception have reported that focusing attention on painful stimuli 
exaggerated the sensation of pain [6,23], and focusing attention away from the stimulus 
location (either on another task or on another perceptual object) reduced pain and resulted 
in increased response latencies [24,25].
 Apart from modulating the subjectively reported experience of pain, attention 
affects ERPs elicited by painful stimuli. In general, pain ERPs are characterised by a negative 
peak around 130-240 ms poststimulus and a positive peak around 230-390 ms poststimulus 
[26]. Crucially, brain responses to incoming electrical stimuli appear in the time range in 
which cognitive potentials, such as the P300 (P3), are usually observed [27–31]. Desmedt et 
al. [32] first described that relevance and occurrence probability of somatosensory stimuli 
are associated with P3 (P300) elicitation in human EEG brain. The P3 component is a family 
of waves that peaks at around 250–400 ms and is intimately related to task performance 
[31,33]. There are at least two variants of this component – P3a and P3b [24,26,29,30,34–
37]. The amplitude of the P3a component is usually smaller than P3b’s amplitude, with 
shorter latency and more frontal topography (larger in Cz than Pz). What is important in 
the context of this study is that the P3a component is thought to be an index of involuntary 
attention allocation to novel, salient and threatening stimuli that appear outside of the 
attention focus [33–36,38], and the latency of the P3 component is thought to be an index 
of stimulus processing speed [39]. As was shown in studies by Legrain et al. [24,27], the 
laser-evoked P2 component (probably a P3a component; for discussion see [40–42]) was 
enhanced for rare stimuli as compared to frequent stimuli. Other studies have reported 
similar results, indicating that standard stimuli delivered to the unattended location elicited 
ERPs of greater amplitude compared to ERPs elicited by standard stimuli delivered to the 
attended location [41–43]. Accordingly, each electrical stimulus in the present study was 
preceded by a visual cue (leftward and rightward arrows) that indicated the spatial location 
of the stimulus application (right or left side; congruent cueing – CC). In addition, to check 
the involvement of attentional processes, incorrect cues were occasionally presented (i.e. 
20% of the trials), which preceded an electrical stimulus that was delivered to the opposite 
spatial location than was indicated by the cue (right cue – left location or left cue – right 
location; incongruent cueing – IC). Thus, in the present study, we expected a modulation of 
both the peak amplitudes and peak latencies of the P3 component elicited by painful and 
non-painful electric stimuli when attention was manipulated by cues [24,30,34–37,44].
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 The use of cues makes the present study different from the study of Gallace et al. 
[15], where participants’ hands were stimulated in an unpredictable manner without any 
additional attentional focus on the side of laser painful and electric non-painful stimulus 
application. In other words, the spatial location (right or left side) of the subsequent 
stimulus was unknown to the participants. To our knowledge, there are no data indicating 
whether crossed-hands analgesia can be also elicited when the participants’ attention is 
directed to the right or left spatial location where electrical stimuli (pain or non-painful) 
are expected to be delivered. Moreover, the design of our study required participants to 
switch their attention from trial to trial and the occasional incorrectly cued stimulus induced 
a re-allocation of attention to a different location in space. Consequently, such a design 
allowed us to explore the effects of transient spatial attention [44]. Other studies that 
report the effects of the processing of tactile stimuli (with either congruent or incongruent 
internal and external reference frames) in the time ranges of 80–160 and 200–300 ms post 
stimuli usually use a sustained manipulation of spatial attention [18–20]. In these studies, 
by contrast to ours, participants’ attention is usually maintained on one specific limb for 
the entire experimental block, and stimuli are consistently delivered to either the attended 
or unattended side (a sustained manipulation of spatial attention) [18–20]. Thus it is worth 
studying whether the transient attentional effect is modulated by crossing the hands. 
 We focused our analysis on P3 components (probably P3a) due to the fact that 
the magnitude of late components (the N2-P2 wave of laser-evoked potentials), contrary 
to early ones (the N1 component), was shown to be affected by crossing the hands [15]. 
Moreover, P3a is one of three components (next to contralateral temporal negativity – CTN 
and fronto-central negativity – FCN) that is elicited by electrical painful stimuli that appear 
to be involved in detecting and orienting attention towards unattended somatic threats 
[36,38]. The relation between the P3 component and attention allocation has been well 
documented [33–36,38,45] but the functional role of this relation is still under investigation.
 To sum up, the present study’s aim was to investigate the effect of transient spatial 
attention on subjective intensity ratings of pain and tactile stimuli and on the P3 component 
elicited by both types of electrical stimuli. Pursuing this aim, we used congruent and 
incongruent cues. Additionally, the second goal of this study was to compare these effects 
under conditions of matched and mismatched internal and external frames of reference (i.e. 
a crossed and an uncrossed hands condition). Consequently, the current experiment created 
four different conditions for each stimulus intensity (uncrossed congruent/incongruent cue 
conditions and crossed congruent/incongruent cue conditions). Based on previous studies, 
we expected that, for both painful and non-painful stimuli (see S1 Figure):
 1.  The NRS ratings will be higher in the condition where the stimulus location is 
correctly signalled (congruent cueing condition) as compared to the condition 
where the stimulus location is incorrectly signalled (incongruent cueing 
condition). 
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 2.  In the crossed hands condition, NRS ratings will be lower compared to the 
uncrossed hands condition (i.e. crossed-hands analgesia).
 3.  The highest NRS pain ratings will occur after congruent cues compared to 
incongruent cues specifically in the uncrossed hands condition, because in this 
condition there is a match between the internal reference frame and the external 
reference frame. In the crossed hands condition the cueing effect should be 
substantially decreased due to an impaired ability to localise stimuli caused by a 
mismatch between both frames of reference.
 4.  The ERP P3 component will have a higher amplitudes and will be delayed in 
latencies after incongruently cued stimuli compared to congruently cued stimuli, 
because of the re-allocation of transient spatial attention. 
 5.  The ERP P3 component amplitudes will be decreased by crossing the hands, due 
to a mismatch between the internal and external frame of reference.
 6.  The ERP P3 amplitudes elicited by stimuli preceded by incongruent cues will be 
higher in uncrossed conditions compared to the crossed conditions.
Material and methods
Participants
Twenty-five right-handed volunteers (4 males and 21 females) aged between 19 and 29 
(mean = 22.8 ± 2.8 years), took part in the experiment. The sample size was based on a 
literature review of EEG and pain research – the number of participants that usually volunteer 
is between twenty and twenty-five [46–49] and between fifteen and twenty [11,44,50] or 
even twelve [15,51–53]. The volunteers were recruited amongst the student population of 
the Radboud University Nijmegen, the Netherlands. All of the participants were healthy, 
free of pain, and not taking any medication. Three female participants were excluded from 
the analyses due to excessive muscle and/or eye artefacts in the EEG. The data from the 
remaining 22 participants were further analysed (mean age = 23.1 ± 2.9). All participants 
provided written informed consent prior to the experiment. The participants were informed 
that they were participating in a study of low and high electrical stimulus perception in 
two hand positions – crossed and uncrossed. They were also informed that they could stop 
participating at any point during the study without giving a reason. The participants received 
remuneration for their participation in the study. The study was approved by the Ethics 
Committee Faculty of Social Sciences of Radboud University in Nijmegen (ECG2012-1301-
005) and by the Research Ethics Committee at the Institute of Psychology of Jagiellonian 
University.
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Procedure
The experiment was performed in a sound-attenuated laboratory room where the 
participants were seated in a comfortable armchair in front of a computer screen (60 Hz 
refresh rate) at a distance of roughly 50 cm, with both of their hands resting on the desk. 
The study consisted of 2 phases: a preparation phase and a testing phase, lasting around 35 
and 55 minutes, respectively.
Painful and non-painful electrical stimuli
The magnitudes of the stimuli (painful and non-painful) were individually determined for 
each of the participants during the preparation phase. Two intensities of electrical stimuli 
were used in the experiment, painful and non-painful electric shocks, which were delivered 
by two Constant Current High Voltage Stimulators (200 μs duration; Digitimer, Welwyn 
Garden City, England, Model DS7AH and DS7A) through two concentric surface electrodes for 
electrical stimulation of nociceptive nerves (K² stimulating electrodes; Inomed, Germany). 
Each of the electrodes was attached to the outer side of the right or left hand between 
the thumb and the index finger, over the superficial branch of the radial nerve. During the 
preparation phase, the participants received a series of electrical stimuli of increasing and 
decreasing intensity, delivered to the non-dominant hand. The participants’ task was to 
rate the magnitude of the stimuli verbally on a modified Numerical Rating Scale (NRS). The 
anchors used in the scale were 0 = ‘no electrical sensation’; 1, the sensation threshold = ‘I 
start to feel something’; 4, the pain threshold = ‘It starts to be painful’; and 10, the maximum 
pain tolerance = ‘the strongest painful sensation imaginable’. To the participants, the NRS 
score of 10 was explained as a painful stimulus that he or she does not want to receive 
anymore. The scale resembles the one used in the study of Romero et al. [54]. On this scale, 
values of 1, 4, and 10 indicate the somatosensory threshold (detection threshold - DT), the 
pain threshold (PT) and the pain tolerance threshold (PTT), respectively. We defined three 
NRS ratings for non-painful stimulation (from 1-3 on NRS) and used 4 on NRS to determine 
the pain threshold (PT). We were interested in ratings representing non-painful (3 on NRS) 
up to highly painful but tolerable stimuli (rating 8 on NRS).
 Stimuli delivered in the preparation phase started at 0.1mA. Then the current was 
increased by 0.1mA per step to determine the DT. Subsequently, the current was decreased 
until the participant was unable to detect the stimulus. The cycle of increasing and 
decreasing the stimulus was repeated until a stable threshold was obtained. This required 
only on average 2-3 increase/decrease cycles for most of the participants. After the DT was 
determined, the current was subsequently increased in increments of 0.2 mA until the PT 
was reached, and subsequently decreased to the DT. This step was repeated three times 
before taking the average of the two scores for the second and third repetition of a ‘3’ NRS 
rating of a non-painful stimulus. Next, the current was increased in increments of 0.5 mA 
to detect the pain tolerance threshold (an NRS score of 10) and decreased to the PT. This 
step was repeated three times before taking the average of the two scores for the second 
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painful and non-painful stimuli intensities were, respectively: 12.54 ± 2.12 mA and 3.99 ± 
1.12 mA; t(24) = -17.78, p < .001). Stimuli at intensities identified as non-painful during the 
calibration phase were never reported as painful during the experiment.
Electroencephalographic recordings and EEG preprocessing
Electroencephalography (EEG) was recorded from 64 Ag/AgCl electrodes (Acticap, Brain 
Products, Munich, Germany) according to the international 10–20 system. The reference 
electrode was located on the right mastoid. Four electrooculographic electrodes (EOGs) 
were attached to the external canthi of both eyes and above and below the left eye to 
monitor horizontal and vertical eye movements. The EOG ground electrode was placed on 
the nose.
 The impedance of the EEG electrodes was kept below 20 kΩ. In total, four hundred 
EEG trials were presented in the two conditions (non-painful and painful electrical stimuli) 
for each participant. Signals were recorded with a Brain Vision Recorder (Brain Products) 
using a 150 Hz low-pass filter, with a time constant of 10 s (0,016 Hz) and a 500 Hz sampling 
frequency. The EEG data were re-referenced off-line to linked mastoids. Subsequently, the 
EEG signal was filtered (bandpass 0.016 – 45 Hz; 24 dB) and epoched into 700 ms intervals 
(epochs between 200 ms before and 500 ms after stimulus onset). All epochs were corrected 
for eye-movements using a method developed by Gratton et al. [55]. Next, trials with EEG 
activity exceeding ±100 μV were semi-automatically rejected. The number of rejected 
trials remained low (mean = 0.87; SD = 1.77). Artefact-free single trials were averaged per 
participant and with respect to the stimulus delivery condition. All EEG preprocessing was 
conducted using the Brain Vision Analyzer (Brain Products).
 The P3 peak amplitude component was defined as the most positive deflection 
within the time window, 250-400 ms after stimulus onset respecting the guidelines of 
Picton et al. [56]. Only data from midline sites were further analysed (Fz, FCz, Cz, CPz, Pz) 
based on the literature [33,35,39,57–59] and by visual inspection in order to contrast late 
components of pain- and non-pain-related somatosensory processing. The P3 latency was 
determined as the time point of maximum positive amplitude on the Cz electrode in the 
250-400 ms window. We analysed P3 peak amplitudes recorded from five vertex electrodes 
in order to compare the magnitude of P3 peak amplitude between electrodes and to be able 
to indicate if the P3a component was elicited. In contrast to the P3b component, the P3a 
component is larger at the Cz electrode than at the Pz electrode.
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Testing phase
At the beginning of the testing phase, the participants were asked to place both hands on 
the table at a distance of 40 cm from each other. After that, the stimulation electrodes were 
attached to their right and left hands. Next, a large wooden tabletop (59×50×15 cm) was slid 
into place above the arms of the participants to block them from view. The participants were 
verbally instructed how properly to keep their arms in the uncrossed or crossed positions, 
before the start of the experiment and between all blocks during the testing phase. The 
white line in the middle of the wooden screen served as the reference point to separate the 
right and left side. The participants were left alone in the laboratory room for the remainder 
of the testing phase but were observed through a camera and received instructions between 
blocks via a speaker.
 The testing phase involved a total of 400 trials (200 trials for each stimulus type) 
presented in 16 blocks. There were separate blocks for each stimulus intensity: eight blocks 
with painful stimuli and eight blocks with non-painful stimuli. In 50% of the blocks the 
participants were instructed to keep their hands uncrossed, and for the other 50% they 
were asked to cross their hands. Thus, four blocks of painful stimuli were delivered to 
crossed hands and another four blocks of painful stimuli were delivered to uncrossed hands. 
Similarly, four blocks of non-painful stimuli were delivered to crossed hands and four blocks 
of non-painful stimuli to uncrossed hands. The order of the blocks was counterbalanced 
between the participants. Within a block only one hand position was required, and no more 
than two consecutive blocks were used with the same hand position.
 Half of the stimuli were delivered to the left hand and half to the right hand. 
The maximum number of consecutive stimuli delivered to one hand was three. Intertrial 
intervals (ITI) lasted on average 7.00 ± 1.65 s (mean ± SD). Such intervals are considered to 
be large enough to observe reproducible ERPs. 
 Both types of electrical stimuli were preceded by a sequence of two visual stimuli 
presented at the centre of a computer screen. These stimuli were a white fixation cross 
(32×32 pixels) and white arrows pointing to the right or the left (both 32×32 pixels), 
presented on a black background for 500 ms and 1000 ms, respectively. See Figure 1A for an 
overview of the trial timing.
 The presentation of the arrow directed the participants’ attention to the spatial 
location of subsequently presented electrical stimuli (right or left side) (see Figure 2). 
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Figure 1. Overview of trial timing (A) and congruent and incongruent cue schemas used in the experiment. Ad A: 
The “+” represents the fixation cross; the right and left arrows represent cue stimuli (during the one trial one of the 
arrows was presented); the lightning flash represents the electric shock. The length of the NRS epoch was about 
3 seconds, which included the time for the participant to evaluate the stimulus plus time for the experimenter to 
record the response. Ad B: Eight blocks consisted of 19 congruent and 5 incongruent cue trials and the remaining 
eight blocks consisted of 21 congruent and 5 incongruent cue trials. The same schema was used for the painful and 
non-painful stimulus blocks. In total, there were 16 blocks (8 painful and 8 non-painful stimulus blocks).
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Figure 2. The four conditions of the experiment. In the uncrossed hands condition (top panel) we observe a 
match between skin-based and external frames of reference (the left hand is placed in the left space). In crossed 
hands condition (bottom panel) the left hand (reflecting the skin-based reference frame) is located in the right 
space (reflecting the external reference frame), inducing a conflict between both reference frames. Congruent 
cueing (left green panel): Left cue allocates participants attention to the left spatial location where stimulus was 
predicted to appear. Incongruent cueing (right red panel): Left cue allocates participants attention to the left 
spatial location where stimulus was predicted to appear but it was applied to the right hand. Note that during the 
experimental phase vision of the hands was prevented and two types of cues were used (leftward and rightward 
arrows); left arrow represents cue; the lightning flash represents the electric shock; green shade represents the 
side of allocation of attention.
 In 80% of the trials, the cue correctly indicated the upcoming side of space of the 
stimulation (congruent cueing – CC), and in 20% of trials the cue incorrectly indicated where 
the stimulus would be delivered (incongruent cueing – IC). A specific schema of the number 
of subsequent congruent and incongruent cues was used (for more details, see Figure 1B). 
The congruent and incongruent cue schemas were presented in a pseudo-random order 
in each of the 16 blocks of the experiment. The stimuli presented in incongruent cue trials 
were always preceded by at least one congruent cue and were never presented in the first 
positions within a block. Each block consisted of a different number of trials in order to 
avoid habituation to the length of the block and to avoid expectancy reactions with respect 
to the last couple of trials and thus avoiding confounding ERP effects (for more details, see 
Figure 1B). The timing of events preceding stimulation was not variable in order to avoid the 
situation where electrical stimuli would be delivered in an unpredictable manner. Otherwise, 
it would have had a huge impact on ERP components and pain ratings [60,61].
 The participants were instructed at the beginning of each recording block: (1) to 
pay attention to the information about the stimulation intensity and their hands’ position; 
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(2) to maintain their gaze at the fixation point; and (3) to pay attention to the arrow stimulus 
that would indicate to which side the electrical stimulus would be delivered. In order to 
examine if the crossed hands position significantly reduced the perceived intensity of the 
painful stimuli, the participants rated the intensity of each of the painful and non-painful 
stimuli using a verbal NRS. Moreover, the participants were instructed not to move their 
head or eyes, and to blink as little as possible, especially during stimuli presentation.
Statistical analysis
We analysed the data obtained from painful and non-painful trials separately due to the fact 
that both the NRS ratings and the ERP P3 component amplitudes elicited by painful stimuli 
are known to be larger than the NRS ratings and the P3 amplitudes elicited by non-painful 
stimuli [29]. 
 For behavioural data, to address the first and second aim of the study and to 
verify hypotheses 1-3, we performed two separate General Linear Model (GLM) repeated 
measures analyses: first for painful NRS ratings and second for non-painful NRS ratings, 
using Cue (2 levels: congruent and incongruent) and Hand Position (2 levels: crossed and 
uncrossed) as within-subject factors. The statistically significant main effect of Cue and 
Hand Position tested our hypotheses 1 and 2, respectively. In the case where statistically 
significant interaction of factors Cue and Hand Position was observed, the F tests were 
followed by planned comparisons (appropriate planned contrasts by means of F tests) to 
test our a-priori defined third hypothesis. We investigated whether a cueing effect was 
present in both hand positions by performing planned comparisons for congruent versus 
incongruent cues separately in the uncrossed and crossed hands condition.
 Statistical analyses of the EEG data were restricted to the EEG signals recorded 
from the midline electrodes Fz, FCz, Cz, CPz and Pz due to the fact that amplitudes of the P3 
component are typically highest over the midline electrodes [33,35,39,57,58]. To address the 
first and second aim of the study and to verify hypotheses 4-6, the P3 peak amplitudes were 
subjected to two separate GLM repeated measures analyses: first for the painful and second 
for non-painful conditions, which included three within-subject factors: Hand Position (2 
levels: crossed and uncrossed), Cue (2 levels: congruent and incongruent) and Electrode 
Location (5 levels: Fz, FCz, Cz, CPz and Pz). The statistically significant main effects of Cue 
and Hand Position tested our hypothesis 4 and 5, respectively. In accordance to our a-priori 
hypotheses, F test was followed by planned comparisons tests when significant interactions 
of factors Cue and Hand Position were observed. First we investigated whether a cueing 
effect was present in both hand positions by performing planned comparisons for P3 peak 
amplitudes of congruently versus incongruently cued stimuli, separately for uncrossed and 
crossed hands conditions. Next, we performed planned comparisons for uncrossed hands 
versus crossed hands condition for P3 peak amplitudes elicited by incongruently cued 
stimuli (sixth hypothesis). Additionally, in order to investigate if crossing the hands reduced 
the magnitude of cueing effect, we performed a GLM for the difference of incongruent P3 
CROSSED-HANDS ANALGESIA STUDY 171
6
and congruent P3 amplitudes (IC - CC difference) with Hand position (2 levels: crossed and 
uncrossed) as within-subject factor. 
 Additional post-hoc comparisons (p adjustment for multiple comparison: 
Bonferroni) were performed to investigate the presence of cueing effect on each of five 
midline electrodes. Additionally, in order to compare the magnitude of cueing effect 
between analysed electrodes, we performed a GLM for the difference of incongruent P3 and 
congruent P3 peak amplitudes (IC-CC difference) with Electrode Location (5 levels: Fz, FCz, 
Cz, CPz and Pz) as within-subject factor. Next, F test was followed by post-hoc comparisons 
(p value adjusted for multiple comparisons: Bonferroni).
 The Cz latencies of the P3 components were analysed using a GLM with repeated 
measures with Cue (2 levels: congruent and incongruent) and Hand position (2 levels: 
crossed and uncrossed) as within-subject factors.
 The Shapiro-Wilks test was used to assess the normality of distribution of 
investigated parameters. All parameters in our study were normally distributed. The level 
of significance was set at p < .05. Greenhouse–Geisser corrected p-values were reported 
where applicable. All the analyses were conducted using SPSS Version 22 (IBM Corporation, 
Armonk, NY, USA).
Results
Behavioural results
The summary of the GLM with repeated measures for painful and non-painful NRS ratings is 
presented in Table 1. The means of the NRS ratings of painful and non-painful stimuli in each 
of the four experimental conditions are presented in Figure 3A. 
 The behavioural results obtained for painful stimuli supported our first hypothesis. 
As was indicated by a statistically significant main effect of Cue, the NRS ratings were 
higher in the condition where the stimulus location was correctly signalled (congruent 
cueing) as compared to the condition where the stimulus location was incorrectly signalled 
(incongruent cueing). Moreover, the participants rated the stimuli on the NRS approximately 
equally in the crossed and uncrossed hands conditions indicated by the non-significant main 
effect of Hand Position (see Table 1). Thus, we did not observe crossed-hands analgesia as 
was suggested in the second hypothesis. Finally, a no significant interaction effect of Cue 
× Hand Position was observed, indicating that the cueing effect for painful stimuli was not 
significantly modulated by hand position which is not in line with our third hypothesis.
 The behavioural results obtained for non-painful stimuli did not support our first 
(overall simple cueing effect) or second hypothesis (overall crossed-hands analgesia) as the 
main GLM revealed no statistically significant main effect for Cue or for Hand Position (see 
Table 1). At the same time, in contrast to our results on the painful stimuli, a significant 
Cue × Hand Position interaction was found, indicating that hand position may influence the 
magnitude of the cueing effect; this supports our third hypothesis. Given this effect, we 
172 CHAPTER 6
performed separate planned comparisons for uncrossed and crossed hands condition to 
investigate whether a cueing effect was present in both conditions. The analysis revealed 
that the cueing effect was present only in the uncrossed hands condition - participants rated 
stimuli preceded by congruent cues as more intense than incongruent ones (F
(1,21)
 = 10.94, 
p = .003, ŋ2
p
 = .34). In the crossed hands condition we did not observe any effect of cueing 
(F
(1,21)
 = 1.03, p = .34, ŋ2
p
 = .05) (see Figure 3A). Thus, crossing the hands over the body’s 
midline abolishes the cueing effect that can be observed in the uncrossed hand condition.
Table 1. Summary of the GLM with repeated measures of the NRS ratings.
NRS – Painful stimuli – the main effects and interaction effects (df) F p ŋ2
Cue (1,21) 9.64 .005 .05
Hand Position (1,21) 1.31 .27 .002
Cue × Hand Position (1,21) 2.71 .11 .01
NRS – Non-painful stimuli – the main effects and interaction effects (df) F p ŋ2
Cue (1,21) 2.05 .17 .01
Hand Position (1,21) 2.93 .10 .01
Cue × Hand Position (1,21) 8.85 .007 .05
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Figure 3. Graphs of the behavioural (A) and neurophysiological results (B and C) of the study. Behavioural 
results (NRS ratings) are presented in panel (A). P3 amplitudes and P3 latencies are presented in panels (B) and 
(C) respectively. Results for painful stimuli are presented on the left side of the figure and for non-painful stimuli 
on the right side.
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Electrophysiological results
P3 peak amplitude
The summary of the GLM with repeated measures of the P3 peak amplitudes obtained for 
painful and non-painful stimuli is presented in Table 2. The P3 peak amplitudes recorded 
from the five midline electrodes in the four experimental conditions are presented in Figure 
2B. The scalp topographies and the grand average ERPs recorded from the five midline 
electrodes in painful and non-painful conditions are presented in Figure 4 and Figure 5, 
respectively.
Table 2. Summary of the GLM with repeated measures of the P3 amplitudes.
P3 amplitude – Painful stimuli – the main effect and the interaction effects (df) F p ŋ2
Cue (1,21) 28.94 <.001 .08
Hand Position (1,21) .34 .58 .001
Electrode Location (4,84) 80.53 <.001 .24
Cue × Hand Position (1,21) 8.62 .008 .01
Cue × Electrode Location (4,84) 6.09 .007 .002
Hand Position × Electrode Location (4,84) .47 .62 .0001
Cue × Hand Position × Electrode Location (4,84) 1.20 .30 .0003
P3 amplitude – Non-painful stimuli – the main effect and the interaction effects (df) F p ŋ2
Cue (1,21) 25.56 < .001 .06
Hand Position (1,21) .08 .80 .0002
Electrode Location (4,84) 63.33 < .001 .16
Cue × Hand Position (1,21) .17 .68 .0002
Cue × Electrode Location (4,84) 6.89 .003 .002
Hand Position × Electrode Location (4,84) 2.92 .07 .0008
Cue × Hand Position × Electrode Location (4,84) .21 .73 .0001
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Figure 4. Painful condition: the grand average ERPs from the midline electrodes (Fz, FCz, Cz, CPz and Pz) (A) and 
spline interpolated maps of potentials representing scalp top-views of the P3 (250–400 ms) as a function of Hand 
Position (uncrossed and crossed) and Cue (congruent and incongruent) (B). Ad A: The highest P3 peak amplitudes 
were observed at Cz and CPz electrodes. Ad B: The uncrossed hands condition is on the left and the crossed hands 
condition is on the right. The colour scales — maximum and minimum — are coded in red and blue, respectively.
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Figure 5. Non-painful condition: the grand average ERPs from the midline electrodes (Fz, FCz, Cz, CPz and Pz) (A) 
and spline interpolated maps of potentials representing scalp top-views of the P3 (250–400 ms) as a function 
of Hand Position (uncrossed and crossed) and Cue (congruent and incongruent) (B). Ad A: The highest P3 peak 
amplitudes were observed at Cz and CPz electrodes. Ad B: The uncrossed hands condition is on the left and the 
crossed hands condition is on the right. The colour scales — maximum and minimum — are coded in red and blue, 
respectively.
 The results of the GLM with repeated measures performed for P3 peak amplitude 
elicited by painful stimuli showed a significant main effect of Cue (fourth hypothesis). 
However, analogously to the NRS ratings to the painful stimuli, no significant main effect 
of Hand Position was observed (fifth hypothesis). Furthermore, the analysis revealed a 
significant Cue × Hand Position interaction. Planned comparison showed that the P3 peak 
amplitudes in response to painful stimuli preceded by incongruent cues were increased 
compared to those preceded by the congruent cues, in both the uncrossed (F
(1,22)
 = 32.01, p 
< .001, ŋ2
p
 = .60) and crossed hands conditions (F
(1,22)
 = 14.32, p = .001, ŋ2
p
 = .41) (see Figure 
3B and Figure 4). Moreover, planned comparisons revealed that crossing the hands did not 
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affect P3 peak amplitudes of the incorrectly cued painful stimuli (F
(1,22)
 = .85, p = . 37, ŋ2
p
 
= .04) (sixth hypothesis). These analyses leave the found Cue × Hand Position interaction 
unexplained. A subsequent GLM for the amplitude difference of the incongruently and 
congruently cued stimuli did reveal a main effect of Hand position (F
(1,21)
 = 7.91, p = .01, ŋ2 
= .04), indicating that the magnitude of the cueing effect of P3 amplitude of painful stimuli 
was more pronounced in uncrossed hands condition compared to crossed one (see Figure 
3B). This result indicates that crossing the hands reduces the magnitude of the cueing effect. 
A main GLM with repeated measures performed for P3 peak amplitude elicited by painful 
stimuli showed also a significant main effect of Electrode Location, with the largest values 
on the central sites (Cz and CPz) (see Figure 4). Moreover a significant Cue × Electrode 
Location interaction was also observed (see Table 2). Further analysis showed that the 
cueing effect was present at five analysed vertex electrodes (post hoc ps < .001). Additional 
GLM analysis on IC-CC difference of P3 peak amplitudes elicited by painful stimuli showed 
that the magnitude of the cueing effect differed between analysed electrodes (F
(4,84)
 = 6,09, 
p = .01, ŋ2 = .03). Further analysis indicated that the effect of cueing was more pronounced 
at frontal-central sites (mean ± SD: Fz: 5.10 ± 4.21 µV, FCz: 5.46 ± 4.70 µV and Cz: 5.00 ± 4.48 
µV) than at more posterior sites (mean ± SD: CPz: 4.17 ± 4.17 µV and Pz: 3.34 ± 3.74 µV).
 For non-painful P3 peak amplitudes, the results of GLM with repeated measures 
showed a significant main effect of Cue, revealing a more pronounced P3 amplitude in 
response to stimuli following incongruent cues compared to congruent ones. Again, we 
obtained a non-significant main effect of Hand Position; thus, crossing the hands did not 
influence the P3 peak amplitude, which contradicts our fifth hypothesis. No Cue × Hand 
Position interaction effect was found, suggesting that the strength of the cueing effect is not 
different when measured in the uncrossed and crossed hands conditions (see Figure 3B). 
Thus, the lack of statistical interaction runs contrary to our sixth hypothesis. A significant 
main effect of Electrode Location and significant Cue × Electrode Location interaction was 
found (see Table 2). Further post hoc analysis revealed that the cueing effect was present for 
each of five vertex electrodes (see Figure 5). Similarly to the painful condition, we found that 
the P3 peak amplitudes elicited by incongruently cued non-painful stimuli were relatively 
larger in comparison to the P3 amplitudes of congruently cued stimuli. We also showed 
that the magnitude of the cueing effect (IC-CC difference) differed between the analysed 
electrodes (F
(4,84)
 = 6,89, p = .003, ŋ2 = .03). We found that the effect of cueing was less 
pronounced at Pz electrode (2.23 ± .63µV) compared to FCz, Cz and CPz electrodes (mean ± 
SD: 3.82 ± .70 µV, 3.56 ± .68 µV and 3.23 ± .71 µV, respectively) (see Figure 5).
P3 latency
The summary of the GLM with repeated measures of the P3 latencies obtained separately 
for painful and non-painful stimuli is presented in Table 3. 
The results revealed a significant main effect of Cue for both stimuli types, which is in line 
with our fourth hypothesis. This result suggests that P3 peaked later when elicited by stimuli 
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following incongruent cues (mean ± SD: 326 ± 26 ms and 330 ± 25 ms for painful and non-
painful stimuli respectively) compared to congruent ones (mean ± SD: 309 ± 26 ms and 
316 ± 29 ms for painful and non-painful stimuli respectively) (see Figure 3C). Interestingly, 
for painful stimuli, longer P3 latency was measured in the crossed (mean ± SD: 323 ± 27 
ms) compared to the uncrossed hands condition (mean ± SD: 313 ± 24 ms), indicating that 
crossing the hands may have influenced P3 latency.
Table 3. Summary of the GLM analysis of the P3 latencies.
P3 latency – Painful stimuli –the main effect and the interaction effects (df) F p ŋ2
Cue (1,21) 9.02 .007 .07
Hand Position (1,21) 16.40 .001 .24
Cue × Hand Position (1,21) .53 .47 .005
P3 latency – Non-painful stimuli –the main effect and the interaction effects (df) F p ŋ2
Cue (1,21) 14.43 .001 .14
Hand Position (1,21) .11 .75 .002
Cue × Hand Position (1,21) 1.75 .20 .02
Discussion
The present experiment used two manipulations to examine their effects on the perception 
and processing of painful and non-painful electrical stimuli. These were transient spatial 
attention manipulation, using congruent or incongruent cueing, and an alteration of the 
frame of reference by crossing the hands over the body midline. The perception of the stimuli 
was quantified with a behavioural measure, namely subjective scoring; the processing was 
quantified with an electrophysiological measure, namely the P3 of the evoked potential. 
Our study shows several main effects of cueing in different analyses, indicating that spatial 
attention influences both subjectively perceived intensity (NRS scores) and processing 
(P3 amplitude and P3 latency) of somatosensory stimuli. Except for the latency of the 
P3 following painful stimuli, we did not find other main effects of crossing the hands, 
demonstrating that crossing the hands over the body’s midline decreased neither subjective 
ratings nor the P3 peak amplitude of painful and non-painful stimuli. However, several Cue 
× Hand Position interaction effects were found in different analyses, indicating that crossing 
the hands modulates the effect of attention, though these modulating effects were only 
present for the non-painful NRS ratings and for P3 peak amplitudes following painful stimuli.
 Our behavioural findings showed that NRS ratings of painful stimuli were 
modulated by the direction of spatial attention. The subjective NRS ratings were higher 
when attention was focused on the same side where the electrical stimulation occurred 
(congruent condition), compared to the ratings of the incongruent condition, which is 
consistent with our first hypothesis. These findings align with previous reports indicating 
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that focusing attention on a nociceptive stimulus exaggerates pain [6,23]. Higher NRS scores 
of congruently cued painful stimuli could also be associated with the observation that 
when a region of the body’s space is cued by a stimulus in one modality, the processing 
of a stimulus from another modality appearing in that region is also facilitated [22,62]. For 
non-painful stimuli, the cueing effect failed to reach significance. However, for non-painful 
stimuli, we did observe a significant interaction effect (Cue x Hand Position) that will be 
discussed below.
 Contrary to our second hypothesis, crossing the hands over the body midline did 
not significantly influence the NRS scores for either painful or for non-painful stimuli. The 
fact that we did not observe crossed-hands analgesia could be caused by a difference in the 
procedures of the present study compared to previous studies by others [15,17]. In the study 
by Gallace et al. [15], the side of the stimulus presentation was unknown to the participants; 
therefore, they did not know to which spatial location the stimuli would be delivered. This 
clearly contrasts with the present study, in which participants were cued with regard to the 
spatial location at which the stimulation would be delivered. In our study the side of the 
stimulus application was correctly cued in 80% of the trials; therefore the processing of 
painful and non-painful stimuli was facilitated (or inhibited with incongruently cued stimuli). 
The cueing effect might have overshadowed the hand position effect, possibly explaining 
the lack of crossed-hands analgesia. However, the study of Valentini et al. [16] proposed 
that vision is critical in eliciting crossed-hands analgesia thus questioning previous findings 
of Gallace et al. [15]. Since in the present study the participants could not see their hands 
(a table top blocked the view of their arms), the lack of visual information might explain 
why no crossed-hands analgesia was induced. Indeed, Valentini et al. [16] suggested that 
only the interaction between the crossed arms and an unobstructed view of the stimulated 
hand would be effective in reducing pain. As a result of these crucial differences, we might 
not have observed simple crossed-hands analgesia, but instead, observed the interaction 
between two different factors: the spatially guided allocation of attention with an internal 
(skin-based) frame of reference, and the externally, spatially guided allocation of attention. 
 The Cue × Hand Position interaction was seen for the non-painful stimuli, but not 
the painful ones, and therefore this finding is only partially in line with the third hypothesis. 
Observed differences in manipulation effects between the painful and non-painful conditions 
may be associated with the threatening character of painful stimuli, which inherently attract 
[63] and captures attention [64,65]. Thus, we assume that due to their saliency, painful 
stimuli are easy to localise even if the hands are kept in a crossed position. However, this lack 
of interaction effect in the painful condition cannot exclude the relevance of the external 
location, since the ERP results did reveal an interaction effect, discussed later.
 In line with the third hypothesis, for non-painful stimuli, participants rated stimuli 
preceded by congruent cues as more intense in comparison to incongruent ones only in 
the uncrossed hands condition (see Figure 3A). Thus, although no crossed-hands analgesia 
was observed, crossing the hands diminished the overshadowing cueing effects. It remains 
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unclear if this effect relies on the same underlying mechanism as crossed-hands analgesia. 
However, a declined tactile localisation accuracy might explain why we did not observe an 
effect of cueing in the crossed hand condition [5,9,11,12,66]. The perception of non-painful 
stimuli (skin-based spatial code) appears to be automatically transferred to the external 
reference frame, which is known as tactile remapping [7,13,67,68]. Thus, skin-based codes 
and transformed external spatial codes are used in order to estimate the location of a 
non-painful stimulus [4,14,69]. In crossed hands condition, the processing of conflicting 
information from two different frames of reference is disturbed, which probably results in 
an abolishment of the cueing effect.
 The effect of spatial attention allocation was also present for both the P3 peak 
amplitudes and P3 latencies of painful and non-painful stimuli. In line with the fourth 
hypothesis, the P3 components had higher amplitudes and prolonged latencies for 
incongruently cued trials as compared to congruently cued trials. For the P3 amplitude 
elicited by painful stimuli however, the magnitude of the cueing effect was reduced in the 
crossed hands condition as compared to the uncrossed hands condition, discussed later.
 Our ERPs results suggest that the brain does respond differently to attended and 
unattended stimuli, reflecting an increased demand on attentional resources in the brain 
to locate a stimulus that is incongruently cued compared to a stimulus that is congruently 
cued [70]. Incongruent cues require re-allocation of attention, whereas attention is already 
focused at the correct position in the case of congruent cueing. The results are in line with 
the re-orienting response that has been reported in previous studies [33–35,38] and with 
the fact that noxious stimuli, such as pain, can attract our attention automatically, especially 
when they are unpredictable, intense, and/or novel [6,63]. Our ERPs results are also in line 
with previous findings showing that nociceptive and tactile stimuli capture participants’ 
attention, even when they are presented outside the focus of spatial attention [24,27,41–43]. 
 Contrary to our fifth hypothesis, the ERP P3 peak amplitude elicited by both painful 
and non-painful stimuli was not decreased by crossing the hands. The lack of main effect 
of Hand Position in the present study is probably associated with the described differences 
between our study and that of Gallace et al. [15]. However, with respect to the painful 
stimuli we did find a main effect of crossing the hands in the P3 latency. Crossing the hands 
leads to more prolonged latencies, which suggests a delayed processing [39] of these stimuli 
due to a mismatch between internal and external references frames. Thus, we propose that 
spatial attention allocation has a cost in terms of processing resources – the brain has to 
realign skin-based coordinates to external spatial coordinates [9,15].
 Contrary to our sixth hypothesis we did not observe that stimuli preceded by 
incongruent cues elicited higher P3 amplitude in uncrossed conditions compared to crossed 
conditions. However, the Cue × Hand Position interaction results obtained for the P3 peak 
amplitude following painful stimuli allowed us to indicate that crossing the hands reduces 
the magnitude of the cueing effect. The Cue × Hand Position interaction suggests that spatial 
attention is not guided by an internal (skin-based) reference frame alone (for tactile stimuli 
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see [19,20]). In order to understand our results we may also exploit the knowledge from 
tactile [5,9,11,12,66,67] and pain [11] information processing studies in which the temporal 
order judgment (TOJ) task was used. In those studies an increase in localization errors was 
observed in the crossed hands condition (a crossed-hands deficit). Thus the reduction of the 
magnitude of the cueing effect in the crossed hands condition may reflect a conflict between 
internal and external left–right coordinates that decreases the ability to localize stimuli. The 
processing of the stimuli location is not disturbed when the hands are uncrossed, since in 
this situation the internal and external reference frames provide congruent information.
 For P3 peak amplitude elicited by non-painful stimuli we have observed a main 
effect of Cue and have not observed a main effect of crossing the hands nor an interaction 
effect of Cue and Hand Position. This result indicates that a comparable magnitude of the 
cueing effect was observed in both hand conditions. In a study of Heed and Röder [20], 
where also tactile stimuli were used, a difference in the 190–300 ms window of the ERPs 
between attended and unattended stimuli was observed for the crossed but not the 
uncrossed condition. However, the manipulation of attention, sustained in their study and 
transient in our experiment, was what may have led to differences between the results of 
the mentioned study and ours. Moreover, the ERP in the Heed and Röder [20] study, to 
which we referred, is not the P3, so a direct comparison cannot be made.
 In the present study we investigated the P3 component recorded from five vertex 
electrodes. The results suggest that our P3 component elicited by electric stimuli seems 
most likely the equivalent of the P3a component due to the fact that the amplitudes of the 
P3 were greater at the Cz than at the Pz electrode. Analogously, to our results, in the study 
of Van der Lubbe et al. [44], where transient attention using a Posner task was studied, the 
amplitude of the P260 component was also maximal at Cz and was larger for unattended 
compared to attended stimuli. The authors assumed that the P260 is an equivalent of the P3a 
component. Moreover, the P260 component was assumed to be the nociceptive correlate of 
the P3a component (for discussion see [40–42]), Another study confirms this, showing that 
this component was enhanced by rarely presented deviant laser stimuli [27]. Moreover, in 
the present study we also observed that the cueing effect was more pronounced at fronto-
central sides.
 Some limitations of the current study should be discussed. The behavioural and 
ERP results show different effects of the experimental manipulations. In the crossed hands 
condition for non-painful stimuli, the NRS scores show no cueing effect, whereas for the 
painful condition the P3 amplitudes show a decrease in magnitude of this cueing effect. 
This discrepancy of behavioural and EEG data is common as was shown in previous studies 
[71,72]. One of the explanations for such a pattern of results is that behavioural data are less 
sensitive because they are the end product of all preceding cumulative cognitive operations 
and thus more vulnerable to noise and variability. Interestingly, in an additional analysis, we 
only found a correlation for the least demanding cognitive task, i.e. a correlation between 
the NRS and P3 amplitude for congruent cued painful stimuli in the uncrossed hands 
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position (see S2 Figure). One drawback is that the electrical painful and non-painful stimuli 
measurements were based on participants’ ratings on the NRS (subjective measurements), 
the veracity of which may be questioned [44]. However, objective measurements obtained 
from the ERP components provide a useful method for investigating the physiological 
effects of modulated pain perception [17,37–39]. Another limitation is that in our study we 
collected painful ratings and recorded EEG activity at the same time, so it is possible that 
our results reflect the effect of cognitive enhancement of pain-related brain activity. An 
alternative approach would be to allow participants to assess pain at the end of each block, 
long after the stimuli were given, but this would likely produce unreliable NRS scores due 
to the long delay between the painful stimulus and its rating. Furthermore, such a design 
might measure participants’ beliefs about pain – this could introduce differences in stimulus 
intensities in the congruent and incongruent cue conditions [76]. Valentini et al. [16] used 
another approach where two separate experiment sessions were used for behavioural and 
psychophysiological measurements. In one session participants were asked to evaluate their 
pain sensation according to the experimental conditions and in the following sessions only 
ERPs were collected during the very same conditions. Such a design would have prevented 
pain-related brain activity’s being affected by cognitive enhancement. The next limitation 
is that in the present study the painful and non-painful stimuli were evaluated for the non-
dominant (left) hand and during the experiment such individually determined stimuli were 
also used for the dominant one. The threshold of pain perception may vary considerably 
for the dominant and non-dominant hand; however, reports concerning this topic are 
conflicting [77,78]. Finally, it should be emphasised that in conducting research on pain and 
attention, one needs to be aware that any interruptive effects of pain could be attributed to 
affective processing (e.g. fear or anxiety) taking place during the anticipation of pain. There 
is evidence that fear of pain is associated with stronger pain-related brain activity [79]. As a 
result, the enhanced P3 amplitudes may merely reflect an increased fear of pain.
 In conclusion, both the behavioural and ERP data indicated that the manipulation 
of transient spatial attention was effective and that hand position may modulate this cueing 
effect. Our results may have an implication for the development of therapies for chronic 
pain, which could focus on the use of attentional training as a pain management strategy. 
Such attentional training may facilitate the ability to focus attention away from the painful 
body part and this may lead to pain reduction.
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Supporting information 
S1 Figure. Graphical representation of the hypotheses for both painful and non-painful stimuli. Panels on the left 
(A-C) depict the hypotheses with respect to the NRS ratings. Panels on the right (D-F) depict the hypotheses with 
respect to the ERP P3 component. Note: Dark grey colours represent expected increments (a.u.) whereas light grey 
colours represent expected decrements of scores. However, the grey colours do not quantify the effect and have 
only illustrative meaning. The horizontal and vertical rectangles (Match and Mismatch) represent relation between 
both frames of reference. 
CROSSED-HANDS ANALGESIA STUDY 187
6
S2 Figure. Correlation of individual NRS scores with P3 peak amplitude.
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Discussion: Main experimental findings
In the first four experimental chapters of this thesis, three different ways to induce placebo 
effects were investigated: social learning, conditioning, and verbal instructions next to factors 
modulating perception of pain. In the last experimental chapter, a relatively new method, 
crossing hands that may modulate the perception of pain was investigated with EEG.
Social learning as a method of placebo effect induction
In Chapter 2 and 3, social learning as a new method of placebo effect induction was studied 
in a modified version of Colloca and Benedetti’s experiment (described in paragraph 4.1). 
In fact, the effect of the colour of light stimuli on pain ratings was explored by adding a 
control group that was used to investigate whether green light would produce an analgesic 
effect without prior social observation. In the previous similar study such a control group 
was lacking [1]. Next, the influence of associated factors such as the sex of the model and 
participants, empathy level, fear and anxiety as traits on pain perception was also studied.
 Two main results were obtained. First, social learning induced a nocebo hyperalgesia. 
At first glance this result replicated the main result of Colloca and Benedetti’s [1] study in 
which placebo analgesia was elicited: the subjects from the experimental group rated pain 
stimuli preceded by green lights (placebo) as significantly less painful than those preceded by 
red lights, regardless of the fact that they received the same intensity pain stimuli. However, 
closer examination of the pain ratings associated with placebo/green and non-placebo/
red stimuli between the experimental and control group revealed that instead of placebo 
analgesia, social learning induced nocebo hyperalgesia. More specifically, it was shown that 
green-associated pain stimuli were rated similarly by both the experimental and the control 
groups, whereas red-associated stimuli were rated as more painful in experimental groups 
(model condition) compared to the control groups (the non-model condition). It seems that 
participants, who observed the pain behaviour of the model, learned that red stimuli are 
associated with more pain while green stimuli got rather associated with less pain. These 
results suggest that nocebo effects could be masked by placebo effects, which underlines 
the necessity of including control groups (in which no manipulation was applied) in studies 
on the placebo effect. Moreover, the elicitation of nocebo hyperalgesia supports the idea 
that social learning is a mechanism that can influence pain.
 Second, the results showed that regardless of the sex of the participants, nocebo 
hyperalgesia was greater after a male model was observed than when a female model was 
observed. 
 In Chapter 3, the type of analgesic placebo stimuli used during the social learning 
procedure was investigated. Moreover, it was studied whether the level of trait anxiety and 
trait fear may predict the magnitude of the placebo effect. The results indicated that placebo 
effects could be induced by observational learning regardless of the type and colour of 
stimuli used as placebos. Moreover, no differences in the magnitudes of the placebo effects 
192 CHAPTER 6
were found when red or green lights or circles were used as placebo stimuli. Additionally, 
the hypotheses concerning the relationship between trait anxiety and trait fear and the 
magnitude of placebo effect was not confirmed. 
 The influence on the placebo effect of empathy induced by social observational 
learning was also investigated in Chapter 2 and 3. The empathic concern (EC) level was a 
significant and positive predictor of the magnitude of nocebo hyperalgesia induced by social 
learning. In contrast, in Chapter 3 no relationship between empathy levels and placebo 
effect induced by social learning was found.
 Concluding, nocebo hyperalgesia can be induced via social learning; physical 
properties of placebo stimuli (such as shape and colour) used as placebo have no influence 
on the formation and magnitude of the placebo effect.
Classical conditioning as a method of placebo effect induction
Chapter 4 presents a set of two subsequent studies focusing on investigation of placebo 
effects induced by classical conditioning via a hidden condition (first study), and via a 
condition that was both hidden and open (second study). In case of hidden conditioning, 
participants were not informed about the relationship between the placebo (the light 
colours; CS) and the pain stimulus (US). In the case of open conditioning, at the beginning of 
the experiment the participants were informed that the level of pain was being manipulated 
during the conditioning procedure.
 The results indicate that in both of the studies placebo analgesia was induced via 
hidden conditioning, which is in line with the results from previous studies [2–7]. Moreover, 
in the second study it was shown that explicit information about manipulation eliminated 
the effects of conditioning, thereby indicating that open conditioning was not sufficient to 
produce placebo analgesia. Additionally, next to placebo analgesia, nocebo hyperalgesia 
was elicited by hidden conditioning (first study).
 Neither expectancy nor self-reported fear (state) ratings influenced placebo 
analgesia nor nocebo hyperalgesia induced by hidden conditioning (the first study). The 
results obtained for expectancy are in line with recent findings which showed that explicit 
expectancy is not always involved in induction of the placebo and nocebo effect [8–10]. At 
the same time, the results obtained for self-reported fear (state) contradict the findings 
from previous studies in which this factor was shown to contribute to the placebo effect 
induced by classical conditioning [4] and verbal suggestion [11].
 The results obtained in the second study indicate that hidden conditioning, in 
contrast to open conditioning, had an effect on expectancy of pain intensity scores and on 
self-reported fear level (state). The participants expected less pain and experienced less fear 
in relation to the placebo stimuli compared to no-placebo stimuli in hidden conditioning. 
Moreover, self-reported fear (state) was shown to predict placebo analgesia. However, 
dispositional fear of pain (trait) measured with the FPQ-III was not involved in placebo 
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analgesia. In contrast and in line with the findings from the first study, expectancy of pain 
intensity ratings did not predict placebo analgesia.
Summing up, both placebo analgesia and nocebo hyperalgesia could be induced by hidden 
conditioning. The obtained results suggest that in specific conditions self-reported fear 
(state) rather than the expectancy of pain intensity predict placebo analgesia induced by 
hidden conditioning.
Verbal suggestion as a method of placebo effect induction
Verbal suggestion about the analgesic effect of the placebo stimuli was used in the context 
of a modified version of VJMP (Chapter 5). Verbal suggestion was sufficient to elicit placebo 
analgesia in both the predictable and unpredictable condition. The participants followed 
the given suggestions and rated stimuli associated with placebo as less painful than non-
placebo ones. In the control group, in which no verbal suggestion manipulation was used, 
participants scored pain stimuli delivered after red and green lights in the same manner. 
However, no differences in the magnitude of placebo analgesia between both experimental 
conditions were found. This result contradicts our hypothesis that in the experimentally 
induced CPRA condition (unpredictable condition) the magnitude of placebo analgesia 
would be lower compared to the condition in which FMRP (predictable condition) was 
elicited.
 The results obtained for the expectancy measurements presented in this chapter 
indicated that participants expected less pain to the placebo stimuli than to non-placebo 
stimuli, which is in line with the findings from the second study presented in Chapter 4. 
Moreover, expectancy has been shown to predict placebo analgesia.
 Manipulation check analysis for the fear ratings (state) showed that participants in 
predictable condition were more afraid of movements that were always followed by painful 
stimuli (CS+) than by movements that were never followed by pain (CS-). This showed that 
the fear conditioning procedure in the predictable condition was efficient, which is in line 
with the thesis’s predictions. However, neither the psychophysiological measurements 
of startle probes (recorded for CS+/right, CS-/left)
5 nor avoidance behaviour measurements 
(response latencies and response duration, T1 and T2 respectively) showed an analogous 
pattern of results. These results contradict the findings of previous studies [12,13] which 
showed higher startle probe amplitude and avoidance behaviour (longer time of movement) 
for CS+ movements.
 At the same time, analysis performed for fear-avoidance measurements indicated 
elevated conditioned defensive responses in the predictable condition. Participants were 
more reluctant to initiate movement (longer response latency) and the time of movement 
was prolonged (longer response time) in the predictable condition compared to the 
unpredictable condition. Results of analysis performed for three types of startle probes (CS+ 
and CS- and ITI) revealed that, regardless of startle probe types, higher startle amplitudes 
were observed in the predictable condition than in the unpredictable condition. Moreover, 
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regardless of the experimental condition, both CS+ and CS- startle amplitudes were higher 
compared to startle amplitudes of ITI.
 Summing up, the results presented in Chapter 5 indicate that adjusted VJMP can 
be successfully used in placebo effect studies. However, no difference in the magnitude 
of the placebo effect induced by verbal suggestion in the predictable and unpredictable 
conditions was found. Finally, the presented results indicate that placebo effect induced 
by verbal suggestion worked via changes in participants’ expectations about pain intensity 
level.
Crossed-hands analgesia
In the last experimental study, presented in Chapter 6, the position of subjects’ hands 
(crossed and uncrossed) and the location of their transient spatial attention (congruent and 
incongruent cueing) were manipulated to test how these factors influence processing of 
painful stimuli.
 No analgesia induced by crossing the hands over the body midline was found. 
At the same time, an analgesic effect of transient attention allocation was observed. 
Specifically, pain was subjectively experienced as stronger when elicited by attended stimuli 
when compared to unattended ones. This effect was elicited by directing attention to the 
left or right hemispace with visual cues. Correspondingly, attended and unattended painful 
stimuli elicited P3 responses of different amplitudes. Moreover, it was demonstrated 
that crossing hands might modulate the magnitude of the cueing effect in the case of P3 
amplitude following painful stimuli and NRS ratings of non-painful stimuli. To the best of our 
knowledge, this has never been reported before.
 Therefore, the results indicate that crossing hands over the body’s midline did not 
decrease subjective NRS ratings nor the P3 peak amplitude of painful and non-painful stimuli. 
On the other hand, NRS ratings of painful stimuli were higher when attention was focused on 
the same side as where the electrical stimulation occurred (congruent condition), compared 
to the ratings in the incongruent condition – the so-called cueing effect. No such effect was 
observed for non-painful stimuli. However, for non-painful NRS ratings the interaction effect of 
cueing and hand position was observed: the cueing effect was present only in the uncrossed-
hands position. Peak amplitudes of P3 elicited by painful stimuli were found to be higher and 
P3 latency was higher for incongruent cued trials compared to congruent ones. Moreover, the 
observed effect was stronger for the uncrossed-hands condition. The cueing effect was also 
observed for peak amplitudes and latencies of P3 elicited by non-painful stimuli. At the same 
time, hand position did not influence the magnitude of the effect.
 Summing up, both the behavioural and ERP data indicated that the manipulation 
of transient spatial attention was effective and that in certain cases hand position may 
modulate this cueing effect.
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Discussion of the experimental results
Sex of the model
In Chapter 2 it was stated that in the case of social learning, the sex of the model but not the 
sex of the participants influenced the magnitude of the nocebo hyperalgesia. Observing a 
male model resulted in higher nocebo hyperalgesia regardless of the sex of the participants. 
Previous studies indicated that male subjects reported decreased pain intensity when 
more females were present in the audience [14]. Accordingly, the results suggest that the 
interaction between the sex of the model and that the sex of the experimenter (in our 
experiments it was always female) may also be an important factor that influences the 
magnitude of the effect. This should be investigated in the future. Despite the fact that sex 
differences in placebo analgesia [15,16] and nocebo hyperalgesia [17] have been previously 
reported, a simple sex effect was not found in the present study. Previous studies showed 
that larger nocebo responses were observed for female compared to male participants 
when a conditioning procedure was used. In the case of the verbal suggestion procedure, 
males responded with a larger nocebo effect than females [18].
Empathy
A discrepancy in the results presented in Chapter 2 and 3 regarding the relationship between 
empathy and the nocebo and placebo effect induced via social learning was noticed. In 
Chapter 2 and in the study of Colloca and Benedetti [1], empathy was a positive predictor 
of nocebo hyperalgesia and the placebo effect, respectively. The link between empathy and 
nocebo hyperalgesia is in line with the results of previous studies which showed that observing 
a person experiencing pain activates part of the neural pain network of the empathizer [19,20]. 
In contrast, in the study presented in Chapter 3, no relation between empathy and placebo 
effect was observed. Such a result is in turn consistent with the results of other studies in 
which a social learning procedure was also used to elicit a placebo effect [21,22].
 It is possible that the discrepancy obtained for the role of empathy in Chapter 2 and 
3 was related to differences in the study design. The study presented in Chapter 3 consisted 
of female participants only. There is evidence that females are more empathic than males 
[23–25], which could have caused higher scores and smaller variability in the sample in this 
study. Additionally, female participants observed only a female model in order to exclude 
any interaction effects between the sex of the model and of the participants. Furthermore, 
it should be noted that the relationship between empathy and the magnitude of nocebo 
hyperalgesia obtained in Chapter 2 was rather weak. However, the results from Chapter 
2 and 3 cannot exclude the role of empathy on the placebo effect. Empathy is of major 
importance for everyday social interaction and it can be assumed that it is also important 
in laboratory conditions when the placebo effect is induced [1,26]. Recent studies have 
shown that inducing placebo analgesia also reduces pain empathy, which is accompanied by 
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decreased activation of empathy-related brain areas. Moreover, pain empathy is grounded 
in neural responses and neurotransmitter activity related to first-hand pain [26].
Trait anxiety and fear
The influence of pain anxiety measured by PASS on the placebo effect induced by social 
learning was investigated in Chapter 3. Moreover, here and in the second study of Chapter 
4, dispositional fear measured by the FPQ-III was also explored. The results of the study 
presented in Chapter 3 extend previous findings by demonstrating that both individual 
differences in pain anxiety and fear of pain are not related to the effects of observational 
learning on the placebo effect. Similarly, in the second study of Chapter 4, fear of pain was 
not involved in the formation of placebo analgesia induced by hidden conditioning.
 The results presented in Chapter 3 regarding the effects of trait anxiety are in line 
with recent findings that the nocebo response induced by social observational learning is 
not correlated with trait anxiety [27]. However, it should be noted that other studies suggest 
that participants with high levels of trait anxiety exhibit a larger placebo and nocebo effect 
[28,29].
 The results regarding whether fear affected pain for both discussed studies 
contradict previous findings in which a higher fear of pain level was associated with a lower 
magnitude of the placebo effect [11,30,31]. The observed discrepancy may be associated 
with crucial differences in the study designs. Specifically, Lyby et al. [11,30,31] used a 
procedure that may mimic the naturally occurring pain and placebo effect induction method 
better than the studies presented in Chapter 3 and Chapter 4. Consequently, this might have 
elicited more pain and a larger placebo effect. Next to the usage of heat stimuli, which is the 
most natural type of pain that can be induced in laboratory conditions and is similar to daily 
life experience, Lyby et al. used a placebo medication combined with a verbal suggestion 
about its powerful and documented analgesic effect on heat pain. This might appeal more 
to the participants due to their prior experience with real medications. Consequently, the 
procedures used in the studies of Lyby et al. [11,30,31] have more natural characteristics 
compared to the laboratory-like methods used in the present thesis (electric stimuli, colour 
paradigm, social learning and hidden conditioning). 
 The FPQ-III was used both in this dissertation and in the studies of Lyby [11,30,31]; 
fear of pain was investigated as a dispositional predictor of the analgesic response elicited 
by the placebo stimulus. FPQ-III assesses fear of pain related to specific situations that would 
normally produce pain and expresses how individuals differ in terms of their emotional 
reactions to painful stimulation or in situations when painful stimulation could be prevented. 
Consequently, FPQ-III assesses the trait fear in a very natural context, which seems more the 
case in the Lyby studies. Therefore, the relation between fear and the placebo effect could 
be captured better there than in the studies presented in this dissertation.
 Finally, the studies presented in Chapter 3 and Chapter 4 (second study) consist 
only of female participants, while in Lyby et al. [11,30,31] both female and male participants 
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were included. This could have caused a limited variability in the sample of the present study 
and therefore be the reason that the same pattern of results was not found. Therefore, the 
possibility that high trait fear may have a moderating effect on placebo analgesia cannot be 
excluded and needs further investigation.
State fear and anxiety
Self-reported fear was investigated in both studies in Chapter 4. In the second study, the 
participants reported less fear in relation to the conditioned stimuli (placebo) compared to 
the control. Moreover, self-reported fear was shown to predict placebo analgesia, which 
is in line with previous placebo studies in which verbal suggestion [11] and conditioning 
alone [4] was used to elicit placebo effect. On the other hand, in the first study self-reported 
fear predicted neither placebo analgesia nor nocebo hyperalgesia induced by hidden 
conditioning.
 At first glance, the results regarding the relationship between state fear and the 
placebo effect are contradictory. This discrepancy may be associated with the modification 
of the procedure implemented in the second study. In the first study, the measurements of 
pain, expectancy and state fear were performed in the first block and this may lead to two 
potential explanations. First, it is possible that the effect of suggestion cannot be measured 
in fear because fear and expectancy were assessed concurrently. Second, the participants 
might not have associated the distinct light stimuli with different pain intensities at the 
beginning of the experiment. As a result, there was no explicit threat for participants and no 
fear was induced.
 On the other hand, in the second study the experimental procedure was modified: 
in the first block of the experiment participants underwent conditioning without additional 
measurements of other factors. Therefore, in contrast to the first study, pain, expectancy, 
and fear measurements were collected in the second and fourth conditioning block of the 
experiment. Participants could focus their attention and effectively associate colours and 
pain stimuli levels at the very beginning of the experiment. As a result, participants might 
have created expectations and elicited fear associated with the colour stimuli; this was 
indeed reflected in the measurements collected during further blocks of conditioning. 
 Next, in the study presented in Chapter 5, the influence of experimentally induced 
state fear (FMRP – predictable condition) and state anxiety (CPRA – unpredictable condition) 
on the magnitude of placebo analgesia was investigated. The results contradict the study’s 
hypothesis: a stronger placebo effect was not observed in the predictable condition. In 
fact, no difference between the predictable and unpredictable conditions was found. This 
contradicts the results of previous studies suggesting that such a difference may exist. 
Previous studies show that a high level of state fear eliminated the placebo effect [11] and 
that administrating a placebo, which lowers state anxiety, is central for placebo analgesia 
to occur [32,33]. Nevertheless, these conclusions may be misleading as in the mentioned 
study of Luby et al. [11] it is unclear what emotional state (fear or anxiety) was elicited. The 
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authors used threat of shock as a method of fear induction, but this is a common method of 
induction of state anxiety [34].
 It is certain that the implemented modified VJMP succeeded in eliciting fear as 
an emotional state. Results for self-reported fear indicate that fear conditioning in the 
predictable condition was effective: participants experienced stronger fear associated with 
joystick movement followed by pain stimuli (CS+) compared to joystick movement not 
followed by pain stimuli (CS-). No such difference between movements was observed in 
unpredictable condition where pain stimuli application was not associated with joystick 
movements. Furthermore, results obtained for startle amplitude, T1 and T2, suggest that 
fear conditioning in the predictable condition was effective. Startle reflexes were increased 
in the predictable condition (state of fear), in line with previous findings [35] indicating 
differences in emotional arousal between both experimental conditions. Additionally, 
longer response latency and response time were observed in predictable compared to 
unpredictable condition, indicating elevated conditioned defensive responses and presence 
of avoiding behaviour in PC. In order to verify if CRPA was elicited, it is recommended to use 
EEG as previous studies have shown that administering placebo decreases brain activity in 
regions related to anxiety processing [36,37]. 
 We did not find any difference between the effect of state fear and anxiety on 
placebo analgesia what could suggest that they influence placebo effect in the same manner. 
However, this conclusion needs further investigation where a baseline group with no fear nor 
anxiety will be included in the study design. However, it is impossible to create such group in 
joystick paradigm and therefore this issue should be approached using a distinct paradigm.
Expectancy
The role of expectancy when the placebo effect is induced by classical conditioning and 
verbal suggestion was investigated in Chapter 4 and 5. The placebo effect induced by both 
methods is theoretically considered to be mediated by expectancies [38–40]. Contemporary 
interpretations of the conditioning phenomenon also stress the mediation of cognitive 
functions such as expectancy [41]. The results, as presented in Chapter 5, confirmed this: 
placebo analgesia induced by verbal suggestion was predicted by expectations. However, 
the results presented in Chapter 4 (both studies) show that this might not always be the 
case: exposure to distinct pain intensities during hidden conditioning was sufficient to 
induce placebo and nocebo effects that were not found to be predicted by self-reported 
trial-by-trial ratings of expectancy. The results obtained for expectancy of pain intensity 
align with studies in which conditioning represents an automatic process that is not 
mediated by expectancy [42]. Therefore, it is suggested that classical conditioning may be a 
distinct mechanism for placebo and nocebo effect induction. This explanation is also in line 
with the results of recent studies in which the role of awareness activation and acquisition 
of conditioned placebo and nocebo effects were investigated [8–10,43]. These authors 
indicate that learning mechanisms trigger placebo effects by partially operating outside 
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of awareness: visual cues that are unconsciously perceived elicit the placebo and nocebo 
effect. Moreover, the results support a model postulating that placebo effects can be learned 
either consciously or unconsciously, depending on the specific circumstances [44–46]. More 
precisely, Wager et al. [45] propose two primary components of the treatment context 
that influence outcomes. The first is conceptual processes that can influence expectations; 
the second is pre-cognitive associations that can be elicited by a conditioning cue and are 
suggested to “influence physiological processes outside conscious control” [45, p. 411]. 
These pre-cognitive associations between colour stimuli and the level of pain intensity may 
have been critical in eliciting the observed placebo and nocebo effects obtained by hidden 
conditioning. Therefore, the effects of conditioned stimuli may not always be mediated by 
self-reported explicit expectancy, as was suggested in Colloca and Miller’s learning model 
[47,48]. As a consequence, the presented results supplement Colloca and Miller’s learning 
model [47,48] of the formation of the placebo effect.
 Notably, the results presented in Chapter 5 do not exclude an overall role of 
expectancy in the placebo effect induced by verbal suggestion. In this case, self-reported 
expectancy may measure “conscious, conceptual belief about the future occurrence of 
an event” [45, p. 406]. Therefore, in accordance with previous studies [49,50], the results 
obtained in Chapter 4 and 5 indicate that placebo effect may be either conscious or 
unconscious.
 It should be also noted that the role of expectancy in the placebo effect induced 
by social learning is still unrevealed. As was proposed by Kirsch [39], modelling may work 
as a kind of suggestion and a mean by which expectations concerning the painfulness of 
the stimuli have been acquired. There was only one study in which social information acted 
as a conditional cue and it indicated that the placebo effect was mediated by expectations 
[51]. In Chapter 2 and 3 expectancy about pain intensity associated with placebo and non-
placebo stimuli was not measured. This could be seen as a limitation. However, investigation 
of the role of expectancy was not the main aim of this particular study. Furthermore, it 
would be extremely difficult to implement such measurement in the study procedure. First, 
the participants were led to believe that their observation was by chance rather than part 
of the experimental procedure. Second, the model’s expectation ratings could be seen as an 
additional verbal suggestion about the colour stimuli associations.
Crossed-hands analgesia 
In contrast to our expectations, crossed-hands analgesia for painful NRS scores was not 
found (Chapter 6). The presented pattern of results could be caused by differences in the 
procedures compared to other studies in which crossed-hands analgesia was found [52–
54]. Notably, in the present study stimuli were delivered in a predicable manner (congruent 
cueing in 80% of trials); thus, the side of the stimuli application was in most cases easy for 
the participants to predict. Incongruent cueing was used in 20% of the trials: the stimulus 
was delivered in a spatial location that was not pointed to by the cue. In the studies of 
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Gallace et al. [53], the side of the subsequent stimuli application was completely unknown 
to the participant. Taking into consideration this difference in procedure and the fact that 
the cueing effect was observed for painful NRS scores (participants scored stimuli after 
congruent cues as more painful), it can be speculated that the lack of crossed-hands 
analgesia could be due to the cue effect overshadowing the hand position effect. Moreover, 
in accordance with the study of Valentini et al. [54], our lack of crossed-hands analgesia 
could result from the fact that vision of the hands was prevented. 
 Stimuli following cues were scored as more painful compared to the stimuli 
following incongruent cues. This result is in line with studies in which focusing attention to 
a nociceptive stimulus exaggerates pain sensation [55–57]. This is also in agreement with 
studies showing that focusing attention away from the location of nociceptive stimuli [57–
61] or distracting attention from pain stimuli by other stimuli [62–64] reduces pain.
 At least two findings regarding the ERP studies and in particular regarding the 
amplitude of the P3 following painful stimuli should be emphasized. Firstly, the P3 peak 
amplitudes following painful stimuli were higher for incongruently cued trials compared to 
congruently cued ones (cueing effect). This is likely caused by the re-allocation of attention 
that is needed following incongruent cues. This reallocation of attention can be reflected in 
the increased demand for attentional resources in the brain to locate such a stimulus [65]. 
The results are in line with the orienting response [66–69], by which noxious stimuli such as 
pain can attract our attention automatically [56,70], and with previous findings showing that 
nociceptive and tactile stimuli capture participants’ attention, even when they are presented 
outside of the focus of spatial attention [58,71–74]. Secondly, it was demonstrated that 
crossing hands might modulate the effect of attention for the P3 peak amplitudes following 
painful stimuli, which were lower in the crossed-hands condition than in the uncrossed-
hands condition. Therefore, this result proves that spatial attention is not guided only by an 
internal reference frame, but also indicates the importance of an external reference frame 
in the proper location of painful stimuli. This explanation is in line with studies that indicate 
that the conflict between both frames of reference induced by crossing hands decreases the 
ability to locate stimuli [75–80]. It is suggested that spatial attention allocation has a cost 
in terms of processing resources because the brain has to realign skin-based coordinates to 
external spatial coordinates [53,76, 81]. 
 The lack of interaction between cue type and hand position for NRS scores of 
painful stimuli could be associated with the fact that painful stimuli inherently attract [70] 
and capture attention [82,83], consequently they are easy to locate even if hands are kept 
in the crossed position. Based on this result, the relevance of the external location of the 
hands cannot be excluded since the ERP results did reveal an interaction effect. However, 
discrepancies between behavioural and psychophysiological results are common [84,85]. 
Behavioural measurements of pain have been shown to be less sensitive because they are 
the end product of all preceding cumulative cognitive operations and are more vulnerable 
to noise and variability.
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 Unlike the painful condition, the results from the non-painful condition showed a 
different pattern that may highlight differences between the processing of painful and non-
painful stimuli. For NRS scores of non-painful stimuli, no crossed-hands analgesia was observed, 
but this might have been overshadowed by the stronger influence of the cueing effect. 
Moreover, it is hypothesized that crossing hands might reduce the overshadowing effects of 
cues. Therefore, only in the uncrossed-hands condition participants rated non-painful stimuli 
preceded by congruent cues as more intense than incongruent ones. The elimination of the 
cueing effect in the crossed-hands position for behavioural measurements may be explained 
by the reduced ability to locate tactile stimuli due to the mismatch between the internal 
and external reference frames [75–79]. Higher amplitudes and prolonged P3 latencies were 
observed for incongruently cued stimuli compared to congruent ones; however, this so-called 
cueing effect had comparable magnitudes in both hand conditions. This suggests that for P3 
amplitude and latency, the cueing effect might have overshadowed the hand position effect, 
as was previously suggested for the behavioural results of painful stimuli.
 To summarize, simply crossing the hands in the condition of the transient spatial 
attention manipulation did not lead to pain reduction. Therefore, attention manipulation 
was shown to influence pain perception more than manipulation of hand position. However, 
crossing the hands over the body midline has the potential to modulate the magnitude of 
the cueing effect (as measured by the amplitude of the P3 elicited by painful stimuli).
Conclusions
Placebo analgesia
The findings from the studies presented in Chapters 2–5 show that the experimental 
procedures to induce placebo or nocebo effects were highly effective. The placebo effect 
was successfully induced by using three different methods: social learning (Chapter 2 and 
3), classical conditioning (Chapter 4), and verbal suggestion (Chapter 5). In all five studies 
a coloured light was used as placebo, which implies that even if no inert treatment is 
administered, the effect of suggestions and expectations can elicit placebo or nocebo effect 
[86]. Moreover, several factors were shown to influence the placebo effect.
 The sex of the model has a strong influence on the magnitude of the nocebo effect 
elicited by social learning. Nocebo hyperalgesia was greater after observation of a male model.
 The role of empathy on the placebo and nocebo effect induced by social learning is 
less clear; however, it cannot be excluded either.
 Anxiety as measured by PASS does not change the size of the placebo effect induced 
by social learning. Analogously, dispositional fear as measured by the FPQ-III has no influence 
on the magnitude of the placebo effect induced by social learning and hidden conditioning.
 The state fear could predict the magnitude of placebo effect induced by hidden 
conditioning. Therefore, it is suggested that state fear might have a crucial role in the 
placebo effect induced by hidden conditioning.
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 Both experimentally induced state fear and state anxiety influence the placebo 
effect induced by verbal suggestion in the same manner.
 Exposure to distinct pain intensities during hidden conditioning was sufficient to 
induce placebo and nocebo effects that were not predicted by trial-by-trial self-reported 
ratings of expectancy. Therefore, it is suggested that classical conditioning may be a distinct 
mechanism for placebo and nocebo effect induction. The placebo effect induced by verbal 
suggestion (without conditioning or any additional interventions) was found to be predicted 
by expectations. The results support the idea that placebo effects can be learned either 
consciously or unconsciously.
Crossed-hands analgesia
Crossing hands over the body midline did not elicit analgesia. However, manipulation of the 
position of the hands influenced the attentional effect (cueing effect) as measured with the 
amplitude of the P3 elicited by painful stimuli and with non-painful NRS ratings.
Pain modulation model 
According to the results presented in this thesis and both Colloca and Miller’s learning 
model [47] and Wager et al.’s theory [45], the following modifications of Colloca and Miller’s 
learning model can be proposed (see Figure 1). 
 First, it is suggested to include pre-cognitive associations [45] that, according to the 
presented results (Chapter 4), may be activated during the hidden conditioning procedure 
and may influence the placebo effect without engagement of expectancy (see Figure 1). 
Brain imaging studies may provide evidence of more implicit mechanisms related to the 
formation of placebo and nocebo effects induced by classical conditioning without explicit 
verbal suggestions, e.g. pre-cognitive associations.
 Second, changes were suggested related to the direction of the influence of 
emotion on the placebo effect induction. In Wager et al.’s theory [45], the pre-cognitive 
associations (e.g. the cues, pre-cognitive social cues, and the situational context that 
influence perception and automatic responses) and emotions influence each other (bimodal 
influence is shown as an arrow with dashed outline between pre-cognitive associations and 
emotions in Figure 1). Additionally, in Colloca and Miller’s model [47] the impact of emotion 
on the formation of placebo effect is mentioned in the place where, throughout learning, 
social information from the environment is associated with higher cognitive functions (e.g. 
emotions, motivation, and beliefs) in the brain. This process of decoding information results 
in the elicitation of expectations that further mediate the placebo effect. Therefore, in 
Colloca and Miller’s learning model [47], emotions were suggested to influence expectations. 
However, this is still an open question because it is also possible that emotions are the result 
of elicited expectations [36,87,88]. Based on the literature it is only possible to conclude 
that there is a relation between emotions and expectancy, but the direction is still unknown. 
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This uncertainty is represented in Figure 1 by a bidirectional white arrow with a dashed red 
outline between emotions and expectations. 
 Thirdly, regarding the factor emotions, it is suggested to implement state fear in 
Colloca and Miller’s model [47]. Emotions are mentioned broadly in Colloca and Miller’s 
model, whereas the results from Chapter 4 are more specific and suggest that fear should 
be implemented in the model. Since state fear (in contrast to expectancy of pain intensity) 
was found to predict placebo analgesia induced by hidden conditioning (Chapter 4), it is 
hypothesized that state fear may influence the placebo effect directly, without elicitation 
of expectations. This is consistent with Evans’ concept [89,90], in which negative emotions 
were considered as a separate placebo mechanism. According to this concept, the reduction 
of fear/anxiety directly affects the level of experienced pain [29,33,90]. Nevertheless, change 
in the fear/anxiety level seems to be more a result of expectations and conditioning rather 
than the independent cause of placebo administration [33,4]. Moreover, the results obtained 
for state fear in Chapter 4 (second study) are very weak. Consequently, implementation of 
state fear into Colloca and Miller’s learning model [47] is a proposition that needs further 
exploration.
 The results from Chapter 2 imply that the factors empathy and sex of the model should 
be included in the learning model when the placebo effect is induced via observational learning.
Figure 1. Theoretical pain modulation model. Graphical representation of proposed modification of Colloca and 
Miller’s learning model of placebo response based on the results obtained in Chapters 2–5 and role of hand position 
and attention on the results of the study presented in Chapter 6. Note: grey colour – represents Colloca and Miller’s 
learning model; blue colour – represents new factors added to the model; red dash line – represents hypothetical 
relation of emotions added to the model; P3 peak amplitude – represents the P3 elicited by painful stimuli; cueing 
effect – represents increased P3 peak amplitude after presentation of incongruent cues and reduction of the 
magnitude of the cueing effect in the uncrossed-hands position. Modifications were made based on Figure 1 from 
Colloca and Miller’s work [47] and Figure 4 from Wager et al.’s work [45].
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 The results from the study presented in Chapter 6 indicated that crossing hands 
over the body midline did not simply elicit analgesia. However, it showed that attention 
influenced pain perception (e.g. lower pain ratings, increased P3 peak amplitude and 
increased P3 peak amplitude after incongruent cueing) and that this effect was modulated 
by crossing hands over the body midline (see Figure 1). 
 Based on the series of five placebo studies Colloca and Miller’s model was adapted 
and supplemented. The obtained results emphasize the relevance of implementation of 
expectancy measurements and the influence of the factors self-reported fear, expectancy 
and the sex of the model on the formation and magnitude of the placebo effects induced by 
social learning, conditioning, and verbal suggestions.
Implications and outlooks
The results as presented in this dissertation may have important implications for pain 
research. Data on expectancy of pain intensity should be collected in studies of placebo 
effects when the role of expectancy of pain intensity is investigated. Only in such cases, the 
role of expectancy can be clearly indicated. Moreover, the placebo study procedure should 
be designed in a way that allows distinguishing placebo analgesia and nocebo hyperalgesia 
in order to be able to unmask nocebo hyperalgesia from placebo analgesia; this can be done 
by including a group without placebo manipulation. Our results also suggest that when 
studying the mechanisms of placebo effects, fear as a state should be measured. 
 The character of the present dissertation is strictly experimental; however, there 
are also possible practical implications. In general, all the obtained results may have 
implications for pain management. The results from Chapter 2–4 highlight the importance of 
the context in which individuals feel pain. Accordingly, stimuli that are associated with pain 
or relief from pain and observation of pain behaviour of another person may have an impact 
on experiencing pain in the future. Furthermore, the sex of people present during medical 
procedures may have an influence on an individual’s pain perception. The obtained results 
suggest that changes in the perception of pain can occur even when participants are not 
fully aware of the ongoing treatment and anticipated outcomes. Therefore, environmental 
factors associated with pain experience may serve as conditioned cues that worsen or 
improve a symptom even if explicit instructions are not given and, presumably, expectancies 
play no role. An assessment of the individual level of fear should also be performed in the 
context of pain management, as it seems to be a crucial factor in the effectiveness of placebo 
interventions and may be important in the effectiveness of active treatment. 
 The results presented in Chapter 5, in which the VJMP was used, allowed speculation 
that placebo may be successfully used to reduce participants’ pain in the context of the 
maintenance process of chronic pain, i.e. fear conditioning. The results obtained for nocebo 
hyperalgesia (Chapter 2 and Chapter 4) may carry the same degree of importance for clinical 
implications as those of placebo analgesia. Specifically, contextual variables are relevant for 
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pain perception. Finally, the findings described in Chapter 6 point to a strategy for improving 
pain management. For instance, acquiring the ability to focus attention away from the 
painful body part (attentional training during therapy) may lead to pain reduction. 
 One of the possible directions for future research is to use the colour paradigm 
in order to compare the magnitude of the placebo effect elicited by the three methods 
of placebo induction: social learning, conditioning with and without verbal suggestions. 
Moreover, studies measuring EEG correlates in the context of the three methods of placebo 
induction might show manipulation effects unnoticed by behavioural markers of pain. The 
use of VJMP opens a new path of placebo research and it seems worthwhile to continue 
using it to investigate nocebo hyperalgesia and placebo analgesia induced by conditioning 
and social learning. 
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Summary of the dissertation
Pain is no longer regarded only as a physical sensation related to noxious stimuli or 
disease: it is now seen as a conscious experience that is modulated by sensory, cognitive 
and emotional factors. This multidimensional character of the nature of pain gives rise to 
a biopsychological model of pain and opens new methods of pain treatment, e.g. the well-
known placebo effect and the less investigated analgesia elicited by crossing hands over 
the body midline. The main objectives of the present dissertation were to investigate and 
explore factors that influence placebo effects and crossed-hands analgesia.
 Many factors are known to influence pain perception and the magnitude of placebo 
effects; however, there are still many unrevealed potential factors such as the sex of the 
model, type of placebos, empathy level, experimentally induced state fear and state anxiety 
that may modulate the magnitude of placebo effect. Moreover, many placebo studies 
present contradictory results and unclear naming of the investigated emotional factors (e.g. 
fear as a state and anxiety as a state). All this hampers clear conclusions about factors that 
influence the placebo effect. An unanswered question regarding crossed-hands analgesia 
concerns whether manipulation of frames of reference (e.g. crossing hands induces a 
conflict between internal and external frames of reference) is sufficient to decrease pain in 
the condition of transient attention manipulation (the focus of attention was changed from 
trial to trial). All this has been briefly reviewed in the Introduction of the thesis.
 Chapter 2 describes the role of the sex of the model and the participants on the 
magnitude of nocebo hyperalgesia induced by social learning. It was demonstrated that the 
sex of the model, regardless of the sex of the participants, has a strong influence on the 
magnitude of the nocebo effect elicited by social learning. Specifically, nocebo hyperalgesia 
was greater after observation of a male model. Moreover, empathic concern was shown to 
be a positive predictor of nocebo hyperalgesia induced by social learning.
 The influence of trait fear and trait anxiety and the potential role of the type of 
placebos (e.g. green/red coloured lights and shapes stimuli e.g. square and circle) used to 
elicit placebo effect via social learning were investigated in Chapter 3. It was shown that 
placebo effects could be induced by social learning, regardless of the type and colour of 
stimuli used as placebos (Chapter 3). The results presented in this chapter also indicate that 
trait fear, trait anxiety and empathy level have no influence on the magnitude of placebo 
effect induced by social learning. 
 In Chapter 4 it was investigated if hidden and open conditioning (i.e. with and 
without information about the relationship between conditioned and unconditioned 
stimuli) could elicit placebo analgesia and nocebo hyperalgesia. Next it was examined 
to what extent expectancy, state and trait fear are related to both nocebo and placebo 
effects induced by hidden conditioning. It was demonstrated that exposure to distinct pain 
intensities was sufficient to induce not only placebo analgesia but also nocebo hyperalgesia. 
Neither expectancy nor fear (state) predicted placebo analgesia or nocebo hyperalgesia 
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(the first study of Chapter 4). However, further investigation (the second study of Chapter 
4) revealed that fear (state) was the only predictor of placebo analgesia in the hidden 
conditioning group. Furthermore, neither expectancy of pain intensity nor fear as a trait 
predicted placebo analgesia induced by hidden conditioning.
 The potential divergent influence of experimentally induced state fear and 
state anxiety and the role of expectancy on the magnitude of placebo effect induced by 
verbal suggestion were investigated in Chapter 5 using a modified voluntary joystick 
paradigm (VJMP). Both emotional states were elicited in separate experimental conditions 
(predictability and unpredictability of pain). It was shown that the magnitude of placebo 
analgesia induced by verbal suggestion did not differ in the context of experimentally 
induced state fear of movement-related pain (state fear induced in the predictable pain 
condition) and contextual pain-related anxiety (state anxiety induced in the unpredictable 
pain condition). To the best of our knowledge it is the first study in which the placebo effect 
induced by verbal suggestion (without conditioning or any additional interventions) was 
found to be predicted by expectations.
 Behavioural and neurophysiological measures of attention manipulation in crossed-
hands paradigm were investigated in Chapter 6. Regarding the influence of crossing hands 
over the body midline on pain perception in the context of transient attention manipulation, 
crossed-hands analgesia was not induced. However, an effect of attention (cueing effect) 
on pain was observed for both behavioural and psychophysiological measurements. Pain 
was subjectively experienced as weaker when elicited by unattended stimuli (incongruent 
condition) as compared to attended ones (congruent condition). Peak P3 amplitudes 
elicited by painful stimuli were higher and P3 latency was longer for incongruent cued trials 
as compared to congruent ones. Moreover, manipulation of hands position influenced the 
attentional effect, as measured with the peak P3 amplitudes elicited by painful stimuli. The 
peak P3 amplitudes following painful stimuli were reduced in the crossed-hands condition 
as compared to the uncrossed-hands condition. No such effect was observed for behavioural 
measures. The results obtained for non-painful stimulation showed a different pattern 
of results: elimination of the cueing effect was observed in the crossed-hands position 
and higher amplitudes and prolonged latencies of P3 were observed for incongruently 
cued stimuli compared to congruent ones; however, this cueing effect had comparable 
magnitudes in the crossed- and uncrossed-hands conditions.
 Finally, although the results of the present thesis are in line with Colloca and Miller’s 
learning model, it is proposed to adapt and extend the model based on the experimental 
findings. This has been done in the General Discussion. More specifically, it is proposed 
to add the pre-cognitive associations that may be activated during hidden conditioning. 
Regarding the factor emotions, it was suggested to implement the state fear. Finally, it was 
proposed that the factors such as the sex of the model and empathy level should be included 
in the learning model when the placebo effect is induced via observational learning.
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 The General Discussion of the thesis ends with a paragraph on clinical implications 
and outlooks for further research. The presented results undoubtedly contribute to the 
general understanding of social, emotional and cognitive modulation of pain perception.
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Pijn wordt niet langer beschouwd als alleen maar een fysieke sensatie die veroorzaakt 
wordt door schadelijke prikkels of ziekte; pijn wordt tegenwoordig gezien als een bewuste 
ervaring die beïnvloed wordt door sensorische, cognitieve en emotionele factoren. 
Het multidimensionale karakter van van pijn geeft aanleiding tot een biopsychologisch 
pijnmodel en opent nieuwe methoden voor pijnbehandeling, zoals door het induceren van 
het welbekende placebo-effect, maar ook door het minder onderzochte pijnstillend effect 
dat veroorzaakt wordt door het kruisen van de handen over de middellijn van het lichaam. 
De belangrijkste doelstelling van dit proefschrift is het onderzoeken van factoren die van 
invloed zijn op het placebo-effect en het pijnstillend effect van het kruisen van de handen.
 Van veel factoren is bekend dat ze de perceptie van pijn en de strekte van het 
placebo effect kunnen beïnvloeden; er zijn echter nog steeds veel andere niet-onderzochte 
factoren zoals het geslacht van de proefpersoon in relatie tot het geslacht van degene die 
het placebo effect bewerkstelligt, de wijze waarop het placebo effect geïnduceerd wordt, 
de mate van empathie, de experimenteel veroorzaakte angst en angst als persoonlijkheids 
kenmerk. Bovendien laten veel placebo-onderzoeken tegenstrijdige resultaten zien en 
worden vaak onduidelijke benamingen van de onderzochte emotionele factoren gebruikt 
(zoals bijvoorbeeld angst voor een gebeurtenis of toestand en angst als persoonlijheids 
eigenschap). Dit alles bemoeilijkt het trekken van duidelijke conclusies over factoren die 
het placebo-effect beïnvloeden. Een onbeantwoorde vraag over het pijnstillende effect 
van het kruisen van de handen betreft de vraag of manipulatie van referentiekaders (het 
kruisen van de handen veroorzaakt een conflict tussen interne en externe referentiekaders) 
voldoende is om pijn te verminderen als voorbijgaande aandachtmanipulatie (transient 
attention manipulation) wordt toegepast. Dit alles wordt kort besproken in de inleiding van 
het proefschrift.
 Hoofdstuk 2 beschrijft de rol van het geslacht van het model (een medewerker van 
de experimentator) en van de deelnemers op de mate van nocebo hyperalgesie veroorzaakt 
door sociaal leren. Aangetoond werd dat het geslacht van het model, ongeacht het geslacht 
van de deelnemers, een sterke invloed had op de omvang van het nocebo-effect en dat met 
name hyperalgesie groter was na waarneming van een mannelijk model. Bovendien bleek 
empathische bezorgdheid een positieve voorspeller te zijn van hyperalgesie door nocebo. 
 In Hoofdstuk 3 werd zowel de invloed van voorspelbare en onvoorspelbare angst 
voor een aversieve stimulus als wel de mogelijke rol van het type placebo stimulus (stimuli 
met verschillende kleuren, zoals rood of groen, en vormen, zoals vierkant of cirkelvormig 
werden gebruikt) als wel de factor empathie onderzocht op het placebo-effect dat 
geïnduceerd werd via sociaal leren. De resultaten lieten zien dat placebo effecten kunnen 
worden geïnduceerd door sociaal leren, ongeacht het type en de kleur van de stimuli die 
worden gebruikt als placebo (Hoofdstuk 3). De resultaten die in dit hoofdstuk gepresenteerd 
218 NEDERLANDSE SAMENVATTING
zijn, geven ook aan dat voorspelbare en onvoorspelbare angst en de mate van empathie 
geen invloed hebben op de omvang van het placebo-effect veroorzaakt door sociaal leren.
 In Hoofdstuk 4 werd onderzocht of verborgen en open conditionering (d.w.z. 
met en zonder informatie over de relatie tussen geconditioneerde en ongeconditioneerde 
stimuli) placebo-analgesie en nocebo-hyperalgesie zou kunnen veroorzaken. Tevens werd 
onderzocht in hoeverre voorspelbare angst en angst als persoonseigenschap, gemeten aan 
de hand van een vragenlijst, gerelateerd zijn aan zowel het nocebo- als aan het placebo-
effect veroorzaakt door verborgen conditionering. Gevonden werd dat blootstelling aan 
verschillende stimulatie intensiteiten voldoende was om niet alleen placebo-analgesie, 
maar ook nocebo hyperalgesie te induceren. Noch voorspelbare angst, nog angst als 
eigenschap voorspelden placebo-analgesie of nocebo hyperalgesie (de eerste studie 
van Hoofdstuk 4). Echter, uit nader onderzoek (de tweede studie van Hoofdstuk 4) bleek 
dat angst (als toestand) de enige voorspeller was van placebo-analgesie in de verborgen 
conditioneringsgroep. Bovendien voorspelden noch de verwachting van de pijnintensiteit 
noch angst als eigenschap de placebo-analgesie veroorzaakt door verborgen conditionering.
 De potentieel uiteenlopende invloed van experimenteel geïnduceerde 
voorspelbare en onvoorspelbare angst op de omvang van het placebo-effect veroorzaakt 
door verbale suggestie werd onderzocht in Hoofdstuk 5. De deelnemers konden de mate 
van ervaren pijn aangeven door met een joystick te bewegen (VJMP). Beide emotionele 
toestanden werden opgewekt in onderling verschillende experimentele omstandigheden 
(namelijk, voorspelbaarheid en onvoorspelbaarheid van de pijnlijke stimulus). Bovendien 
werd de rol van verwachtingen bij de inductie van placebo-analgesie via verbale suggestie 
onderzocht. Gevonden werd dat de mate van placebo-analgesie veroorzaakt door verbale 
suggestie niet verschilde binnen de context van experimenteel geïnduceerde angst 
voor bewegingsgerelateerde pijn (angst als toestand veroorzaakt door de voorspelbare 
pijnconditie) en contextuele pijngerelateerde angst (angst als toestand veroorzaakt door 
onvoorspelbare pijnconditie). Voor zover ons bekend is dit de eerste studie waarbij het 
placebo-effect veroorzaakt door verbale suggestie (zonder conditionering of aanvullende 
interventies) werd voorspeld door verwachtingen.
 Gedrags- en neurofysiologische variabelen van aandachtsmanipulatie in het 
gekruiste-handen-paradigma zijn in Hoofdstuk 6 onderzocht. Er werd geen pijnstillend effect 
gevonden door het kruisen van de handen over de middellijn van het lichaam in de context van 
voorbijgaande aandachtsmanipulatie. Er werd echter wel een effect van aandacht (cueing-
effect) op pijn waargenomen voor zowel gedrags- als psychofysiologische (opgewekte 
potentialen) uitkomst metingen. Pijn werd subjectief als zwakker ervaren wanneer zij werd 
opgewekt door prikkels waar de aandacht niet op gevestigd was (incongruente toestand) in 
vergelijking met de prikkels waar de aandacht wel op gevestigd was (congruente toestand). 
De piek P3-amplituden die werden opgewekt door pijnprikkels waren hoger en de P3-
latentie was langer voor incongruente cued-trials in vergelijking met congruente. Bovendien 
beïnvloedde manipulatie van de positie van de handen het aandachtseffect, gemeten met 
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de piek P3-amplituden opgewekt door pijnlijke stimuli: de piek P3-amplituden als reactie op 
pijnprikkels waren verminderd als proefpersonen hun handen kruisten in vergelijking met 
de conditie waarin zij dit niet deden. Een dergelijk effect van het ket kruisen van de armen 
werd niet waargenomen voor de gedragsmaat. De resultaten verkregen voor niet-pijnlijke 
stimulatie vertoonden een ander patroon: eliminatie van het cue-effect werd waargenomen 
in het geval van gekruiste handen en hogere P3-amplitude en langdurige P3-latentie werden 
waargenomen voor incongruente cued stimuli in vergelijking met congruente cued stimuli; 
dit cueing-effect had een vergelijkbare grootte in zowel de de gekruiste als ongekruiste 
handen conditie.
 Hoewel de resultaten van dit proefschrift goed aansluiten bij het leermodel van 
Colloca en Miller, toch wordt door ons voorgesteld om het model aan te passen en uit te 
breiden op basis van de experimentele bevindingen. Dit is gedaan in de algemene discussie. 
Meer specifiek wordt voorgesteld om pre-cognitieve associaties toe te voegen die tijdens 
verborgen conditionering kunnen worden geactiveerd. Met betrekking tot de factor emoties 
werd gesuggereerd om angst als toestand in het model te implementeren. Ten slotte werd 
voorgesteld om factoren zoals geslacht van het model en de mate van empathie in het 
leermodel op te nemen wanneer het placebo-effect via sociaal leren wordt geïnduceerd.
 De algemene discussie van het proefschrift eindigt met een paragraaf over klinische 
implicaties en vooruitzichten voor verder onderzoek. De gepresenteerde resultaten 
dragen bij aan het algemene begrip van sociale, emotionele en cognitieve modulatie van 
pijnperceptie.
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Streszczenie rozprawy doktorskiej
Ból nie jest wyłącznie fizjologicznym zjawiskiem związanym z działającym bodźcem 
bólowym czy też chorobą: obecnie jest definiowany jako świadome odczucie, które może 
być modyfikowane poprzez różnego typu czynniki sensoryczne, poznawcze i emocjonalne. 
Wielowymiarowy charakter bólu leży u podstaw biopsychologicznego modelu bólu i otwiera 
nowe drogi jego leczenia, takie jak stosowanie dobrze znanego placebo lub mniej poznanej 
analgezji wywołanej krzyżowaniem rąk. Głównym celem niniejszej pracy jest zbadanie 
czynników, które wpływają na powstanie i wielkość efektów placebo i analgezji wywołanej 
krzyżowaniem rąk.
 Wiele czynników wpływających na odczuwanie bólu i wielkość efektu placebo 
zostało już określonych; jednakże istnieje szereg innych, potencjalnych czynników, które 
mogą modyfikować wielkość efektu placebo. Do wspomnianych potencjalnych czynników 
można zaliczyć płeć obserwowanej osoby (modela), rodzaj stosowanego placebo, poziom 
empatii, eksperymentalnie wywołany lęk i strach (oba rozumiane jako stan). Ponadto, 
badania nad związkiem placebo i emocji często dają sprzeczne wyniki. Dodatkowo, częste 
nieprawidłowości w nazewnictwie badanych emocji uniemożliwiają jednoznaczną ocenę ich 
wpływu na efekt placebo. Wszystko to utrudnia wyciągnięcie rozstrzygających wniosków 
dotyczących czynników wpływających na efekt placebo. Nawiązując do analgezji wywołanej 
krzyżowaniem rąk, pytaniem pozostawionym bez odpowiedzi jest to, czy manipulacja ramami 
odniesienia (krzyżujące się dłonie wywołują konflikt między wewnętrzną i zewnętrzną 
ramą odniesienia) jest wystarczająca do zmniejszenia bólu w kontekście manipulacji uwagą 
(zmiana koncentracji uwagi z próby na próbę). Wszystkie przytoczone pojęcia i pytania 
zostały krótko omówione we wprowadzeniu do niniejszej rozprawy doktorskiej.
 Rozdział 2. dotyczy wpływu płci modela i badanych osób na wielkość hiperalgezji 
nocebo wywołanej w procesie społecznego uczenia się. Wyniki badań wskazują, że płeć 
modela, bez względu na płeć badanych osób, ma istotny wpływ na wielkość powstałego 
efektu nocebo. W szczególności hiperalgezja nocebo była silniejsza w przypadku, gdy badane 
osoby obserwowały modela płci męskiej. Co więcej, wykazano, że empatia jest predyktorem 
wielkości hiperalgezji nocebo wywołanej poprzez społeczne uczenie się.
 W Rozdziale 3. przedstawiono wyniki badań nad wpływem cechy strachu, cechy 
lęku oraz rodzaju placebo (tj. koloru bodźca, np. czerwony i zielony; kształtu prezentowanych 
bodźców np. kwadrat i koło) na powstanie i wielkość efektu placebo wywołanego w 
procesie społecznego uczenia się. Wykazano, że efekt placebo może być wywołany poprzez 
społeczne uczenie się, niezależnie od koloru i rodzaju bodźców użytych w roli placebo. 
Wyniki przedstawione w tym rozdziale wskazują również, że czynniki takie jak strach, lęk 
(oba rozumiane jako cecha) i poziom empatii nie wpływają na wielkość efektu placebo 
wywołanego przez społeczne uczenie się.
 W Rozdziale 4. przedstawiono badania, w których sprawdzano, czy ukryte i jawne 
warunkowanie (tj. brak vs. dostarczenie informacji o związku między bodźcem warunkowym 
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i bezwarunkowym) może wywołać analgezję placebo oraz hiperalgezję nocebo. Po 
drugie, zbadano, w jakim stopniu oczekiwania oraz strach rozumiany jako stan i cecha są 
związane zarówno z efektem nocebo, jak i efektem placebo wywoływanymi przez ukryte 
warunkowanie. Wykazano, że ekspozycja na zróżnicowane natężenie bólu była wystarczająca, 
aby wywołać zarówno analgezję placebo, jak i hiperalgezję nocebo. Stwierdzono, że ani 
poziom oczekiwań, ani poziom strachu (stan) nie przewidywały wielkości analgezji placebo i 
hiperalgezji nocebo (pierwsze badanie z Rozdziału 4.). Jednak dalsze badania (drugie badanie 
Rozdziału 4.) ujawniły, że strach (stan) był jedynym predyktorem analgezji placebo w grupie, 
w której zastosowano ukryte warunkowanie. Co więcej, wykazano, że ani oczekiwania, 
ani cecha strachu nie są predyktorami analgezji placebo wywołanej na drodze ukrytego 
warunkowania.
 W Rozdziale 5., przy użyciu zmodyfikowanego paradygmatu dowolnych ruchów 
dżojstikiem (ang. voluntary joystick movement paradigm – VJMP) został zbadany potencjalny 
zróżnicowany wpływ wywołanego eksperymentalnie strachu (stan) i lęku (stan) oraz wpływ 
oczekiwań na wielkość efektu placebo powstałego na drodze sugestii słownej. Oba stany 
emocjonalne zostały wywołane w odmiennych warunkach eksperymentalnych (tj. warunku 
przewidywalności i nieprzewidywalności bólu). Ponadto, zbadano rolę oczekiwań w 
wywoływaniu analgezji placebo za pomocą sugestii słownej. Wykazano, że wielkość analgezji 
placebo nie różniła się w zależności od strachu przed bólem związanym z ruchem (strach 
wywołany w warunku przewidywalności bólu) i lęku związanego z bólem (lęk wywołany 
w warunku nieprzewidywalności bólu). Zgodnie z naszą wiedzą, to pierwsze badanie, w 
którym wykazano, że poziom oczekiwań może być predyktorem wielkości efektu placebo 
wywołanego poprzez sugestię słowną (bez warunkowania lub jakichkolwiek dodatkowych 
interwencji).
 W rozdziale 6. zostały przedstawione wyniki pomiarów behawioralnych i 
neurofizjologicznych dotyczących manipulacji uwagą w paradygmacie skrzyżowanych rąk. 
Wyniki badania wykazały, że w kontekście manipulacji uwagą, krzyżowanie rąk nie wywołuje 
znieczulenia. Zarówno w przypadku pomiarów behawioralnych, jak i psychofizjologicznych 
zaobserwowany został jednak efekt związany z wpływem uwagi (efekt uwagi/wskazówki) na 
ból. Ból był subiektywnie oceniany jako słabszy, gdy był wywołany przez bodźce pojawiające 
się poza miejscem skupienia uwagi (niespójne wskazówki), w porównaniu z sytuacją, gdy 
bodźce bólowe pojawiały się w miejscu, na którym uwaga badanych była skupiana (spójne 
wskazówki). Szczytowe amplitudy P3 wywołane przez bodźce bólowe były wyższe, a latencja 
komponentu P3 była dłuższa dla niespójnych wskazówek, w porównaniu do wskazówek 
spójnych. Co więcej, wykazano, że efekt wskazówki był modulowany przez manipulowanie 
pozycją rąk, tj. zaobserwowano zmniejszone szczytowe amplitudy P3 wywołane bodźcami 
bólowymi w warunkach krzyżowania rąk w porównaniu do warunku, w którym ręce były 
ułożone w naturalnej pozycji (ręce nieskrzyżowane). W przypadku pomiarów behawioralnych 
nie zaobserwowano takiego efektu. Wyniki uzyskane dla bezbolesnych stymulacji wykazały 
inny wzór wyników: efekt wskazówki został zniesiony, gdy ręce badanych były krzyżowane, 
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zaobserwowano również większe amplitudy i przedłużone latencje P3 w przypadku bodźców 
poprzedzonych niespójnymi wskazówkami, w porównaniu z bodźcami poprzedzonymi 
spójnymi wskazówkami; jednakże efekt wskazówki miał porównywalną wielkość w 
warunkach skrzyżowanych i nieskrzyżowanych rąk.
 Wreszcie, chociaż część prezentowanych wyników dotyczących efektu placebo 
jest zgodna z uczeniowym modelem działania placebo, zaproponowanym przez Collocę i 
Millera, w ogólnej dyskusji niniejszej pracy doktorskiej zaproponowano rozszerzenie modelu 
o niektóre prezentowane wyniki. Mówiąc dokładniej, zaproponowano dodanie do modelu 
skojarzeń przedpoznawczych, które mogą być aktywowane podczas powstawania efektu 
placebo w procesie ukrytego warunkowania. Jeśli chodzi o wpływ emocji na powstanie 
efektu placebo, zasugerowano również wprowadzenie do modelu lęku rozumianego jako 
stan. Ponadto, w przypadku efektu placebo wywołanego poprzez społeczne uczenie się 
zaproponowano, włączenie do modelu czynników takich jak: płeć modela i poziom empatii.
Dyskusja rozprawy doktorskiej kończy się akapitem dotyczącym implikacji klinicznych i 
perspektyw dalszych badań. Przedstawione wyniki niewątpliwie przyczyniają się do ogólnego 
zrozumienia społecznej, emocjonalnej i poznawczej modulacji bólu.
 Dyskusja rozprawy doktorskiej kończy się akapitem dotyczącym implikacji 
klinicznych i perspektyw dalszych badań. Przedstawione wyniki niewątpliwie przyczyniają 
się do ogólnego zrozumienia społecznej, emocjonalnej i poznawczej modulacji bólu.
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